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CHAPTER 1 
INTRODUCTION 
 
The overall aim of this work is to further the understanding of the enzymes involved with 
fatty acid and polyketide synthesis. Although scientific questions remain to be resolved about 
them, they are significant as well due to the human use of their products. Fatty acids are 
major components of detergents, cosmetics, foods, and fuels. Polyketides are complex 
chemicals with medicinal applications, such as antibiotics and cancer-combating drugs. 
Additionally, the fatty acid and polyketide synthetic pathways have been proposed as 
alternative sources for the chemical industry’s platform compounds. It is of great interest to 
be able to design these enzymes to produce desired fatty acids or polyketides. 
The initial goal of this work was to classify and organize fatty acid and polyketide 
synthesis enzymes based on sequence and structure, providing a framework to access and 
understand the existing information and knowledge about them. Many sequences with 
extensive experimental information exist, as well as some with resolved tertiary structures. 
However, a significantly greater number of similar sequences present in nature have been 
identified but have no confirmed activity or biochemical information. This framework assists 
and promotes ways to rationally discover the diversity of the enzymes’ natural specificity and 
activity. Most of the work included in this report is directed to such an aim. 
Being able to engineer enzymes to produce compounds not found in nature or existing 
ones in greater quantities is an ultimate goal of studying enzymes. Additional efforts of this 
work are directed towards understanding the mechanisms of enzyme catalysis in atomic-level 
resolution. This provides fundamental knowledge that may contribute towards enzyme and 
product design. 
Fatty acid and polyketide synthesis enzymes include acyl-coenzyme A (CoA) synthases, 
acyl-CoA carboxylases, acyl transferases, ketoacyl synthases, ketoacyl reductases, 
hydroxyacyl dehydratases, enoyl reductases, and thioesterases. The substrates, most 
commonly acyl chains, are covalently bound to either CoA or acyl carrier proteins (ACPs) 
during the course of reactions. This work reports the efforts and findings resulting from 
studying these enzymes, focusing mainly on thioesterases. 
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The next chapter presents an overview of the computational methods used throughout. 
Bioinformatics techniques were used to study sequences and structures, and molecular 
modeling and simulation methods were employed to study structures and mechanisms. 
Chapter 3 describes the ThYme database, where almost all sequences and structures of 
the enzyme groups in fatty acid and polyketide synthesis are gathered and classified into 
families based on amino acid sequence similarity. This chapter has a detailed description of 
the enzyme groups present, as well as an overview of the database’s organization and use. 
Chapter 4 describes work with thioesterases. A computational protocol to identify and 
populate enzyme families was developed with thioesterases and is described in this chapter. 
An overall and detailed review of thioesterases appears, including classification into families 
and clans, structural analysis, known catalytic residues and mechanisms, and the pathways 
and products involved. 
Chapter 5 focuses on a single acyl-ACP thioesterase family, presenting my contribution 
to a collaborative effort to characterize and explore the substrate specificities of this family’s 
acyl-ACP thioesterases that determine free fatty acid chain length. Statistical and 
phylogenetic studies identified representative sequences for biochemical characterization, so 
that the entire substrate specificity and enzyme activity space was explored. 
In Chapter 6, mixed quantum mechanics/molecular mechanics simulations, done to find 
the mechanism of a thioesterase in atomic resolution, along with its reaction energy barrier 
and transition-state geometry, are presented. 
Chapter 7 is a review of ketoacyl reductases, hydroxyacyl dehydratases, and enoyl 
reductases, including their classification into families, structural analysis, known catalytic 
residues and mechanisms, and pathways and products. 
ACP findings are reported in Chapter 8. Besides presenting ACP families and reviewing 
the pathways and products involved, normal vibrational mode analysis on ACP structures 
was conducted, and unknown ACP structures were predicted. 
The Appendix presents work started during a summer research program at ISU and 
completed before graduate school. The proton donor residue in a glycoside hydrolase was 
identified with theory and automated docking calculations. 
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CHAPTER 2 
OVERVIEW OF METHODS 
 
This chapter presents an overview of the computational methods used, falling into three 
categories: sequences, structures, and molecular simulation. An overview of the fatty acid 
and polyketide synthesis enzymes is included in Chapter 3. More detailed reviews of 
thioesterases appear in Chapters 4 and 5, thioesterase mechanisms in Chapter 6, ketoacyl 
reductases, hydroxyacyl dehydratases, and enoyl reductases in Chapter 7, and acyl carrier 
proteins in Chapter 8. 
 
Sequences 
Alignments and phylogeny 
Proteins and enzymes are composed of amino acid residues arranged in a sequence. 
When two sequences are highly similar, their functions may be same and/or come from a 
common ancestor. Before comparing two or more sequences, they need to be aligned. When 
two sequences are aligned, each paired site may have a match with same residues at the same 
site, a mismatch when different residues occupy the same site, or a gap when one sequence 
does not have a residue at such position. A scoring matrix rewards points for matches and 
penalties for mismatches and gaps. There are different scoring matrices; the most reliable 
ones for proteins are the PAM and BLOSUM matrices that are based on observed mutations 
in nature.
1
 Alignment algorithms try to find the optimal pairing between sequences that 
maximizes the alignment score. 
A pairwise alignment is when two sequences are aligned, while aligning more than two 
sequences gives a multiple sequence alignment (MSA). MSAs are more challenging, as the 
best alignment between a single pair may not be the ideal for the whole set. Several strategies 
have been developed to solve MSAs. Most have either a progressive approach where 
additional sequences are added to an initial pair, or iterative approaches where MSAs are 
made multiple times by changing the order of sequences, or clustering approaches. Sequence 
alignments can be done with nucleotide or amino acid sequences. In this work, all alignments 
and sequence comparisons are of amino acid sequences, and they appear in Chapters 3, 4, 5, 
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7, and 8. 
A phylogenetic tree is a visual representation of an MSA. They can be used to make 
evolutionary inferences. However, in this work phylogenetic trees are made to visually 
identify groups of similar sequences within a larger set, and to confirm that groups of 
sequences are more similar to each other than to those outside the group. Phylogenetic work 
appears mainly in Chapter 5, but also in Chapter 8. 
 
Searching 
There are many identified sequences in nature, most if not all deposited at the National 
Center for Biotechnology Information. Most sequences have not been expressed and 
characterized experimentally, and their putative functions are inferred from sequence 
similarities. Given the large number of existing sequences, making pairwise alignments 
between a query sequence and all existing ones would be very time-consuming. BLAST
2
 
(Basic Local Alignment Search Tool) is a heuristic algorithm that allows finding all 
sequences in a library or database similar to a query sequence. It does not produce optimal 
alignments, but it is computationally very efficient and is widely used. BLAST in this work 
was used to find and populate enzyme families, appearing in Chapters 3, 4, 7, and 8. 
 
Structures 
Superimposition and comparison 
Proteins have three-dimensional structures that include α-helices, β-strands, and loops, 
known as secondary structure elements. Primary sequence determines secondary structure. 
The way that secondary structure elements are arranged is known as a fold. Protein folds are 
very conserved, and not much primary sequence similarity is required for different proteins 
to maintain the same structural fold. 
To compare and quantify the structural difference between two proteins with the same 
fold, they are superimposed, and the distance between corresponding atoms is calculated, 
typically reported as root mean square deviations (RMSDs). A correct superimposition, or 
structural alignment, is required to properly identify corresponding residues and atoms 
between two structures. Existing methods to superimpose protein structures seek to minimize 
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the RMSD between two structures. Most are based solely on geometric criteria, others seek 
to align secondary structure elements, or require identification of key residues.
1
 In this work, 
protein structure superimpositions, comparisons, or RMSD calculations appear in Chapters 
3–8. 
 
Normal mode analysis 
The dynamic behavior of equilibrium protein structures can be described by their 
vibrational normal modes. The normal modes of a structure include three translational, three 
rotational, and various vibrational ones. The slowest vibrational modes of a protein represent 
their dynamic equilibrium behavior. Although molecular dynamics or first-principles 
calculations (see the molecular simulation section) methods can be used to find the normal 
modes of any molecule, more efficient methods exist for proteins such as elastic network 
models.
3
 In such models, nodes connected by springs with force constants represent a 
protein. A node is placed for every α-carbon atom, and the system is allowed to oscillate. 
Parameters such as force constant and spring equilibrium distances can be changed so that 
average residue fluctuations agree with residue fluctuations from experimentally resolved 
three-dimensional structures. Normal mode analyses done with elastic network models 
appear in Chapter 8. 
 
Predictions 
There are two main approaches for protein three-dimensional structure prediction: 
comparative modeling and physics-based modeling. Predicting the structure of a protein 
solely from its sequence with a physics-based model, or a de novo approach, is challenging 
and time-consuming. Comparative modeling methods were used in this work, in Chapter 8, 
to predict unknown protein structures, followed by molecular dynamics (a physics-based 
approach, discussed in the molecular simulation section) to refine predicted structures. 
Comparative modeling uses experimentally resolved three-dimensional structures and 
sequence similarity to predict the three-dimensional structure of a protein. Comparative 
modeling methods assume that structure is more conserved than is its sequence. Two types 
were used in this work, homology modeling and threading. 
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In homology modeling,
4
 when the sequence of a protein with known structure (template 
structure) is similar to the sequence of a protein with unknown structure (target structure), the 
template structure is used to predict the target structure. Sequence similarity needs to be 
above ~25% to have a reliable prediction using homology modeling. Loops and sections with 
no defined secondary structure, as well as the orientation of amino acid side chains, are 
difficult to predict. Energy minimizations with physics-based methods can be used to refine 
the predicted structures. Threading,
4
 or fold recognition, like homology modeling uses a 
template based on known structures to predict the structure of a target protein. Threading 
differs from homology modeling in that while homology modeling strictly uses a single 
structure as a template, threading uses many structures within a conserved fold to build the 
template. Threading is used over homology modeling when no template structures have 
sequence similarity above ~25% to the target structure. 
 
Molecular simulation 
Classical molecular dynamics 
Molecular dynamics (MD) is a simulation method used to study the time-resolved 
behavior of a system. A model, or force field, describes the energy of a system separated into 
units. From the energy, the forces acting on each unit can be obtained, and using Newton’s 
equations of motion, the velocities of each unit can be calculated. For each time step, the 
simulation allows each unit of the system to move according to its mass and velocity, the 
energy is recalculated in the new conformation, and the new velocities are recalculated. The 
behavior of the system will tend toward equilibrium and energy minima. 
In the case of proteins, usually the units of the system are atoms, and the system is a 
protein solvated in water at physiological conditions. However, the system can vary 
according to what is desired to be studied. Several force fields have been developed specially 
for proteins, and they are known to accurately model their behavior. In this work, the Amber 
force field
5
 was used to account for covalent bond stretching, bending, and turning, as well as 
for van der Waals and electrostatic non-bonded interactions. If the system is solvated in 
water, their atoms also require a force field. MD allows studying the behavior of proteins and 
enzymes, solvated in water, time-resolved, and in atomic resolution. Atom-resolved MD 
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methods with elaborate force fields such as Amber are limited to systems in the order to 10
6
 
atoms and in nanosecond time scales to conform with available computational resources. MD 
is used in Chapters 6 and 8. 
 
First-principles molecular dynamics 
In ab initio, or first-principles, MD the electronic configuration of the system is taken 
into account to calculate the energy of the system, while the nuclei are treated with classical 
MD. Traditional ab initio MD is known as Born-Oppenheimer molecular dynamics 
(BOMD). In BOMD, the electron wave functions are optimized in each time step to calculate 
the energy of the system at each nuclear configuration. Car-Parrinello molecular dynamics
6
 
(CPMD) differs from BOMD in that the electron wave functions are optimized once at the 
start of the simulation, and fictitious electron variables allow the wave functions to evolve 
with the nuclei along the simulation. However, shorter time steps are required due to 
electronic degrees of freedom: time steps in BOMD are typically around ~1 fs, while those of 
CPMD are ~0.10 fs. However, CPMD is computationally cheaper. CPMD uses density 
functional theory (DFT) for electronic calculations. CPMD simulations are limited to systems 
with less than 500 atoms and picosecond time scales with available computational resources. 
All first-principles MD calculations in this work appear in Chapter 6 and used CPMD. 
Mixed quantum mechanics/molecular mechanics (QM/MM) methods can be used to 
study enzyme reactions. Classical MD methods model the behavior of solvated proteins well; 
however, since classical force fields do not account for electrons explicitly, ab initio methods 
are needed to simulate chemical reactions. In QM/MM methods, atoms in the QM region are 
treated with ab initio MD, and atoms in the MM region with classical MD. In this study, 
QM/MM simulations were done where the enzyme active site was the QM region and the 
rest of the enzyme and water were in the MM region. The developed method,
7
 where CPMD 
determines the behavior of the QM region was used in Chapter 6. 
 
Metadynamics 
While the QM/MM approach allows first-principles calculations on a relatively large 
system, such as a solvated enzyme, to simulate enzymatic reaction a time-scale barrier needs 
 8 
to be overcome. A QM/MM simulation would need to run for at least 1/kcat to spontaneously 
observe a reaction. This is in the millisecond time scale and is very much outside the range of 
ab initio MD methods. Therefore, rare-event, or non-equilibrium, simulation methods are 
needed. 
Metadynamics
8
 is used to simulate rare events by reducing the dimensions of a system, 
and has been used to solve problems in chemistry, materials science, and biophysics.
9
 
Collective variables (CVs) are chosen, and repulsive energy terms (Gaussian-like potentials) 
are added in CV space of the system explored by MD. This allows the system to escape free 
energy minima and to explore non-equilibrium conformations. CVs need to clearly describe 
the event desired to be simulated, and to differentiate clearly between initial and final states. 
Further, the free energy surface (FES) of the simulated event as a function of CV space can 
be reconstructed by summing the Gaussian-like repulsive terms added during the simulation. 
The metadynamics technique was used in Chapter 6 to induce the enzymatic reaction and to 
reconstruct the FES of the process. 
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CHAPTER 3 
THYME: A DATABASE FOR THIOESTER-ACTIVE ENZYMES 
David C. Cantu
1
, Yingfei Chen
1
, Matthew L. Lemons
2
 and Peter J. Reilly
1
 
Department of Chemical and Biological Engineering
1
, and Information Technology 
Services
2
, Iowa State University 
 
Modified from a paper published in Nucleic Acids Research, 39, D342-D346, with the same 
title and authors. 
 
Abstract 
The ThYme (Thioester-active enzYme; http://www.enzyme.cbirc.iastate.edu) database 
has been constructed to bring together amino acid sequences and three-dimensional (tertiary) 
structures of all the enzymes constituting the fatty acid synthesis and polyketide synthesis 
cycles. These enzymes are active on thioester-containing substrates, specifically those that 
are parts of the acyl-CoA synthase, acyl-CoA carboxylase, acyl transferase, ketoacyl 
synthase, ketoacyl reductase, hydroxyacyl dehydratase, enoyl reductase, and thioesterase 
enzyme groups. These groups have been classified into families, members of which are 
similar in sequences, tertiary structures, and catalytic mechanisms, implying common protein 
ancestry. ThYme is updated as sequences and tertiary structures become available. 
 
Introduction 
The ThYme (Thioester-active enzYme, http://www.enzyme.cbirc.iastate.edu) database 
presents enzymes acting on thioester-containing substrates, especially those involved in fatty 
acid and polyketide synthesis. 
There are different ways to classify enzymes and proteins. The Enzyme Commission 
(EC) scheme classifies enzymes by the reactants or substrates that they primarily attack and 
by the reactions that they catalyze.
1
 Another way is by three-dimensional (tertiary) structure, 
as found in the SCOP database.
2
 A third method is to classify enzymes by primary (amino 
acid sequence) structure similarity. We have done so for thioesterases
3
 (TEs) and now for the 
other enzyme groups in the fatty acid synthesis cycle. Previously, this has been done with 
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glycoside hydrolases and other carbohydrate enzymes
4
 and with peptidases.
5
 Also, Pfam
6
 has 
done the same in a more universal way. 
The fatty acid synthesis cycle (Figure 3.1) is the main pathway used by organisms to 
form lipids. The constituent members of this cycle are activated by the presence of thioester 
groups binding either coenzyme A (CoA) or acyl carrier protein (ACP). First, catalyzed by 
acyl-CoA synthases (ACSs), an acyl group is joined with CoA to make acyl-CoA, also called 
the priming substrate. Second, the priming substrate is carboxylated by acyl-CoA 
carboxylases (ACCs) to make the elongating substrate. The elongating substrate’s carrier 
molecule may be changed from CoA to ACP by acyl transferases (ATs). Then ketoacyl 
synthases (KSs) join the priming and elongating substrates, releasing a carbon dioxide and 
making ketoacyl-ACPs. The ketoacyl-ACP molecule then passes through a series of 
reduction, dehydration, and reduction steps catalyzed by ketoacyl reductases (KRs), 
hydroxyacyl dehydratases (HDs), and enoyl reductases (ERs), respectively, to create an acyl-
ACP molecule two carbon atoms longer than the priming substrate. This new longer acyl-
ACP molecule is then joined by a KS to another elongating substrate. This cycle elongates 
the acyl chain by two carbon atoms each turn until TEs hydrolyzes the CoA or ACP from the 
acyl group, effectively terminating fatty acid biosynthesis. Also, methylketone synthases 
(MKSs) can release molecules from the cycle before the reduction-dehydration-reduction 
steps. These enzymes first hydrolyze the thioester bond and then decarboxylate the carboxyl 
group of a 3-oxoacyl-ACP molecule, leaving a terminal methyloxo group.
7
 They have a TE 
domain, which appears in ThYme with other TEs; they do not form a large enzyme group. 
More specifically, the enzyme groups involved in the fatty acid synthesis cycle and that 
appear in ThYme are the following: 
(1) ACSs (part of EC 6.2.1, acid-thiol ligases). These enzymes add coenzyme A (CoA) or 
occasionally an acyl-carrier protein (ACP) to acetate or longer acceptors, powered by 
ATP or occasionally by GTP. This yields the activated compound and usually AMP, but 
in some cases ADP or GDP. ACSs are described by EC 6.2.1.1 to EC 6.2.1.36, with two 
entries having been deleted. 
(2) ACCs (part of EC 6.4.1, ligases that form carbon-carbon bonds). In this step, the 
activated acceptor is elongated by the addition of a keto group derived from CO2, 
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yielding malonyl-CoA, malonyl-ACP, or a longer activated molecule. Seven ACCs with 
EC designations from 6.4.1 to 6.4.7 are listed. 
(3) ATs (part of EC 2.3.1, acyl transferases transferring groups other than amino-acyl 
groups). These enzymes catalyze the transfer of an acyl chain from a CoA to an ACP or 
vice versa. 
(4) KSs (part of EC 2.3.1, acyl transferases transferring groups other than amino-acyl 
groups). Here the activated malonyl or longer moiety is joined to an activated cycle 
constituent, releasing CO2 and HSX, where SX is CoA or ACP. The growing chain is 
elongated by generally two, but occasionally more, carbon atoms. This EC category 
contains 190 entries, of which three has been deleted. Twenty EC entries out of 187 are 
KSs. 
(5) KRs (part of EC 1.1.1, oxidoreductases acting on the CH–OH group of donors with 
NAD
+
 or NADP
+
 as acceptor, describing the reverse reaction). In those fatty acid 
synthesis cycle reactions, 3-oxo groups are reduced to 3-hydroxy groups by NADH or 
NADPH. EC 1.1.1.– contains at present 300 entries, 15 having been deleted. 
(6) HDs (part of EC 4.2.1, carbon-oxygen hydro-lyases). Here the 3-hydroxy group is 
removed as water, yielding a double bond linking the 2- and 3-carbon atoms. There are 
120 listings in this EC group, 16 having been deleted. 
(7) ERs (part of EC 1.3.1, oxidoreductases acting on the CH–CH group of donors with 
NAD
+
 or NADP
+
 as acceptor). The 2,3-ene bond is reduced to a single bond. This EC 
group has 84 listings, of which four have been deleted. 
(8) TEs (part of EC 3.1.2, thioester hydrolases). The thioester group is cleaved with water, 
leaving a fatty acid and HSX. The 27 EC entries have lost three members by deletion. 
Polyketide biosynthesis is similar to fatty acid biosynthesis, yet it is more flexible and 
complex. Here the condensation-reduction-dehydration-reduction cycle is not completed at 
every turn; the KS-catalyzed reaction can occur between an intermediate in the cycle and an 
elongating substrate. This allows carbonyl, hydroxyl, and/or ethylene groups into the acyl 
chain. The TE will either hydrolyze acyl-CoA or acyl-ACP with a water molecule, or cyclize 
the chain using an alcohol on the chain itself for hydrolysis. Also, different compounds can 
be used for priming and elongating substrates. 
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These processes can be carried out by individual independent enzymes, or by large multi-
modular fatty acid synthases (FASs) or polyketide synthases (PKSs) that contain the number 
of domains necessary, and in a specific order, to produce the desired molecule. 
Among other uses, fatty acids have been recently proposed as biofuel feedstocks,
8
 while 
short-chain fatty acids could become feedstocks for biorenewable platform chemicals.
9
 
Polyketides are a diverse family of chemicals, with some having medicinal applications such 
as erythromycin and tetracycline as antibiotics and doxorubicin and mithramycin in 
chemotherapy. Tailoring these molecules is of great interest; for that effort ThYme can be a 
useful tool in finding naturally occurring enzymes and in facilitating enzyme design. 
 
Identifying and populating families 
Family members must have strong sequence similarity and near-identical tertiary 
structures, and they must share general mechanisms as well as catalytic residues located in 
the same position. Methods for identifying and populating families were developed with TEs 
and later applied to other sequence groups. They were detailed in our previous work.
3
  
(1) Experimentally confirmed enzyme sequences were used as queries. They were gathered 
from UniProt
10
, using only reviewed entries noted as having “Evidence at protein level”. 
(2) A series of successive Basic Local Alignment Search Tool (BLAST)
11 
searches and 
comparison among results reduced query sequences to a few representative ones. 
(3) The catalytic domains of representative query sequences were subjected to BLAST to 
populate the families. These domains were selected by referring to Pfam-A,
6
 or by 
constructing a hidden Markov model profile
12
 from a multiple sequence alignment 
(MSA) based on the initial BLAST result. 
(4) Experimentally confirmed enzymes were surveyed to search for missing potential 
enzyme families. 
(5) The uniqueness of the families was confirmed by MSAs, by tertiary structure 
superposition and comparison, and by catalytic residue positions. 
 
Content 
At present, ACSs are divided into five families, ATs into one, KSs into five, KRs into 
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four, HDs into six, ERs into six, and TEs into 23. ACCs are multidomain proteins first shown 
organized into domains followed by each domain divided into families: one family of the 
biotin carboxylase (BC) domain, one family of the biotin carboxyl carrier protein (BCCP), 
and two families of the carboxyl transferase (CT) domain appear. These enzyme groups’ 
annotation and sequences in each family appear in ThYme organized in the way mentioned 
below. 
 
Database organization and features 
The home page gives links to every enzyme group, as well as general information for 
viewers and citing and contact information. In each enzyme group’s main page, all families 
are listed in a table with “Names of enzymes and genes present”, which presents a non-
exhaustive overview of the sequences found. This is meant to guide new users to the family 
that contains their enzymes of interest. 
At the top of each enzyme family’s page (Figure 3.2), a table gives general information 
about the family, describing protein folds (if known from crystal structures), the names of 
enzymes and genes present (the list is not exhaustive), EC numbers (the most common ones), 
the catalytic residues (if they are known from the literature), and other notes. Also shown is 
the total number of Protein Data Bank
13
 (PDB) structures, and enzymes with “Evidence at 
protein level” and “Evidence at transcript level (See “Experimentally characterized proteins” 
section below). This annotation might not be complete for all families. 
Within an enzyme family’s page, all sequences appear by rows ordered into archaea, bac-
teria, and eukaryota, and alphabetically by producing species. All sequences in a row are 
identical and come from only one species. Identical sequences from different species are 
separated into different rows; however, identical sequences from different strains of the same 
species are not separated. If more than 500 rows exist, they are shown in multiple pages for a 
single family. The information is organized into the following columns: a) names or 
designations given to the proteins; b) EC numbers assigned to them, with a link to the 
ExPASy
14
 proteomics server; c) genus and species names along with strain designations of 
the organisms that produced them, with a link to the National Center for Biotechnology 
Information (NCBI) taxonomy browser;
15
 d) their GenBank identification, with a link to the 
 14 
NCBI’s protein database;16 their RefSeq identification, with a link also to the NCBI’s protein 
database;
16
 their UniProt identification, with a link to the UniProt database;
10
 and their PDB 
identification, with a link to the PDB, if their known tertiary structure is available.
13
 All 
sequence names and EC numbers are taken from either UniProt or NCBI’s protein database; 
we do not assign sequence names or EC numbers. 
Three features make navigating and retrieving information in ThYme easier. A search 
tool allows keywords, EC numbers, and GenBank, RefSeq, UniProt, or PDB accession codes 
to be searched. Furthermore, each family can be downloaded into a comma-separated value 
(csv) file, which can be viewed in a spreadsheet. Also, on each family’s page, only rows that 
include a PDB link or a UniProt link marked with “Evidence at transcript level” or “Evidence 
at protein level” can be viewed. 
 
Updates 
The content of existing families is updated continuously as NCBI’s protein database, 
UniProt, and PDB databases are updated; if a new sequence belongs in an existing family, it 
will appear there. To delete or merge existing families, as well as to define new families, the 
authors’ inspection and judgment is necessary; this cannot be automated. 
 
Experimentally characterized sequences 
Most sequences have no underlying specific experimental work, as they come from large 
genomic sequencing projects. The UniProt database, under the field “Protein existence” 
marks their entries with either “Evidence at protein level” or “Evidence at transcript level” if 
some experimental work has been done on the sequence. In ThYMe, we mark UniProt 
accessions with “Evidence at Protein Level” with a [P], and those with “Evidence at 
Transcript Level” with a [T]. The UniProt link or its equivalent in GenBank shows the 
experimental work’s literature. This should help users identify previous work on enzymes of 
interest. 
 
Sequences with multiple domains 
Some enzymes that appear in ThYme are multidomain FASs, PKSs, or non-ribosomal 
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peptide synthases. Each domain in these enzymes has its specific function, but all appear in a 
single sequence under the same GenBank, RefSeq, UniProt, or PDB accession. When the 
accession code of a multidomain enzyme appears in a family, only the domain of the enzyme 
group in which the family appears belongs in the family. (Example: UniProt P12785 is a rat 
fatty acid synthase. Its AT domain appears in AT2, its KS domain appears in KS3, its HD 
domain appears in HD4, and its TE domain appears in TE16.) A single multidomain 
sequence can have different PDB structures for each domain. Only the structure related to 
each family’s domain is shown. (Example: UniProt P49327 has several PDB structures. 
Among them, TE domain 1XKT appears in a TE family, AT domain 2JFD appears in an AT 
family, and so forth.) 
 
Similarity to other enzyme databases 
ThYme is most similar to CAZy
17
 in appearance and structure, in that both are interactive 
lists of enzyme primary and tertiary structures. However they are different in content, as 
ThYme shows enzymes active on substrates with thioester groups and CAZy shows enzymes 
active on carbohydrates. ThYme encompasses eight enzyme groups; CAZy on the other hand 
brings together four enzyme groups as well as different families of carbohydrate-binding 
modules. 
ThYme is somewhat similar to MEROPS,
18
 which classifies peptidases and therefore has 
many more different enzyme groups and total number of listings. MEROPS and ThYme are 
also different in appearance and in the method by which listings are accessed. 
The ESTHER database
19
 and the Lipase Engineering Database
20
 report sequences of the 
a/b hydrolase superfamily and lipases, respectively. In both databases, some of their families 
correspond with some TE families in ThYme, although the exact content and format differ. 
Finally, Pfam
6
 has identified many protein families. Most ThYme families have an 
equivalent in Pfam. Our differences in methodology lead to different family content: Pfam 
families are more inclusive, covering a wide range of sequences, while ThYme families are 
smaller, with all sequences within a family having strong sequence similarity. Also, the 
purpose and format of the two databases are different; we focus on thioester-active enzymes 
and provide sequences and structures in families, while Pfam covers all proteins and, given a 
 16 
query, it identifies the family or domain. 
 
Conclusion 
The ThYme database should provide a useful source of information on these enzymes 
that can help predict active sites, catalytic residues, and mechanisms of individual sequences, 
as well as providing a standardized nomenclature. 
 
March 2013 update 
Since the publication of this manuscript, the following changes have been done to the 
database: ACP families were added, two new TE families were found and added, one ER 
family was merged with a KR family, and two HD families were added. 
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Figures 
 
Figure 3.1: The fatty acid synthesis cycle and the enzyme groups that comprise it 
 
 
Figure 3.2: A family homepage in ThYme 
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Abstract 
Thioesterases (TEs) are classified into EC 3.1.2.1 through EC 3.1.2.27 based on their 
activities on different substrates, with many remaining unclassified (EC 3.1.2.–). Analysis of 
primary and tertiary structures of known TEs casts a new light on this enzyme group. We 
used strong primary sequence conservation based on experimentally proved proteins as the 
main criterion, followed by verification with tertiary structure superpositions, mechanisms, 
and catalytic residue positions, to accurately define TE families. At present TEs fall into 23 
families almost completely unrelated to each other by primary structure. It is assumed that all 
members of the same family have essentially the same tertiary structure; however, TEs in 
different families can have markedly different folds and mechanisms. Conversely, the latter 
sometimes have very similar tertiary structures and catalytic mechanisms despite being only 
slightly or not at all related by primary structure, indicating that they have common distant 
ancestors and can be grouped into clans. At present four clans encompass 12 TE families. 
The new constantly updated ThYme (Thioester-active enzYmes) database contains TE 
primary and tertiary structures, classified into families and clans that are different from those 
currently found in other databases. 
 
Introduction 
The thioesterases (TEs), or thioester hydrolases, comprise a large enzyme group whose 
members hydrolyze the thioester bond between a carbonyl group and a sulfur atom. They are 
classified by the Nomenclature Committee of the International Union of Biochemistry and 
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Molecular Biology (NC-IUBMB) into EC (Enzyme Commission) 3.1.2.1 to EC 3.1.2.27, as 
well as EC 3.1.2.– for unclassified TEs.1 Substrates of 15 of these 27 groupings contain 
coenzyme A (CoA), two contain acyl carrier proteins (ACPs), four have glutathione or its 
derivatives, one has ubiquitin, and two contain other moieties. In addition, three groupings 
have been deleted. 
The EC classification system is based on enzyme function and substrate identity, and it 
was first formulated when very few amino acid sequences (primary structures) and three-
dimensional (tertiary) structures of enzymes were available. Another way to classify enzymes 
is by primary structure into families and by tertiary structure into clans or superfamilies. 
Some databases are built this way: Pfam
2
 has a collection of protein families and domains, 
and SCOP
3
 classifies protein structures into classes, folds, families, and superfamilies. Other 
databases treat certain enzyme groups more specifically. For instance, MEROPS
4
 is a major 
database for peptidases, and CAZy
5
 covers carbohydrate-active enzymes. 
It is common to observe that members of more than one EC grouping are found in one 
enzyme family based on similar amino acid sequences, implying that they have a common 
ancestor, mechanism, and tertiary structure. Conversely, members of a single EC grouping 
may be located in more than one enzyme family, being totally or almost totally unrelated in 
primary structure and potentially in mechanism and tertiary structure. 
A further observation is that members of two different enzyme families may have very 
similar tertiary structures and mechanisms even though their primary structures are very 
different. This may imply that they are members of the same clan or superfamily, descended 
from a more distant common ancestor. 
In this work, TE primary and tertiary structures will be analyzed to conclude how TEs are 
divided (and united) into families and clans. Structures, mechanisms, and catalytic residues 
are compared between families and clans. We compare our findings with existing databases 
such as Pfam and SCOP. Results also appear in a new continuously-updated database, 
ThYme (Thioester-active enzYmes, http://www.enzyme.cbirc.iastate.edu) that includes 
families and clans of enzyme groups that are part of the fatty acid synthesis cycle, TEs 
among them. 
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Identification of thioesterase families 
Family members must have strong sequence similarity and near-identical tertiary 
structures, and they must share general mechanisms as well as catalytic residues located in 
the same position. 
In general, TE families were identified in the following way: 1) experimentally 
confirmed TE sequences were used as queries; 2) a series of successive Basic Local 
Alignment Search Tool (BLAST)
6 
 searches and comparison among results reduced query 
sequences to a few representative ones; 3) the catalytic domains of representative query 
sequences were subjected to BLAST to populate the families, 4) experimentally confirmed 
TEs were surveyed to search for missing potential TE families; 5) the uniqueness of the 
families was confirmed by multiple sequence alignments (MSAs), by tertiary structure 
superposition and comparison, and by catalytic residue positions. Methods are detailed 
below. 
 
BLAST searches 
TE families were identified by using BLAST on the catalytic domains of query TE 
sequences. Query sequences were taken from EC 3.1.2.1 to EC 3.1.2.27 and EC 3.1.2.– 
entries in the UniProt
7
 database. Only reviewed Swiss-Prot
8
 entries, which have a higher 
level of annotation, and those noted by “Evidence at Protein Level”, were used. Those 
described by “Inferred from Homology” or “Evidence at Transcript Level”, as well as 
fragments and putative or probable enzymes, were excluded from the query sequences. The 
sequences that met these criteria at that time made up the query sequence list. This list 
contained only 11 of the 27 TE EC numbers, as well as sequences having EC 3.1.2.– 
numbers, whereas 16 EC numbers did not meet these criteria, had no sequences, or had been 
deleted by the NC–IUBMB. Literature searches were also done to search for confirmed TEs 
whose information was not yet in UniProt or that were labeled under another EC number. 
The first entry from the query sequence list was compared to the National Center for Bio-
technology Information’s (NCBI) GenBank9 nr peptide sequence database using BLAST. 
The protein–protein BLAST algorithm was used, the cutoff E-value was set to 0.001, and 
Max Target Sequences was set to 10,000 to ensure that all results with E = 0.001 or less were 
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reported. All other parameters were default values. Later query sequences found in the 
BLAST results were deleted from the list. The remaining query sequences were subjected to 
BLAST in turn until all the listed sequences were either deleted or used. To automate this 
step, blast-2.2.19 was downloaded from NCBI’s webpage 
(http://www.ncbi.nlm.nih.gov/staff/tao/URLAPI/unix_setup.html) and installed on a Unix 
platform. The nr peptide sequence database was also downloaded from this URL and updated 
before using BLAST. A script was written to successively use BLAST, compare results, and 
delete retrieved query sequence list members automatically. This identified representative 
query sequences. 
After the first BLAST run, catalytic domains of representative query sequences were 
identified from Pfam-A (http://pfam.sanger.ac.uk/). Only these domains were subjected to 
BLAST to populate the families. If Pfam-A did not identify a domain with TE activity, 
MSAs using ClustalX 2.0
10
 or MUSCLE 3.6
11
 were performed on ~50 random sequences 
from the BLAST output file of the corresponding query sequence. Then profile hidden 
Markov models
12
 using hmmer-2.3.3 (http://hmmer.janelia.org) were used to identify a 
conserved domain in those sequences that was likely to be the catalytic domain.  
The completeness of the representative query sequences was ascertained by searching all 
original query sequences in the BLAST output files, and checking for catalytic domains not 
included in the representative query sequences. 
 
Multiple sequence alignments 
The above procedures yielded BLAST output files making up each family. MSAs were 
then constructed to confirm or disallow each BLAST output file as a single family, or to 
check whether two or more output files should be merged into one family. 
MSAs were constructed by randomly selecting ~50 sequences from one or more BLAST 
output files. If a sequence entry appeared in more than one BLAST output file, suggesting 
that these output files comprise one family, equal numbers of sequences were taken from 
each output file to obtain ~50 sequences in total. The sequences in FASTA format were 
obtained from Batch Entrez (http://www.ncbi.nlm.nih.gov/sites/batchentrez?db=Protein) and 
all sequences of protein fragments were deleted. ClustalX and MUSCLE default parameters 
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were used. Sufficient conservation of residues and residue chemical character confirms the 
presence of a single family. Lack of conservation suggests that more than one family exists, 
and if so, MSAs were performed on smaller sets of sequences. 
 
Comparison of tertiary structures 
All tertiary structures from the BLAST output files were obtained from the Research 
Collaboratory for Structural Bioinformatics Protein Data Bank (PDB) webpage 
(http://www.rcsb.org) and compared within one family and among families. PyMOL version 
1.1 (DeLano Scientific, Palo Alto, CA; http://www.pymol.org/) was used to select the 
monomer of each PDB file containing the TE catalytic domain. Those structures were then 
superimposed with MultiProt
13
 version 1.0. MultiProt scoring and biocore parameters were 
both set to 2, with all other parameters remaining at their default values. All the monomer 
structures within one family were superimposed in MultiProt, and a-carbon atoms of all 
superimposed monomer structures were extracted to calculate the root mean square 
deviations (RMSDs) using the methods described below. Also, the positions of the catalytic 
residues in all tertiary structures within a family were determined to verify that they 
coincided. 
 
RMSD calculations 
An RMSD between as many a-carbon atoms as possible in two structures was calculated 
using. When two structures are superimposed, the RMSD is between the distances of 
corresponding a-carbon atoms. The shortest molecule was chosen as a pivot. The RMSD was 
found by calculating the distances between each α-carbon atoms in the compared molecule to 
those of the pivot molecule. An n x m distance matrix was built, where n is the number of 
residues of the pivot molecule and m is the number of residues of the structure being 
compared. The lowest value in each row was considered for the RMSD calculation if it was 
lower than a cutoff value: the mean distance between two sequential α-carbon atoms within 
the pivot molecule. The number of residues in the molecule compared to the pivot that are 
used to calculate the RMSD was compared to the total number of residues in that molecule. 
Its ratio gives a percentage value (P) of residues used to calculate the RMSD. This P value is 
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a measure of the significance of the RMSD value. However, when more than two 
superimposed structures were being compared, more than one molecule was compared to the 
pivot and each RMSD was calculated. The RMSD calculation between a molecule and the 
pivot was done s – 1 times, where s is the number of superimposed structures. When s > 2, 
average RMSD (RMSDave) and P (Pave) values were calculated. In addition, minimal 
(RMSDmin and Pmin) and maximal (RMSDmax and Pmax) values, for single comparisons 
between the pivot molecule and any other molecule, can be obtained. 
 
Identification of thioesterase clans 
Two or more TE families are grouped into a clan if all the sequences within them show 
some (not strong) sequence similarity, if their structures are strongly similar (narrowing the 
search to families with the same fold), and if they share similar active sites and general 
mechanisms. To consider all aspects of clan classification criteria, several methods are used 
to combine sequence and structural analysis. In addition, catalytic mechanisms of members 
of each family were gathered from the literature, and positions of catalytic residues were 
determined to verify that they coincided. 
 
Sequence analysis 
PSI–BLAST6 is an iterative method that builds an amino acid sequence profile and 
compares that profile to a primary structure database. It was conducted on each TE family; 
the sequence profile was built out of sequences that have known tertiary structures, and only 
sequences within a family were used for the profile. Two iterations were done with an E-
value of 0.001 for the first BLAST search and 0.005 for the iterations. PSI–BLAST results 
were searched for sequences of structures that are part of other TE families. If sequences of 
one family appeared in the PSI–BLAST results of another family, then those two families 
have some sequence similarity. 
 
Secondary structure element analysis 
The arrangement of secondary structure elements (SSEs) (α-helices and β-sheets only) in 
the core of TE tertiary structures was considered. This was done for only one structure per 
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family, since all structures within a family share nearly identical protein cores. Structures 
were viewed in PyMOL, and the SSE arrangement from N- to C-terminus was recorded for 
every TE family. Two families are considered to have similar structures if they have the same 
SSE order and arrangement. 
 
Visual inspection 
Adding to SSE analysis, one can view tertiary structures and visually decide which ones 
are similar. They can be viewed in PyMOL using the ‘align’ command to quickly see two or 
more superimposed structures. 
 
Superpositions and RMSDs 
All the previous methods can point to suspected clans, but a more quantitative 
comparison of tertiary structures is needed. Monomers of all structures in a suspected clan 
were superimposed with MultiProt. The superposition was verified visually. MultiProt 
reports an RMSD between matched residues in all the superimposed structures. Because few 
residues are matched among all superimposed structures within a clan, the reported RMSDs 
thus represent how those residues are superimposed, but not the whole similarity between the 
structures. For that, an RMSD more representative of structural similarity needs to be 
calculated: a-carbon atoms of all superimposed monomer structures were extracted to 
calculate RMSDs between them using the method detailed previously. 
 
ThYme database 
All the sequences in each family are displayed on the ThYme database website 
(http://www. enzyme.cbirc.iastate.edu). These sequences are taken, using a series of scripts, 
from the BLAST results of the catalytic domains of the representative query sequences. 
Matching accessions, taxonomical data, protein names, and EC numbers are taken from 
UniProt and GenBank databases, and in some cases, EFetch requests. Each TE family is 
shown on a page where sequences are arranged into archaea, bacteria, and eukaryota, then 
alphabetically by species. In each row, a single sequence or group of sequences with 100% 
identical catalytic domains are shown with their protein name and UniProt and/or GenBank 
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accession codes. EC numbers are shown only when they appear in a sequence’s UniProt or 
GenBank annotation. If a crystal structure is known, the PDB accession code also appears. 
ThYme will be continuously updated: the content of each family will grow as GenBank, 
UniProt, and PDB do; however, to create a new family, or to merge or delete existing ones, 
human judgment and manual changes will be necessary. 
 
Results and discussion 
Thioesterase family classification 
Use of BLAST with TE query sequences followed by construction of MSAs and 
superposition of tertiary structures yielded 23 families almost completely unrelated by 
primary structure (Table 4.1). 
Enzymes in families TE1 to TE13 hydrolyze substrates with various acyl moieties and 
CoA, those in TE14 to TE19 attack bonds between acyl groups and ACP, and those in TE20 
and TE21 cleave the bonds between acyl groups and proteins. Members of TE22 and TE23 
break bonds between acyl groups and glutathione and its derivatives (Table 4.2). The sulfur-
carrying moiety in CoA and ACP is a pantethiene residue, while glutathione itself carries the 
sulfur moiety, and in non-ACP proteins, the sulfur-carrying moiety is built up mainly from a 
cysteine residue. 
All tertiary structures within each family have almost identical cores and very strong 
overall resemblance (Table 4.3) shown by RMSDave values of <1.8 Å and Pave values of 
>75%, with two exceptions. TE4 has a Pave value of 33.3% because it has only two crystal 
structures, of which one monomer (1C8U) is a double HotDog, while another monomer 
(1TBU) is incomplete with only a single HotDog. Similarly, in TE16 the Pave value is 65.8% 
because the TE domain of one structure (2VSQ) is smaller than the rest. 
Of the families whose members hydrolyze acyl-CoAs, all have HotDog
14,15
 folds (Table 
4.3, Figure 4.1) except for TE1, TE2, and TE3. TE1 enzymes have NagB folds, and they 
have acetyl-CoA hydrolase (EC 3.1.2.1) activity as well as acetate or succinate-CoA 
transferase (EC 2.8.3.–) activity. They are found mainly in bacteria and fungi, although they 
are also present in archaea. Enzymes coded by the acetyl-CoA hydrolase ACH1 gene from 
Saccharomyces cerevisiae are present in TE1.
16
 Fungal enzymes in this family are involved 
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with acetate levels and CoA transfer in mitochondria.
17
 
TE2 enzymes have α/β-hydrolase18 folds (Figure 1). They are mainly found in eukaryotes 
(animals), but they are also present in bacteria. They have mostly palmitoyl (EC 3.1.2.2) and 
bile acid-CoA:amino acid N-acyl transferase (BAT) (EC 2.3.1.65) activities. The acyl-CoA 
TE (Acot) genes ACOT1, ACOT2, ACOT4, and ACOT6 from Homo sapiens are present in 
this family, as well as the Acot1 through Acot6 genes from Mus musculus, Rattus 
norvegicus, and similar species.
19
 Also in TE2 are the BAAT TEs that transfer bile acid from 
bile acid-CoA to amino acids in the liver; these conjugates later solvate fatty acids in the 
gastrointestinal tract.
20
 
Enzymes in TE3 are part of the SGNH hydrolase superfamily with a flavodoxin-like fold. 
They are mainly found in bacteria and have acyl-CoA hydrolase (EC 3.1.2.20), arylesterase 
(EC 3.1.1.2) and lysophospholipase (EC 3.1.1.5) activities. Some TE3 enzymes come from 
the tesA gene, and they are located in the periplasm and are involved in fatty acid synthesis.
21
 
TE3 enzymes are also called acyl-CoA thioesterase I, protease I, and lysophospholipase L1, 
and the genes that code for them, tesA, apeA, and pldC, respectively, are nearly identical.
22
 
The rest of the acyl-CoA hydrolase families have HotDog folds. TE4 enzymes, present in 
bacteria and eukaryotes, are acyl-CoA hydrolases as well as palmitoyl-CoA (EC 3.1.2.2) and 
choloyl-CoA (EC 3.1.2.27) hydrolases. The Acot8 gene encodes for peroxisomal TEs,
23
 
which are found in TE4. Also in this family are acyl-CoA thioesterase II enzymes, encoded 
by the tesB gene, that can hydrolyze a broad range of short- to long-chain acyl-CoA 
thioesters, but whose physiological function is not known.
24
 
TE5 acyl-CoA enzymes, also known as thioesterase IIIs, are present in bacteria. They are 
encoded by the tesC (or ybaW) gene, and are long-chain acyl-CoA TEs preferring 3,5-
tetradecadienoyl-CoA as a substrate.
25
 
TE6 members, present in eukaryotes, bacteria, and archaea, have acyl-CoA hydrolase 
activities with various specificities. Acot enzymes 7, 11, and 12, present in eukaryotes, are 
found in TE6. Acot7 enzymes (also known as BACH: brain acyl-CoA hydrolases) are 
expressed mainly in brain tissue and preferentially attack C8 to C18 acyl-CoA chains.
26
 
Acot11 (also known as BFIT: brown fat inducible thioesterase, or Them1: thioesterase 
superfamily member 1) enzymes are specific toward medium- and long-chain acyl-CoA 
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molecules, and they may be involved with obesity in humans.
27
 Acot12 (also known as 
CACH: cytoplasmic acyl-CoA hydrolase) enzymes in humans hydrolyze acetyl-CoA.
28
 Many 
bacterial TE6 sequences are YciA TEs that hydrolyze a wide range of acyl-CoA thioesters 
and may help to form membranes.
29
 They preferentially attack butyryl, hexanoyl, lauroyl, 
and palmitoyl-CoA substrates.
30
 
TE7 enzymes are acyl-CoA TEs found in eukaryota and bacteria. In this family are the 
Acot9 and Acot10 enzymes (previously known as MT-ACT48), which are expressed in the 
mitochondria and have short- to long-chain acyl-CoA TE activity, showing preference for 
C14 chains.
31
 
Most TE8 members, mainly present in eukaryota but also in bacteria, are acyl-CoA 
thioesterase 13 (Acot13) enzymes, also known as thioesterase superfamily member 2 
(Them2). Enzymes in this family hydrolyze short to long acyl-CoA (C6 to C18) chains, 
preferring the latter.
32
 
TE9 members are found only in bacteria, and they have acyl-CoA hydrolase activity, 
mostly unclassified (3.1.2.–), but ADP-dependent short-chain acyl-CoA hydrolases (EC 
3.1.2.18), and 4-hydroxybenzoyl-CoA hydrolases (EC 3.1.2.23) are also found. The YbgC 
TEs are found in this family; some hydrolyze primarily short-chain acyl-CoA thioesters,
33
 
while others prefer long-chain acyl-CoA thioesters.
34
 Also, the thioesterase domain of 
methylketone synthase, MKS2, recently discovered in tomato, is found in TE9.
35
 
The enzymes in TE10 and TE11 are found only in bacteria, and most have 4-hydroxyben-
zoyl-CoA hydrolase (EC 3.1.2.23) activity. They, along with other enzymes, convert 4-
chlorobenzoate to 4-hydroxybenzoate in soil-dwelling bacteria.
36
 Also in TE11 are the EntH 
(YbdB) TEs, involved with enterobactin (an iron chelator) biosynthesis in Escherichia coli.
37
 
This is a unique example of a HotDog-fold enzyme involved in non-ribosomal peptide 
biosynthesis. 
Most TE12 enzymes are 1,4-dihydroxy-2-napthoyl (DNHA)-CoA hydrolases, involved in 
vitamin K1 biosynthesis,
38
 and they are found mostly in bacteria. TE13 enzymes occur in 
archaea and bacteria. Most are either PaaI or PaaD enzymes in the phenylacetic acid 
degradation pathway, and they are part of the paa gene cluster.
39
 
TE14 to TE19 enzymes hydrolyze acyl-ACP thioesters, with those in TE14 and TE15 
 29 
having HotDog folds while the rest have α/β-hydrolase folds. TE14 enzymes are found in 
bacteria and plants; they have acyl-ACP hydrolase (EC 3.1.2.14) activity. Many plant 
enzymes in this family have been experimentally characterized: they contain FatA and FatB 
genes and can hydrolyze C8 to C18 acyl-ACP thioesters.
40
 All TE14 bacterial sequences come 
from genomic or structural genomic studies. 
TE15 is a small family whose enzymes are present mainly in bacteria. Among them is the 
thioesterase CalE7 involved with enediyne biosynthesis. After substrate-ACP hydrolysis, 
these enzymes decarboxylate the product before release.
41
 Enzymes in this family are the few 
TEs with HotDog domains involved with polyketide biosynthesis. 
TE16 enzymes occur in both eukaryotes and bacteria, and they have oleoyl-ACP 
hydrolase (EC 3.1.2.14) activity. They include the TE domains of fatty acid synthases 
(FASs), also known as Thioesterase I, that terminate fatty acid synthesis,
42
 and the TE 
domain of polyketide synthases (PKSs) and non-ribosomal peptide synthases (NRPs), also 
known as Type I thioesterases (TE I), that terminate polyketide biosynthesis,
43
 or non-
ribosomal peptide biosynthesis.
44
 In the case of NRPs, instead of an ACP as the carrier 
molecule, a polypeptide carrier protein (PCP) is used. TE17 enzymes are only found in 
bacteria, mainly in Streptomyces. They are the TE domains of various PKSs. FASs, PKSs, 
and NRPs are large multimodular enzymes with many domains having different functions. 
Only the TE domains were used to identify these family members. 
Enzymes in TE18 are present in eukaryotes and bacteria and mainly have oleoyl-ACP 
hydrolase (EC 3.1.2.14) activity. Some enzymes in this family are S-acyl fatty acid 
synthetases/thioester hydrolases (Thioesterase II).
45
 They work with FASs to produce 
medium-chain (C8–C12) fatty acids in milk.
46
 The Type II thioesterases (TE IIs) are found in 
TE18; these enzymes play an important role in polyketide and non-ribosomal peptide 
biosynthesis by removing aberrant acyl chains from multimodular polyketide synthases and 
non-ribosomal peptide synthases.
47,48
 TE18 enzymes are independent TEs, not integrated to 
the multimodular FASs, PKSs or NRPs. 
TE19 enzymes are classified as acyltransferases (EC 2.3.1.–), but they hydrolyze acyl-
ACP molecules, mainly myristoyl-ACP.
49
 These enzymes divert fatty acids to the 
luminescent system in certain bacteria. 
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TE20 members, found only in eukaryotes, are palmitoyl-protein TEs (EC 3.1.2.22) 
encoded by PPT genes. They hydrolyze the thioester bond between a palmitoyl group and a 
cysteine residue in proteins.
50
 Mutations in PPT enzymes have been linked to neuronal ceroid 
lipofuscinosis, a genetic neurodegenerative disorder.
51
 
TE21 enzymes were originally identified as lysophospholipases,
52
 but they are also acyl-
protein APT1 TEs.
53
 They hydrolyze thioester bonds between acyl chains and cysteine 
residues on proteins. Many proteins in this family also have carboxyesterase (EC 3.1.1.1) 
activity. 
Among TE22 enzymes are S-formylglutathione hydrolases (EC 3.1.2.12) catalyzing 
formaldehyde detoxification; they hydrolyze S-formylglutathione into formate and 
glutathione.
54
 Also in TE22 are enzymes with acetyl esterase (EC 3.1.1.6) and 
carboxyesterase (EC 3.1.1.1) activity. 
TE23 members are hydroxyglutathione hydrolases (EC 3.1.2.6), also known as 
glyoxalase II enzymes, that hydrolyze S-D-lactoyl-glutathione to glutathione and lactic acid 
in methylglyoxal detoxification.
55
 TE23 enzymes occur in archaea, bacteria, and eukaryotes 
and have a metallo-b-lactamase fold.
56
 
 
Correspondence to EC groupings 
These TE families bear rather limited resemblance to EC numbers representing TEs. For 
instance, acetyl-CoA hydrolases (3.1.2.1) occur in TE1, TE6, and TE7; palmitoyl-CoA 
hydrolases (EC 3.1.2.2) are found in TE2, TE4, TE6, and TE7; oleoyl-ACP hydrolases (EC 
3.1.2.14) occur in TE14 and TE16 to TE18, and acyl-CoA hydrolases (EC 3.1.2.20) are 
found in TE3, TE6, and TE7. Conversely, of the 24 EC numbers remaining after three 
deletions, only 11 of them (EC 3.1.2.1, 3.1.2.2, 3.1.2.6, 3.1.2.12, 3.1.2.14, 3.2.1.18, 3.1.2.19, 
3.1.2.20, 3.1.2.22, 3.1.2.23, and 3.1.2.27, along with unclassified thioesterases (EC 3.1.2.–)) 
occur in significant numbers among the 23 TE families. Of course, further EC numbers 
characteristic of TEs will likely appear as more TEs are sequenced and characterized. 
 
Other thioesterases 
Ubiquitin carboxyl-terminal hydrolases (EC 3.1.2.15) cleave a wide variety of products 
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from the C-terminal glycine residue of ubiquitin. They were first identified as thiolesterases 
because they cleave dithiothreitol from ubiquitin, and they were thought to also hydrolyze 
ubiquitin-glutathione and other ubiquitin thiolesters.
57
 It was later shown that they hydrolyze 
amides and other groups from ubiquitin.
58
 These enzymes belong to a larger class of 
peptidases called deubiquitinating enzymes that hydrolyze lysine-glycine amide bonds in 
ubiquitinated proteins.
59
 Several families of these enzymes can be found in MEROPS, the 
peptidase database. We identified eleven ubiquitin thiolesterase families by the methods 
described above, but we have not included them here or in the ThYme database, as peptidase 
activity is their main function, and they can be found in MEROPS. 
Certain acyl transferases (EC 2.3.1.–), for example 2.3.1.9, 2.3.1.16, 2.3.1.38, and 
2.3.1.39 among others, can hydrolyze acyl-CoA or acyl-ACP substrates and later join the 
liberated acyl group to another acyl-CoA or acyl-ACP molecule. Although they hydrolyze 
thioesters, this is not their main function, and therefore we also decided not to include these 
enzymes here. 
 
Thioesterase clan classification 
TE families 4 to 6 and 8 to 15, all with members having HotDog crystal structures, were 
subjected to the methods described above and two clans were found: TE-A comprising 
families TE5, TE9, TE10, and TE12; and TE-B with TE8, TE11, and TE13. 
PSI–BLAST analysis suggested that TE5, TE9, TE10, and TE12 should be grouped into 
one clan and TE8, TE11, and TE13 into another, since slight sequence similarities among 
these families were found. SSE analysis of the structures pointed to TE5, TE6, TE10, TE12, 
and TE15 (having five -strands) being placed in one clan and TE8, TE11, and TE13 (having 
six -strands) being placed in another (Table 4.4); visual inspection suggested the same two 
groupings, with the first also including TE9. All crystal structures in candidate families of 
both possible clans were tested with superpositions and RMSD analysis (Figure 4.1, Table 
4.5). These different tests led to the two clans being defined. Members of TE-A are all acyl-
CoA hydrolases active on many substrates including short, long, branched, and aromatic acyl 
chains. Catalytic residues (see below) in TE6 are placed differently than those of other TE-A 
families, and TE6 was therefore not included in this clan. The different substrate specificities, 
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catalytic residues, and mechanism (see below) of TE15 members suggested that it also be 
excluded from TE-A. TE-B enzymes are also acyl-CoA hydrolases, except for the YbdB TEs 
in TE11 involved with enterobactin biosynthesis. TE4, TE7 (which has no known tertiary 
structure), and TE14 enzymes are sufficiently different from members of TE-A and TE-B 
that they were not considered for placement in either clan; the first two are acyl-CoA 
hydrolases, while the third is an acyl-ACP hydrolase. 
TE families 2 and 16 through 22, whose members all have α/β-hydrolase crystal 
structures, belong to two clans: TE-C comprising TE16, TE17, and TE18, and TE-D with 
TE20 and TE21. 
Both sequence analysis and SSE arrangement suggested only one clan of TE16, TE17, 
and TE18 (Table 4.4). Visual inspection suggested the two clans described above, and they 
were confirmed by superpositions, RMSD analysis, and the position of catalytic residues 
(Figure 4.1, Table 4.4). Families in TE-C contain acyl-ACP hydrolases present in 
multidomain FASs, PKSs, and NRPs, as well as independent acyl-ACP TEs involved in 
those pathways. TE-D enzymes hydrolyze palmitoyl and other acyl groups from protein 
surfaces. TE2, an acyl-CoA hydrolase, TE19, a myristoyl-ACP hydrolase, and TE22, active 
on glutathione-activated molecules, are not part of either clan. 
 
TE tertiary structures, catalytic residues, and mechanisms 
Catalytic mechanisms and residues of each TE family were gathered from crystal 
structure articles. The PDB files, proposed catalytic residues, and producing organisms of the 
relevant TEs are listed in Table 4.6. 
HotDog-fold enzymes lack defined non-solvated binding pockets and conserved catalytic 
residues,
29
 thus a variety of catalytic residues and mechanisms exist. 
In TE-A, only TE9 and TE10 can be further analyzed, as TE5 and TE12 at present have 
only one crystal structure each with no corresponding refereed article. In TE9 the YbgC 
structure 2PZH is a tetramer of two dimers. After comparing this structure to 1LO9 in TE10 
and other YbgC crystals, the authors proposed that His18, Tyr7, and Asp11 play important 
roles in catalysis.
34
 
TE10 4-hydroxybenzoyl-CoA TEs have homotetrameric quaternary structures. It was 
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suggested from structures 1LO7, 1LO8, and 1LO9 that hydrogen bonds and the positive end 
of a helix dipole moment make the thioester carbonyl group more susceptible to a 
nucleophilic attack by Asp17 through an acyl-enzyme intermediate.
60
 
TE-B families include TE8, TE11, and TE13. Members of TE8 are tetramers composed 
of two HotDog dimers. Based on a crystal structure of a human Them2 enzyme (3F5O), it 
was proposed that Gly57 and Asn50 bind and polarize the thioester carbonyl group while 
Asp65 and Ser85 orient and activate the water nucleophile.
61
 
In TE11, Arthrobacter sp. strain SU 4-hydroxybenzoyl-CoA TE crystal structures reveal 
a tetrameric enzyme with a dimer of dimers. Structures 1Q4S, 1Q4T, and 1Q4U led to the 
proposal that Gly65 polarizes the carbonyl group for a nucleophilic attack carried out by 
Glu73.
62
 
Both TE10 and TE11 are 4-hydroxybenzoyl-CoA TEs of similar substrate specificities 
and metabolic functions; however, their tertiary and quaternary structures are different and 
they use different active-site regions and residues for catalysis. This supports placing these 
two families in two different clans. 
TE13 PaaI thioesterase from Thermus thermophilus HB8 yielded homotetrameric 
quaternary structures 1WLU, 1J1Y, 1WM6, 1WLV, and 1WN3. From those structures, a 
study proposed that these enzymes use an induced-fit mechanism to hydrolyze the substrate 
via an Asp48-activated water nucleophile.
63
 Comparison of the structure of another PaaI, 
from E. coli (2FS2) with the Arthrobacter TE11 structures, as well as site-directed 
mutagenesis, pointed to a mechanism similar to that in TE11: Gly53 prepares the thioester 
for a nucleophilic attack from Asp61.
64
 4-Hydrozybenzoyl-CoA enzymes from TE11 and the 
PaaI enzymes from TE13 catalyze two different reactions in different organisms, and their 
primary sequences are not related; yet their tertiary structures, catalytic residues, and 
mechanisms are similar, supporting the conclusion that both TE11 and TE13 are part of TE-
B. 
Of TE families with HotDog structures not placed in clans, TE4 catalytic residues and 
mechanisms have been identified based on structure 1C8U and site-directed mutagenesis: an 
Asp204–Gln278–Thr228 triad orients a water molecule for nucleophilic attack on the 
substrate.
65
 The double HotDog structure of 1C8U and its catalytic residues and mechanism 
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differ from other HotDog enzymes, supporting the exclusion of TE4 from TE-A and TE-B. 
In TE6, Acot7 structure 2Q2B is a trimer of HotDog dimers; both domains are required 
for activity and Asn24 from the N-domain and Asp213 from the C-domain have been 
identified as catalytic residues through site-directed mutagenesis.
66
 Also in TE6, YciA 
structures 1YLI and 3D6L have a trimer of dimers with two binding sites across the dimer 
interface. An D44A mutation (3BJK) of 1YLI eliminated activity.
67
 
The two known tertiary structures in TE14 come from structural genomic studies and do 
not have supporting literature. However, based on a bioinformatics-guided site-directed 
mutagenesis study on a FatB enzyme from Arabidopsis, a study proposed that Cys264, 
His229, and Asn227 make up a papain-like catalytic triad.
68
 
Structure 2W3X of TE15 CalE7 has no acidic residues in the catalytic region. Based on 
site-directed mutagenesis, a mechanism different from other HotDogs was proposed: Asn19 
and Arg37 anchor the substrate with hydrogen bonds while a water molecule or hydroxide 
anion acts as a nucleophile, attacking the substrate carbonyl group. Arg37 also acts as an 
oxyanion hole to stabilize the intermediate, and Tyr29 facilitates decarboxylation following 
hydrolysis.
41
 
Unlike HotDogs, / hydrolases have very conserved catalytic residues: a nucleophile–
histidine–acid triad.18 The nucleophile can be serine, cysteine, or aspartate; the histidine is 
always conserved, and the third residue is always acidic. Fold architecture, substrate 
specificities, and binding sites vary within this fold.
69
 Generally, the acid stabilizes a 
histidine residue that acts as a base, accepting a proton from the nucleophile that forms an 
intermediate with the substrate, which is then attacked by water. In some PKSs and NRPs 
that make cyclic products, a hydroxyl group from the substrate chain is used for lactonization 
instead of a water molecule. 
TE-C encompasses TE16, TE17, and TE18. Members of all three families have the same 
Ser–His–Asp triad. The position of the acid residue differs from what is usually found in / 
hydrolases, as was seen in human FAS TE domain 1XKT.
70
 In TE17, a substrate channel was 
found in the TE domain of 6-deoxyerythronolide B synthase (DEBS-TE) from Saccharopoly-
spora erythraea (1KEZ), unique among TE / hydrolases.71 The substrate channel depends 
on pH and supports the prediction that all macrocycle-forming TEs from PKSs have a similar 
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catalytic mechanism. Many macrocycle-forming TE domains from PKSs were found in 
TE17, again supporting this prediction. 
Members of the two families, TE20 and TE21, in TE-D also have Ser–His–Asp catalytic 
triads. TE21 structure 1AUO confirmed that some bacterial carboxylesterases with broad 
substrate specificity have an / hydrolase fold.72 These enzyme structures are very similar 
to the mainly eukaryotic acyl-protein hydrolases, even though they have very different 
specificities. 
TE2, TE19, and TE22 are other / hydrolases that are not part of any clan, but they still 
maintain the characteristic catalytic triad. 
TEs are found in NagB (TE1), SGNH (TE3) and lactamase (TE23) folds. TE1 has two 
structures with no refereed literature, so their mechanism and catalytic residues remain 
unknown. 
From TE3 structures 1IVN, 1JRL and 1J00, the existence of a Ser–His–Asp catalytic 
triad similar to those in the TE / hydrolases was proposed.73 The later crystal structures 
1U8U and 1V2G suggested that a conformational change, described as a switch loop 
movement, occurs during catalysis.
74
 
Since TE23 hydroxyglutathione hydrolases (glyoxalase IIs) have metallo--lactamase 
folds, their mechanisms are very different from the rest of TEs that do not have catalytic 
metal ions. Two crystal structures, 1QH3 and 1QH5, have seven His and Asp residues and a 
water molecule interacting with two zinc ions. Based on this, a study proposed that a 
hydroxide ion bonded with both ions attacks the carbonyl carbon atom of the glutathione 
thioester substrate, forming a tetrahedral intermediate, followed by breakage of the C–S 
bond.
75
 
 
Predicted catalytic residues 
Some TE tertiary structures, including all those in TE1, TE5, TE12, and TE14, are not 
supplemented by refereed literature. Furthermore, TE7 does not have a known tertiary 
structure. Therefore the catalytic residues and mechanisms for TEs in these families are not 
securely known. 
Since the positions of catalytic residues must be conserved within families and clans, 
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unknown identities of catalytic residues in TEs can be predicted by viewing the positions of 
the catalytic residues in all superimposed structures in a family or clan. 
In TE2, we predict that in the human ACOT4 structure 3K2I the catalytic triad is 
Ser232–His360–Asp326, based on the human ACOT2 structure 3HLK. In TE6, based on 
structures from mouse Acot7 (2Q2B), Haemophilus influenzae YciA (3BJK), and 
Campylobacter jejuni (3D6L), Asp245 in human ACOT7 and Asp36 in human ACOT12 
appear to be catalytic residues. In TE8, study of the structures of human Them2 (3F5O and 
2F0X) leads to the prediction that human TE structure 2H4U and mouse TE structure 2CY9 
have the same catalytic residues: Asn50, Asp65, Ser83, and Gly57. In TE9, based on 
Helicobacter pylori YbgC enzyme 2PZH, we predict that in E. coli 1S5U the catalytic 
residues are Tyr14, Asp18, and His25, in Bartonella henselae 3HM0 they are Tyr23, Asp28, 
and His35, and in Thermus thermophilus they are 1Z54 Tyr11, Asp15, and His22. All three 
residues in the three structures superimposed very closely and in the same position with the 
exception of Tyr35 in 3HM0, where the ring is facing in another direction and the residue is 
one amino acid position displaced. This might lead to a difference in enzyme substrate 
specificity. In TE11, based on TE structures 1Q4S, 1Q4T, and 1Q4U from Arthrobacter sp., 
we predict that the catalytic residues are Gly55 and Glu63 in both structure 1VH9 of the 
putative TE from E. coli and in structures 2B6E, 1SC0, and 3LZ7 of a hypothetical H. 
influenzae TE. In TE13, E. coli structure 1PSU shares the same Gly53 and Asp61 catalytic 
residues with E. coli PaaI 2FS2, and T. thermophilus 2DSL shares the same Gly40 and 
Asp48 catalytic residues with the other T. thermophilus PaaI structures 1J1Y, 1WLU, 1WLV, 
1WM6, and 1WN3. 
Comparing TE20 bovine PPT1 (1EI9) and human PPT2 (1PJA) suggests that human 
PPT1 structure 3GRO has the catalytic triad Ser115–His289–Asp233, the same residues as 
the bovine PPT1. In TE21, Pseudomonas fluorescens carboxylesterases 1AUO and 1AUR, 
and human acyl-protein TE 1FJ2 lead to predicting that the catalytic residues in 
Pseudomonas aeruginosa structures 3CN7 and 3CN9 should be Ser113, His197, and 
Asp166. In TE22, esterase A 2UZ0, S-formylglutathione hydrolase 1PV1, human esterase D 
3FCX, and a putative enzyme (3E4D), suggest that in Oleispira antartica esterase 3I6Y the 
catalytic triad is Ser148–His257–Asp224. 
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Within TE-A, two families, TE5 and TE12, only have one crystal structure each (1NJK 
and 2HX5, respectively) with no supporting refereed article. Superimposition of structures 
within TE-A lead us to predict that the catalytic residue in TE5 YbaW probable enzyme is 
Asp13, while in TE12 putative thioesterase (2HX5) the catalytic residue is Asp19. 
 
Convergent and divergent evolution 
These results show the effects of both convergent and divergent evolution. The former is 
exemplified by the fact that members in TE families from different clans and/or folds, 
descended from different ancestors, are active on substrates, many of them the same and all 
containing the thioester group, attacking the bond between its carbonyl carbon atom and its 
adjacent sulfur atom. Divergent evolution is shown by the presence in many TE families of 
enzymes with separate names and EC numbers (beyond the undifferentiated number EC 
3.1.2.–), signifying activities on different substrates, even though they have similar primary 
and tertiary structures and mechanisms. A more profound indication of divergent evolution is 
the presence of clans containing families with very different primary structures but common 
tertiary structures and mechanisms. 
 
Thioesterases in existing databases and previous classifications 
Some TEs have been previously classified by sequence or structure in different databases. 
The subjective boundaries between subfamilies, families, and clans or superfamilies, as well 
as the use of different methodologies, give rise to differences among databases. A summary 
of these differences can be found on Table 4.7. 
The SCOP classification system
3
 is based on protein structure, and the SCOP database 
was assembled mainly by visual inspection and comparison, with some automation. We used 
it to search for the structures of TE family members. Our classes and folds correspond with 
SCOP; however, some differences arise at the superfamily and family levels. For example, 
structures in TE2, TE15, and TE18 are not classified, nor are those in TE7, which does not 
have a known structure. Some of our clans correspond to SCOP families: TE-B corresponds 
to the PaaI/YdiI-like SCOP family, and TE-A is somewhat similar to the 4HBT-like SCOP 
family. 
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Pfam has identified and classified many protein families. Pfam-A is manually curated and 
its families are identified with hidden Markov model profiles built from carefully chosen 
seed multiple alignments.
76
 The main difference in methodology is that in Pfam, sequences 
that fit a profile from a seed alignment are part of a family, while in ThYme sequences 
strongly similar to a query sequence that has TE function and evidence at protein level are 
part of a TE family. This leads to differences in the families: Pfam families are more 
inclusive and cover a wider range of sequences, while ThYme families are smaller, with all 
sequences having a very strong sequence similarity. For example, Pfam-A family 4HBT 
includes our families TE5 to TE13 and TE15. We have shown that these families have varied 
structures and overall functions, as well as different mechanisms and catalytic residues. 
Furthermore, some of these ThYme families appear in two clans, TE-A and TE-B, and some 
are not part of any clan. 
Dillon and Bateman
15
 in 2004 defined subfamilies for the HotDog fold. Among HotDog 
fold enzymes are TEs, and some of the subfamilies presented correspond with our families. 
For instance, TE4 corresponds to the TesB-like subfamily, TE5 to the YbaW subfamily, TE6 
to the Acyl-CoA thioesterase subfamily, TE9 to the YbgC-like subfamily, TE10 and TE11 to 
the 4HBT-I and 4HBT-II subfamilies, TE13 to the PaaI subfamily, and TE14 to the Fat 
subfamily. However, the exact content, sequences, and structures of these subfamilies might 
not correspond to the corresponding families in ThYme. 
Two other more specific databases, ESTHER,
77
 a database for the a b hydrolase fold, 
and the Lipase Engineering Database,
78
 contain some TEs. Both have families that resemble 
TE19, TE20, and TE21, and ESTHER also has one family similar to TE16. Again, the exact 
content, sequences, and structures in these families might not correspond to those in ThYme. 
ThYme has detailed structural and biological annotation for TEs and other thioester-
active enzymes. It does not compete with but rather supplements existing databases such as 
Pfam, as it is focused on thioester-active enzymes in the same way that CAZy is focused on 
carbohydrate-active enzymes and MEROPS is focused on peptidases. It can accurately point 
out differences and similarities in structure, mechanisms, and catalytic residues. The 
differences in methodology and purpose lead to differences with other databases. We follow 
the SCOP classification system, but differences in the databases arise because SCOP’s 
 39 
purpose is to present a tertiary structure classification, while ThYme classifies TEs and other 
thioester-active enzymes mainly by primary structure. Pfam has a wide scope, and it is an 
extremely useful tool to identify domains within sequences, but it is not specific to a 
particular enzyme group. Dillon and Bateman’s article,15 as well as ESTHER and the Lipase 
Engineering Database, have different focuses, and their overall contents do not correspond to 
that in ThYme. 
 
Concluding remarks 
Analysis of primary and tertiary structures has led to classifying all TEs into families and 
clans. Within families all enzymes share very similar primary and tertiary structures, active 
sites, catalytic residues, and mechanisms. Within clans, enzymes share some sequence 
similarity and similar structures, active sites, catalytic residues, and mechanisms. This 
classification system can help to predict an individual enzyme’s structure, function, or 
mechanism. It also provides a standardized nomenclature. 
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Tables 
 
Table 4.1: Thioesterase Families and Common Names of their Members 
___________________________________________________________________________ 
Family Producing 
 organisms Genes and/or other names of family members 
 __________________________________________________________________________ 
TE1 A, B, E
a
 Ach1 
TE2 A, B, E Acot1–Acot6, BAAT thioesterase 
TE3 A, B tesA, acyl-CoA thioesterase I, protease I, lysophospholipase L1 
TE4 B, E tesB, acyl-CoA thioesterase II, Acot8 
TE5 B tesC (ybaW), acyl-CoA thioesterase III 
TE6 A, B, E Acot7 (BACH), Acot11 (BFIT, Them1), Acot12 (CACH), YciA 
TE7 B, E Acot9, Acot10 
TE8 A, B, E Acot13 (Them2) 
TE9 B YbgC 
TE10 B 4HBT-I 
TE11 B 4HBT-II, EntH (YbdB) 
TE12 B, E DNHA-CoA hydrolase 
TE13 A, B paaI, paaD 
TE14 B, E FatA, FatB 
TE15 B Thioesterase CalE7 
TE16 A, B, E TE domain of FAS (Thioesterase I), TE domain of PKS or NRP 
   (type I thioesterase (TE I)) 
TE17 B TE domain of PKS 
TE18 B, E Thioesterase II, type II thioesterase (TE II) 
TE19 B luxD 
TE20 E ppt1, ppt2, palmitoyl-protein thioesterase 
TE21 A, B, E apt1, apt2, thioesterase, phospholipase, carboxylesterase 
TE22 A, B, E S-formylglutathione hydrolase, esterase A, esterase D 
TE23 A, B, E Hydroxyglutathione hydrolase, glyoxalase II 
___________________________________________________________________________ 
a
 A: archaea, B: bacteria, E: eukaryota. Most prevalent producers bolded. 
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Table 4.2: Thioesterase Functions and Substrate Specificities 
 __________________________________________________________________________________________________________ 
Family General function EC number Preferred substrate specificity (if known) 
 __________________________________________________________________________________________________________ 
TE1 Acyl-CoA hydrolase  3.1.2.1, 2.8.3.– Acetyl-CoA 
TE2 Acyl-CoA hydrolase  3.1.2.–, 3.1.2.2, 2.3.1.65 Palmitoyl-CoA, bile-acid-CoA 
TE3 Acyl-CoA hydrolase  3.1.2.–, 3.1.2.20, 3.1.1.2, 3.1.1.5 Medium- to long-chain acyl-CoA 
TE4 Acyl-CoA hydrolase  3.1.2.–, 3.1.2.2, 3.1.2.27 Short- to long-chain acyl-CoA, palmitoyl-CoA, choloyl-CoA 
TE5 Acyl-CoA hydrolase  3.1.2.– Long-chain acyl-CoA, 3,5-tetradecadienoyl-CoA 
TE6 Acyl-CoA hydrolase  3.1.2.–, 3.1.2.1, 3.1.2.2, 3.1.2.18, Short- to long-chain acyl-CoA, C4 to C18 
   3.1.2.19, 3.1.2.20 
TE7 Acyl-CoA hydrolase  3.1.2.–, 3.1.2.1, 3.1.2.2, 3.1.2.20 Short- to long-chain acyl-CoA 
TE8 Acyl-CoA hydrolase  3.1.2.– Short- to long-chain acyl-CoA, C6 to C18 
TE9 Acyl-CoA hydrolase  3.1.2.–, 3.1.2.18 Short- to long-chain acyl-CoA, 4-hydroxybenzoyl-CoA 
TE10 Acyl-CoA hydrolase  3.1.2.23 4-Hydroxybenzoyl-CoA 
TE11 Acyl-CoA hydrolase  3.1.2.– 4-Hydroxybenzoyl-CoA 
TE12 Acyl-CoA hydrolase  3.1.2.– 1,4-Dihydroxy-2-napthoyl-CoA 
TE13 Acyl-CoA hydrolase  3.1.2.– Short and medium-chain acyl-CoA, several 
    hydroxyphenylacetyl-CoA substrates 
TE14 Acyl-ACP hydrolase 3.1.2.–, 3.1.2.14 Short- to long-chain acyl-ACP, C8 to C18 
TE15 Acyl-ACP hydrolase — — 
TE16 Acyl-ACP hydrolase 3.1.2.14
a
 Long-chain acyl-ACP, various polyketides and non- 
    ribosomal peptides 
TE17 Acyl-ACP hydrolase 3.1.2.14
b
 Several polyketides 
TE18 Acyl-ACP hydrolase 3.1.2.–, 3.1.2.14 Medium-chain acyl-ACP, various polyketides and non- 
    ribosomal peptides 
TE19 Acyl-ACP hydrolase 2.3.1.– Myristoyl-ACP 
TE20 Protein-palmitoyl hydrolase 3.1.2.–, 3.1.2.22 Palmitoyl-protein 
TE21 Protein-acyl hydrolase 3.1.2.–, 3.1.1.1 — 
TE22 Glutathione hydrolase 3.1.2.12, 3.1.1.1, 3.1.1.6 S-formylglutathione 
TE23 Glutathione hydrolase 3.1.2.6 D-lactoylglutathione 
 ___________________________________________________________________________________________________________ 
a
 TE domain. FASs, PKSs and NRPs can have several EC numbers such as 2.3.1.85, 2.3.1.94, 2.3.1.–, 2.7.7.–, and 5.1.1.–. 
b
 TE domain of PKSs. 
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Table 4.3: Thioesterase Folds 
 ___________________________________________________________________________________________________________ 
Family Fold RMSDave, Å Pave, % PDB files 
 ___________________________________________________________________________________________________________ 
TE1 NagB 1.25 96.4 2G39, 2NVV 
TE2 α/β-Hydrolase 1.00 96.6 3HLK, 3K2I 
TE3 Flavodoxin-like 0.58 96.6 1IVN, 1J00, 1JRL, 1U8U, 1V2G, 3HP4 
TE4 HotDog 0.90 33.3 1C8U, 1TBU 
TE5 HotDog — — 1NJK 
TE6 HotDog 1.39 75.9 3B7K, 2Q2B, 2V1O, 2QQ2, 1YLI, 3BJK, 3D6L 
TE7 HotDog — — 
TE8 HotDog 0.58 88.3 2H4U, 3F5O, 2F0X, 2CY9 
TE9 HotDog 1.19  88.8 2PZH, 1S5U, 3HM0, 1Z54 
TE10 HotDog  0.67 97.1 1BVQ, 1LO7, 1LO8, 1LO9 
TE11 HotDog 0.87 93.9 1Q4S, 1Q4T, 1Q4U, 1VH9, 2B6E, 1SC0, 3LZ7 
TE12 HotDog — — 2HX5 
TE13 HotDog 0.43  94.6 2FS2, 1PSU, 2DSL, 1J1Y, 1WLU, 1WLV, 1WM6, 1WN3 
TE14 HotDog 1.65 87.7 2OWN, 2ESS 
TE15 HotDog — — 2W3X 
TE16 α/β-Hydrolase 1.51 66.9 2VZ8a, 2VZ9a, 2PX6, 1XKT, 2ROQb, 2CB9, 2CBG, 2VSQ, 1JMK 
TE17 α/β -Hydrolase 1.67 82.4 1MO2, 1KEZ, 1MN6, 2H7X, 2H7Y, 2HFK, 2HFJ, 1MNA, 1MNQ 
TE18 α/β -Hydrolase 0.83 97.2 3FLA, 3FLB, 2RONb, 2K2Qb 
TE19 α/β -Hydrolase — — 1THT 
TE20 α/β -Hydrolase 1.41 91.2 1EH5, 3GRO, 1EI9, 1EXW, 1PJA 
TE21 α/β -Hydrolase 0.82 96.7 1FJ2, 1AUO, 1AUR, 3CN7, 3CN9 
TE22 α/β -Hydrolase 1.69 78.9 3FCX, 3C6B, 2UZ0, 1PV1, 3I6Y, 3E4D, 3LS2 
TE23 Lactamase 1.67 78.5 2QED, 1XM8, 2P18, 2GCU, 2Q42, 1QH3, 1QH5, 2P1E 
 __________________________________________________________________________________________________________ 
a
 2VZ8 and 2VZ9 have TE domains in their FASTA format. Therefore these were picked up by BLAST, but their PDB files do not include the 
TE domain, and they where not included in the RMSD calculation. 
b
 NMR-resolved structures not included in RMSD calculation. 
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Table 4.4: Thioesterase Core Secondary Structure Elements 
 ________________________________________________ 
Clan Family Secondary structural element 
________________________________________________ 
 
HotDog 
TE-A TE5 ----- 
TE-A TE9  ---- 
TE-A TE10 ----- 
TE-A TE12 ----- 
TE-B TE8 ------ 
TE-B TE11 ------ 
TE-B TE13 ------ 
 — TE4 ----------- 
 — TE6 ----- 
 — TE14 ----------- 
 — TE15 ----- 
 
α/β-Hydrolase 
TE-C TE16  ---------- 
TE-C TE17  ---------- 
TE-C TE18 ----------- 
TE-D TE20 ------------ 
TE-D TE21 ----------- 
 — TE2 ------------ 
 — TE19 -------------- 
 — TE22 -------------- 
_______________________________________________ 
 
 
Table 4.5: RMSD Analysis of TE Clan Members 
 ________________________________________________________________________ 
Clan RMSDmin, RMSDave, RMSDmax, Pmin, Pave, Pmax, Cutoff, 
 Å Å Å % % % Å 
 ________________________________________________________________________ 
TE-A 1.14 1.33 1.53 77.5 87.1 90.9 3.81 
TE-B 0.11 0.97 2.02 72.3 86.8 100.0 3.80 
TE-C 1.81 1.94 2.13 52.6 58.3 75.2 3.82 
TE-D 0.44 1.45 2.00 67.0 80.9 100.0 3.79
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Table 4.6: TE Family and Clan Mechanisms 
____________________________________________________________________________________________________________ 
Clan Family Catalytic residues
a
 PDB file Producing organism 
____________________________________________________________________________________________________________ 
 — TE1 — — — 
 — TE2 Ser294, His422, Asp388 3HLK Homo sapiens 
   Ser232
b
, His360
b
, Asp326
b
 3K2I H. sapiens 
 — TE3 Ser10, His157, Asp154 1IVN, 1JRL, 1J00, 1U8U, 1V2G Escherichia coli 
 — TE4 Asp204, Thr228, Gln278 1C8U E. coli 
TE-A TE5 Asp13
c
 1NJK E. coli 
 — TE6 Asn24, Asp213 2Q2B, 2V1O Mus musculus 
   Asp44 1YLI, 3BJK Haemophilus influenzae 
   Asp34 3D6L Campylobacter jejuni 
   Asp36
b
 3B7K H. sapiens 
   Asp245
b
 2QQ2 H. sapiens 
 — TE7 — — — 
TE-B TE8 Asn50, Asp65, Ser83, Gly57 2F0X, 3F5O, 2H4U
b
 H. sapiens 
   Asn50
b
, Asp65
b
, Ser83
b
, Gly57
b
 2CY9 M. musculus 
TE-A TE9 Tyr7, Asp11, His18 2PZH Helicobacter pylori 
   Tyr14
b
, Asp18
b
, His25
b
 1S5U E. coli 
   Tyr23
b
, Asp28
b
, His35
b
 3HM0 Bartonella henselae 
   Tyr11
b
, Asp15
b
, His22
b
 1Z54 Thermus thermophilus  
TE-A TE10 Asp17  1BVQ, 1LO7, 1LO8, 1LO9 Pseudomonas sp. 
TE-B TE11 Gly65, Glu73 1Q4S, 1Q4T, 1Q4U Arthrobacter sp.  
   Gly55
b
, Glu63
b
 1VH9 E. coli 
   Gly55
b
, Glu63
b
 2B6E, 1SC0, 3LZ7 H. influenzae 
TE-A TE12 Asp19
c
  2HX5 Prochlorococcus marinus 
TE-B TE13 Gly40
b
, Asp48 1WLU, 1J1Y, 1WM6, 1WLV, 1WN3, Thermus thermophilius 
    2DSL
b
 
   Gly53, Asp61 2FS2, 1PSU
b
 E. coli 
 — TE14 Cys264, His229, Asn227  Arabidopsis thaliana 
 — TE15 Asn19, Tyr29, Arg37  2W3X  Micromonospora echinospora 
TE-C TE16 Ser2308, His2481, Asp2338 1XKT, 2PX6 H. sapiens 
   Ser80, His207, Asp107 1JMK Bacillus subtilis 
   Ser84, His201, Asp111 2CB9, 2CBG B. subtilis 
4
8
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TE-C TE17 Ser142, His259, Asp169 1KEZ, 1MO2 Saccharopolyspora erythraea 
   Ser148, His268, Asp176 1MN6, 1MNA, 1MNQ S. erythraea 
   Ser148, His268, Asp176 2HFK, 2HFJ, 2H7X, 2H7Y Streptomyces venezuelae 
TE-C TE18 Ser94, His228, Asp200 3FLA, 3FLB Amycolatopsis mediterranei 
 — TE19 Ser114, His241, Asp211 1THT Vibrio harveyi 
TE-D TE20 Ser115, His289, Asp233 1EI9, 1EH5, 1EXW Bos taurus 
   Ser115, His289, Asp233 3GRO H. sapiens 
   Ser111, His283, Asp228 1PJA H. sapiens 
TE-D TE21 Ser114, His199, Asp168 1AUO, 1AUR Pseudomonas fluorescens 
   Ser114, His203, Asp169 1FJ2 H. sapiens 
   Ser113
b
, His197
b
, Asp166
b
 3CN7, 3CN9 Pseudomonas aeruginosa 
 — TE22 Ser120, His231, Asp202  2UZ0 Streptococcus pneumoniae 
   Ser161, His276, Asp241 1PV1, 2C6B S. cerevisae 
   Ser149, His260, Asp226 3FCX H. sapiens 
   Ser147, His256, Asp223 3E4D Agrobacterium tumefaciens 
   Ser147, His258, Asp255 3LS2 Pseudoalteromonas h 
   Ser148
b
, His257
b
, Asp224
b
 3I6Y Oleispira antartica 
 — TE23 Various His and Asp residues,  1QH3 H. sapiens 
   along with Zn, Fe, or Mn ions 
____________________________________________________________________________________________________________ 
a
 As proposed by the authors in the literature cited, except as noted. 
b
 Predicted by the authors of this paper based upon the position of catalytic residues in superimposed structures within families. 
c
 Predicted by the authors of this paper based upon the position of catalytic residues in superimposed structures within clan TE-A. 
4
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Table 4.7: Comparison of Family and Clan Nomenclature 
__________________________________________________________________________________________________________________ 
ThYme ThYme Reference 15 ESTHER
a
/Lipase   
clan family subfamily Engineering Database
b
 Pfam-A family SCOP database family 
__________________________________________________________________________________________________________________ 
 TE1 — — AcetylCoA_hydro CoA transferase a subunit-like 
 TE2 — — BAAT_C — 
 TE3 — — Lipase_GDSL TAP-like 
 TE4 TesB-like — Acyl_CoA_thio — Acyl-CoA thioesterase 
TE-A TE5 YbaW — 4HBT 4HBT-like 
 TE6 Acyl-CoA — 4HBT 4HBT-like 
  thioesterase 
 TE7 — — 4HBT — 
TE-B TE8 — — 4HBT PaaI/YdiI-like 
TE-A TE9 YbgC-like — 4HBT 4HBT-like 
TE-A TE10 4HBT-I — 4HBT 4HBT-like 
TE-B TE11 4HBT-II — 4HBT PaaI/YdiI-like 
TE-A TE12 — — 4HBT 4HBT-like 
TE-B TE13 PaaI — 4HBT PaaI/YdiI-like 
 TE14 Fat subfamily — Acyl-ACP_TE Acyl-Acp thioesterase-like 
 TE15 — — 4HBT — 
TE-C TE16 —  aThioesterase Thioesterase Thioesterase domain of polypeptide, 
     polyketide, and fatty acid synthases 
TE-C TE17 — — Thioesterase Thioesterase domain of polypeptide, 
    polyketide, and fatty acid synthases 
TE-C TE18 — — Thioesterase — 
 TE19 — aThioesterase_acyltransferase Acyl_transf_2 Thioesterases 
   
b
Acyl transferases 
TE-D TE20 — aPalmitoyl-protein thioesterase Palm_thioest Thioesterases 
   
b
Thioesterases 
TE-D TE21 —            aLysophospholipase_carboxylesterase Abhydrolase_2 Carboxylesterase/thioesterase 1 
    
b
Lysophospholipase 
 TE22 — — Esterase Hypothetical esterase YLLJ068C 
 TE23 — — Lactamase B Glyoxalase II 
5
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Figures 
 
Figure 4.1: Superimposed tertiary structures of single representatives of each TE family in a 
clan. A: TE-A acyl-CoA hydrolases from Escherichia coli (TE5) (green), Helicobacter pylori 
(TE9) (red), Pseudomonas sp. (TE10) (yellow), and Prochlorococcus marinus (TE12) (blue). 
B: TE-B acyl-CoA hydrolases from Homo sapiens (TE8) (blue), Arthrobacter sp. (TE11) 
(red), and E. coli (TE13) (yellow). C: TE-C acyl-ACP hydrolases from H. sapiens (TE16) 
(blue), Saccharopolyspora erythraea (TE17) (red), and Amycolatopsis mediterranei (TE18) 
(yellow). D: TE-D protein-acyl hydrolases from Bos taurus (TE20) (blue) and H. sapiens 
(TE21) (yellow). 
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Abstract 
Thioesterases (TEs) have been recently classified into families based on sequence and 
three-dimensional structure similarity. TE14 is a family that includes the plant enzymes FatA 
and FatB as well as many uncharacterized bacterial sequences. The FatA and FatB enzymes 
terminate fatty acid biosynthesis in plants and are key in determining fatty acid length and 
overall composition in seed oil. We have separated TE14 into subfamilies based on 
phylogenetic and statistical analyses, giving a more detailed classification that allows the 
better inference of biochemical properties, and an experimental biochemical characterization 
of individual enzymes in each subfamily. TE14 is made up of ten subfamilies, with four 
composed of plant sequences and six of bacterial sequences. 
 
Introduction 
The thioesterases (TEs) are a large enzyme group whose members cleave the bond 
linking the sulfur and carbonyl carbon atoms of a thioester group. They have been classified 
into families,
1
 where all sequences in a family have strongly related amino acid sequences 
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and very similar three-dimensional (tertiary) structures and positions of catalytic residues. 
This implies that they are descended from a common protein ancestor and that they use 
similar catalytic mechanisms. Virtually all TE amino acid sequences are found, classified 
into families, in the constantly-updated ThYme database (www.enzyme.cbirc.iastate.edu), 
separated into those of archaeal, bacterial, and eukaryotic origin, with information on their 
EC numbers (if available), GenBank, RefSeq, and UniProt identifiers, and Protein Data Bank 
(PDB) locators of any with known tertiary structures. 
At present 23 TE families exist of which 13 families (TE1–TE13) are composed of acyl-
CoA hydrolases, six (TE14–TE19) of acyl-acyl carrier protein (ACP) hydrolases, two (TE20 
and TE21) of protein-acyl hydrolases, and two (TE22 and TE23) of glutathione hydrolases.
1
 
This work focuses on one acyl-ACP TE family, TE14, which is made up of sequences 
produced by bacteria and plants. Among the plant-derived members in TE14 are the FatA 
and FatB enzymes.
2
 All bacterial sequences come from genomic projects, including PDB 
structures 2ESS and 2OWN. No existing bacterial sequence in this family has been experi-
mentally characterized. TE14 members have HotDog folds and their catalytic residues have 
been proposed to be cysteine, histidine, and asparagine, arranged in a papain-like catalytic 
triad.
3
  
Several FatA and FatB enzymes have been characterized biochemically, with some 
examples below. FatA enzymes act on long-chain acyl-ACPs with a preference for 18:1 fatty 
acids.
2,4-6
 FatB enzymes preferably hydrolyze acyl-ACPs with saturated fatty acid chains.
2
 
Many Cuphea sequences have been characterized: Cuphea hookeriana FatB enzymes are 
specific for acyl-ACPs with 8- and 10-carbon-long chains,
2
 Cuphea palustris enzymes for 8-, 
10-, 14-, and 16-carbon-long chains,
7
 and Cuphea wrightii enzymes for 12-, 14-, and 16-
carbon-long chains.
8
 Sequences from Arabidopsis thaliana are specific for chains of 14 to 18 
carbon atoms.
9
 Myristica fragans FatB enzymes hydrolyze acyl-ACPs with chains of 14 to 
18 carbon atoms, and Ulmus americana enzymes hydrolyze acyl-ACP with chains of mainly 
8, 10, 14, and 16 carbon atoms.
10
 
TE14 plant acyl-ACP TEs are plastid-targeted enzymes encoded in the nucleus
11
 that 
terminate fatty acid synthesis in plants.
12
 Produced fatty acids later become part of 
membranes or are stored as triacylglycerols.
13
 Since they are key in determining fatty acid 
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length and composition in seed oils, TE14 enzymes become a target for producing oils and 
other carbon-chain-based molecules. Plant triacylglycerols have been proposed as biofuel 
feedstocks,
14
 while short-chain fatty acids could become feedstocks for biorenewable 
platform chemicals.
15
 
This study has two main objectives: 1) to identify TE14 subfamilies and to 
experimentally characterize their members, and 2) to search for naturally occurring TEs that 
hydrolyze short-chain acyl-ACP molecules. To do that, we have conducted a phylogenetic 
and statistical study of TE14, dividing it into subfamilies, allowing researchers to better infer 
biochemical properties of closely related sequences.  
 
Phylogenetic and statistical analysis methods 
TE sequences that make part of TE14
1
 in the ThYme database to date were taken from 
the GenBank
16
 and UniProt
17
 databases. Fragments and incomplete sequences were removed, 
yielding 360 amino acid sequences. The catalytic domains of these sequences were aligned 
using MUSCLE 3.6
18
 with default parameters to create a multiple sequence alignment 
(MSA). 
An unrooted phylogenetic tree based on the MSA was built using Molecular Evolutionary 
Genetics Analysis 4 (MEGA4).
19
 The minimum evolution algorithm was used due to its high 
effectiveness with large data sets,
20
 gaps were treated with pairwise deletion, and an amino 
acid Jones-Taylor-Thornton (JTT) distance model
21
 was chosen. The phylogenetic tree was 
further verified by a bootstrap test with 1000 replicates. 
The bootstrapped consensus tree was qualitatively analyzed and broken down into 
apparent subfamilies. A statistical analysis was done to show that all sequences within a 
subfamily are more closely related to each other than to those in other subfamilies. Based on 
the MSA, JTT distances between all sequences were calculated and arranged into a j x j 
matrix, where j is the total number of sequences. Inter-subfamily distances and variances 
were determined using this matrix. For each apparent subfamily a smaller k x k matrix, where 
k is the number of sequences in a given subfamily, was calculated. From this, intra-subfamily 
mean distances and variances can be determined. These values were applied to the equation 
below to determine z: 
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where xavg,ij, xavg,ii, and xavg,jj are the inter- and intra-subfamily mean JTT distances, nij, nii, and 
njj are the total number of taxa used for each xavg value, and σ
2
i, σ
2
ii, and σ
2
jj are the pooled 
inter- and intra-subfamily variances.
22
 
A z-value > 3.3 between two subfamilies shows that the difference between the 
subfamilies is statistically significant to p < 0.001. If a z-value between two apparent 
subfamilies were < 3.3, different apparent subfamilies were chosen and/or individual 
sequences were removed, and the statistical calculations were repeated. Subfamilies were 
finally defined with a phylogenetic tree in which all z-values exceeded 3.3, sometime leaving 
some sequences outside any subfamily (i.e. non-grouped sequences). 
All sequences within individual subfamilies were aligned using MUSCLE 3.6 and rooted 
phylogenetic trees were built in MEGA4 with the same tree and bootstrap parameters as des-
cribed above. A few sequences from another subfamily (that with the highest z-value) were 
chosen to root individual subfamily’s trees. 
 
Results and discussion 
A subfamily must have at least five sequences from different species, and it must pass the 
statistical tests. Ten subfamilies were found (Figure 5.1) in which 326 sequences appear; in 
addition 34 sequences could not be grouped into a subfamily. All z-values are > 3.4, ranging 
from 3.41 to 29.7 (Table 5.1), and mean distances between different subfamilies are larger 
than those within subfamilies (Table 5.1). Individual trees of each subfamily appear in the 
Supplementary Information at the end of the chapter. 
All 81 Subfamily A (SubA) members are produced by angiosperms, many encoded by 
various FatB genes, of which some have been previously experimentally characterized 
(Supplementary Information, Figure 5S-A). Several genes were chosen for experimental 
characterization: two Iris and two Sorghum genes, also one from Ulmus and one from 
Cuphea that have been previously characterized as controls. Three coconut genes previously 
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identified appear in this subfamily. 
Of the 21 SubB members, most come from angiosperms with some from the moss 
species Physcomitrella patens (Figure 5S-B). No previous experimental work has been done 
on any sequence appearing in SubB. Three genes were experimentally characterized, two 
from Sorghum and one from Physcomitrella. 
SubC has 32 members, all produced by angiosperms, and a significant number of them 
are encoded by FatA genes act on long-chain acyl-ACP molecules (Figure 5S-C). No genes 
were chosen for experimental characterization in this family, as many have already been 
characterized. 
SubD has six algal sequences, with none having any previous experimental work, found 
in Chlamydomonas, Ostreococcus, and Micromonas (Figure 5S-D). One Micromonas 
sequence was selected for further experimental characterization. 
The 17 sequences in SubE all come from Gram-negative bacteria: halophilic 
(Salinibacter and Rhodothermus), sulfate-reducing (Desulfovibrio, Desulfohalobium, and 
Desulfonatronospira), chemoorganotrophic (Spirosoma), metal-reducing (Geobacter, 
Pelobacter, and Anaeromyxobacter), and marine (Microscilla). (Figure 5S-E) No subfamily 
member has been experimentally characterized. One Desulfovobrio sequence was 
experimentally studied. 
SubF consists of 24 sequences, mainly from Bacteroides but also from other related 
bacteria (Figure 5S-F). No member of this subfamily has been experimentally characterized, 
but PDB structure 2ESS (Figure 5.2), obtained from a structural genomic effort, is part of this 
subfamily. One Bacteroides and one Parabacteroides genes were experimentally 
characterized. 
SubG has 31 sequences, primarily from Clostridium (Figure 5S-G). No subfamily G 
member had been subjected to experimental work. One Clostridium gene was experimentally 
characterized.  
SubH has 27 bacterial sequences with no previous experimental information (Figure 5S-
H). All members are from bacterial genera, mainly from Clostridium. One Clostridium gene 
and one Bryantella gene were chosen for experimental characterization. 
SubI has eight bacterial sequences with no previous experimental information (Figure 5S-
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I). Members come from various bacterial genera, mainly from Clostridium. One Geobacillus 
gene was experimentally studied. 
SubJ has 79 members, all Gram-positive lactic acid bacteria, almost completely from the 
genera Lactobacillus, Enterococcus, and Streptococcus (Figure 5S-J). No previous 
experimental characterization has been done on any sequence in this family, but PDB 
structure 2OWN (Figure 5.2), obtained from a structural genomic effort, appears in this 
family. One Streptococcus gene and two Lactobacillus genes were experimentally 
characterized. 
Some sequences were not grouped into any subfamily. These include two plant, four 
moss, and 28 bacterial sequences. They appear throughout the overall phylogenetic tree, with 
most more closely related to subfamilies SubF, SubG, SubH, SubI, and a few closely related 
to SubA, SubC, and SubE. No experimental work has been done in any of these sequences.  
 
Comments on published paper and conclusion 
Thirty-one genes were chosen based on this phylogenetic work, cloned in E. coli, and the 
in vivo substrate specificities found. Based on their specificities, these enzymes were 
clustered into three classes: 1) Class I acyl-ACP TEs act primarily on 14- and 16-carbon 
acyl-ACP substrates; 2) Class II acyl-ACP TEs have broad substrate specificities, with major 
activities toward 8- and 14-carbon acyl-ACP substrates; and 3) Class III acyl-ACP TEs act 
predominantly on 8-carbon acyl-ACPs. Several novel acyl-ACP TEs act on short-chain and 
unsaturated acyl-ACP or 3-ketoacyl-ACP substrates, indicating the diversity of enzymatic 
specificity in this enzyme family. 
This study revealed that bacterial sequences provide access to additional functional 
diversity, both relative to acyl chain length specificity (shorter acyl chains, as short as four 
carbon atoms), as well as acyl chains that contain additional chemical functionalities 
(unsaturated acyl chains and acyl chains containing carbonyl groups). This additional 
functional diversity in acyl-ACP TEs can potentially be used to diversify the fatty acid 
biosynthesis pathway to produce biorenewable chemicals. Also, it is important to highlight 
that subfamily and substrate specificity did not correlate. Two very similar sequences in the 
same subfamily can show different substrate specificities, and vice versa.  
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Tables 
 
Table 5.1: Mean JTT distances and z values (bolded) within and between different subfamilies 
 __________________________________________________________________________________________________________________ 
 SubA SubB SubC SubD SubE SubF SubG SubH SubI SubJ 
 __________________________________________________________________________________________________________________ 
SubA 0.36 ± 0.13
a 
 — 
SubB 0.68 ± 0.13 0.58 ± 0.20 
 4.37 — 
SubC 0.94 ± 0.10 0.97 ± 0.13 0.25 ± 0.10 
 25.37 10.95 — 
SubD 1.40 ± 0.08 1.42 ± 0.11 1.29 ± 0.14 0.95 ± 0.30 
 6.14 5.03 5.55 — 
SubE 1.80 ± 0.17 1.85 ± 0.19 1.76 ± 0.20 1.77 ± 0.18 1.53 ± 0.37 
 9.28 7.67 9.10 3.41 — 
SubF 2.09 ± 0.12 2.19 ± 0.20 2.00 ± 0.17 2.04 ± 0.16 1.98 ± 0.20 0.46 ± 0.36 
 22.37 18.53 20.95 9.26 8.20 — 
SubG 2.04 ± 0.19 2.08 ± 0.19 2.01 ± 0.17 2.13 ± 0.18 2.02 ± 0.25 2.05 ± 0.23 1.13 ± 0.40 
 17.24 13.96 17.18 7.57 5.76 11.80 — 
SubH 2.12 ± 0.13 2.23 ± 0.18 2.08 ± 0.14 2.12 ± 0.19 2.05 ± 0.24 2.03 ± 0.22 1.81 ± 0.26 0.96 ± 0.24 
 29.34 21.29 28.10 8.71 7.58 14.37 8.43 — 
SubI 2.24 ± 0.16 2.32 ± 0.17 2.28 ± 0.19 2.37 ± 0.22 2.28 ± 0.26 2.37 ± 0.23 2.22 ± 0.26 2.38 ± 0.26 1.95 ± 0.34 
 8.78 7.98 9.37 5.08 3.41 7.94 4.63 6.81 — 
SubJ 2.21 ± 0.13 2.24 ± 0.15 2.23 ± 0.15 2.36 ± 0.20 2.20 ± 0.22 2.16 ± 0.17 1.91 ± 0.17 2.19 ± 0.25 2.26 ± 0.21 1.23 ± 0.40 
 29.37 20.72 29.69 9.73 8.05 15.06 8.47 15.98 5.10 — 
 __________________________________________________________________________________________________________________ 
a
Standard deviation 
6
0
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Figures 
 
Figure 5.1: Unrooted phylogenetic tree of TE14. Stars denote sequences to be experimentally 
characterized 
 
 
 
 
Figure 5.2: Superimposed PDB structures 2OWN (red) from Lactobacillus plantarum (SubJ) 
and 2ESS (blue) from Bacteroides thetaioatmicron (SubF). 
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Supplementary Information for Chapter 5 
Phylogenetic characterization of an acyl-ACP thioesterase family 
 
Figure 5S-A: Rooted phylogenetic tree of SubA. Black diamonds mark genes that were 
synthesized for experimental characterization, and black circles mark sequences isolated. 
 
Figure 5S-B: Rooted phylogenetic tree of SubB. Black diamonds mark genes that were 
synthesized for experimental characterization. 
 
Figure 5S-C: Rooted phylogenetic tree of SubC. 
 
Figure 5S-D: Rooted phylogenetic tree of SubD. Black diamonds mark genes that were 
synthesized for experimental characterization. 
 
Figure 5S-E: Rooted phylogenetic tree of SubE. Black diamonds mark genes that were 
synthesized for experimental characterization. 
 
Figure 5S-F: Rooted phylogenetic tree of SubF. Black diamonds mark genes that were 
synthesized for experimental characterization, and the black square marks a sequence with 
a known PDB structure. 
 
Figure 5S-G: Rooted phylogenetic tree of SubG. Black diamonds mark genes that were 
synthesized for experimental characterization. 
 
Figure 5S-H: Rooted phylogenetic tree of SubH. Black diamonds mark genes that were 
synthesized for experimental characterization. 
 
Figure 5S-I: Rooted phylogenetic tree of SubI. Black diamonds mark genes that were 
synthesized for experimental characterization. 
 
Figure 5S-J: Rooted phylogenetic tree of SubJ. Black diamonds mark genes that were 
synthesized for experimental characterization, and the black square marks a sequence with 
a known PDB structure. 
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Abstract 
Many thioesterases have a structural HotDog fold. Based on crystal structures, many 
putative mechanisms have been proposed for HotDog fold thioesterases. The reaction of the 
human thioesterase enzyme (hTHEM2) is explored by first-principles methods to elucidate 
atomic and electronic details of the mechanism, transition-state conformation, and energy of 
the process. Mixed quantum mechanics/molecular mechanics simulations using the 
metadynamics technique are used. An acid-base-like mechanism is found. The activation of 
nucleophilic water by an aspartate residue acting as a base, as well as the tetrahedral-like 
intermediate, are confirmed as previously proposed. Additionally, new evidence pointing 
toward thioester substrate protonation from a histidine residue via a serine residue is 
presented. To our knowledge, this is the first time a thioesterase has been studied by first-
principles methods. 
 
Introduction 
Thioesterases (TEs) (EC 3.1.2.–) hydrolyze the thioester bond between a sulfur atom and 
a carbonyl group. At present TEs are classified into 25 families
1
 by statistically significant 
differences in amino acid sequence, and are present in the ThYme database.
2
 Families with 
strong structural similarities may be grouped into clans. Most TEs hydrolyze acyl-acyl carrier 
protein (ACP) or acyl-coenzyme A (CoA) molecules. Acyl-ACP TEs mainly occur in fatty 
acid synthesis, while acyl-CoA TEs are found in numerous biochemical pathways. Most 
acyl-ACP and acyl-CoA TEs have one of the two major structural folds: the α/β hydrolase 
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fold,
3
 and the HotDog fold.
4
 The mechanism of α/β hydrolase-fold TEs has been resolved; it 
is very similar to that of serine proteases that employ a serine/histidine/aspartate catalytic 
triad that forms a covalent intermediate with the substrate that is hydrolyzed by water.
5
 
HotDog-fold enzymes lack defined binding pockets and conserved catalytic residues. A 
variety of catalytic residues and mechanisms have been proposed for TEs with this structural 
fold.
6
 Given the sequence and structural variety displayed and the wide array of substrates 
that HotDog-fold TEs act upon, several mechanisms exist in different TEs of this type. They 
can be roughly divided into two main groups, Clan TE-A and Clan TE-B by structure.
1
 and 
active-site geometry Arrangement Ψ and Arrangement R.7 In most cases, Clan TE-A TEs 
display an active-site Arrangement Ψ, while Clan TE-B TEs have an active-site Arrangement 
R. There are other HotDog TEs that do not fall into these two clans, such as acyl-ACP TEs of 
type II fatty acid synthesis, as well as CalE7 TEs, and fluoroacyl-CoA TEs. 
The 4-hydroxybenzoyl-CoA thioesterase 1 (4HBT1) from Family TE10 shows the 
mechanism present in Clan TE-A enzymes. In 4HBT1, an aspartate residue attacks the 
thioester carbon atom, forming an anhydride acyl-enzyme intermediate. Then the cleaved 
CoASH group activates a water nucleophile that hydrolyzes the intermediate, the second step 
being rate-limiting.
8,9
 
Several mechanisms for Clan TE-B enzymes have been proposed. Two mechanisms have 
been found for the 4-hydroxybenzoyl-CoA thioesterase 2 (4HBT2) enzyme, present in TE11. 
In one mechanism, a glutamate residue acts as a nucleophile that attacks the thioester carbon 
atom in the substrate, forming a substrate-enzyme intermediate. This is followed by 
hydrolysis by a water molecule activated by a threonine residue, while glutamine and glycine 
residues stabilize the thioester.
10,11
 Interestingly, in the second proposed mechanism, when 
the glutamate residue is substituted by an aspartate, the aspartate acts as a base that activates 
a water nucleophile that attacks and hydrolyzes the thioester carbon atom.
11
 The proposed 
mechanisms of TE8 and TE13 are similar to the second proposed mechanism of TE11. In 
thioesterase PaaI, present in TE13, it has been proposed that an aspartate residue acts as a 
base, activating a water molecule that acts as a nucleophile attacking the thioester carbon 
atom.
12,13
 
In the human TE superfamily member 2 (hTHEM2) enzyme, from TE8, the proposed 
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mechanism is a nucleophilic attack by a water molecule activated by Asp65, and oriented by 
Asp65 and Ser83, on the thioester carbon atom.
14
 A tetrahedral-like intermediate is formed 
where Asn50 and Gly57 polarize the thioester, and Asn50 assists the leaving thiolate group. 
No residue was proposed to protonate the thioester substrate’s sulfur. The physiological 
function of hTHEM2 is unknown; however, it acts on a range of acyl-CoA substrates in 
vitro.
14
 Mutagenesis studies reveal that only mutating Asp65 stops enzymatic activity 
completely. Other active-site mutations reduce activity significantly.
14
 The enzyme and 
active site are shown in Figure 6.1. 
This work is an effort to further study HotDog-fold TE mechanisms. The hTHEM2 
enzyme in TE8 was chosen because its Protein Data Bank (PDB) structure 3F5O
14
 was 
crystallized with an inhibitor (undecan-2-one-CoA, in which O=C-CH2-S substitutes for 
thioester O=C-S) in the active site, which allows for first-principles molecular simulation. 
The reaction of the hTHEM2 enzyme is explored by first-principles methods to elucidate 
atomic and electronic details of the mechanism, transition-state conformation, and energy of 
the process. The activation of a nucleophilic water by Asp65, acting as a base, as well as the 
tetrahedral intermediate, are confirmed. Additionally, new evidence pointing toward thioester 
substrate protonation from a histidine residue via a serine residue is presented. To our 
knowledge, no TE reaction has been studied by first-principles methods. Procedures closely 
follow previous work done with hydrolytic enzymes.
15-18
 
 
Computational methods 
Classical Molecular Dynamics 
Molecular dynamics (MD) simulations were done on crystal structure 3F5O
14
 with 
hexanoyl-CoA as the substrate. Chains A and B of 3F5O were taken from the PDB with the 
undecan-2-one-CoA inhibitor removed. Protonation states of histidine residues (HIP, double-
protonated; HID, ND protonated; or HIE, NE protonated) were chosen based on the 
surrounding environment and the potential hydrogen bonds with neighboring residues. 
Amino acid residues were modeled with the FF99SB Amber
19
 force field. Active-site 
crystallographic water molecules were kept, and the enzyme was solvated by adding a water 
box with a 12-Å cushion around the protein surface. Water molecules were treated using the 
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TIP3P
20
 force field. Chlorine ions were added to neutralize the charge. The thioester 
substrate, hexanoyl-CoA, was prepared by editing the inhibitor undecan-2-one-CoA 
molecules using MacMolPlt
21
 software. It was placed in the enzyme active site keeping 
crystallographic CoA coordinates. The antechamber module in Amber and the Generalized 
Amber Force Field
22
 with RESP charges were used to obtain substrate parameters. Topology 
and coordinate files of the neutralized and solvated substrate-enzyme system were created for 
MD in Amber11.
23
 
The system was minimized in steps. First the enzyme and substrates were restrained and 
water and ions were allowed to move freely, followed by restraining only the substrate and α-
carbon atoms of enzyme residues, followed by minimization with no restrictions. The system 
was then taken slowly over 100 ps to 300K with substrate and enzyme restrained. Then the 
system was simulated for 1 ns with active-site atom restraints. The structure and simulation 
were analyzed with the Visual Molecular Dynamics
24
 (VMD) package. The final frame was 
chosen as the starting geometry for QM/MM simulations. 
 
QM/MM Molecular Dynamics 
The method developed by Laio and coworkers
25
 that combines first-principles Car-
Parrinello MD
26
 (CPMD) method with classical MD was used to perform quantum 
mechanics/molecular mechanics (QM/MM) simulations. It couples a QM region of the 
system, whose atomic dynamics are ruled by electron density computed with density 
functional theory, with an MM region whose atomic dynamics are described by an empirical 
force field. The QM/MM interface is modeled by link-atom pseudopotentials that saturate the 
QM region.
27
 The electrostatic interactions between QM and MM regions were treated with a 
Hamiltonian coupling scheme where short-range electrostatic interactions between QM and 
MM regions were explicitly taken into account.
25
 A modified Coulomb potential ensures no 
unphysical escape of the electronic density from the QM to the MM region. Distant 
electrostatic interactions are treated via a multipole expansion. 
The QM region (Figure 6.2) includes the side chains of active-site residues Asp65, Ser83, 
and His134 from chain A, Asn50 from chain B, the nucleophilic water molecule, and a 
section of the hexanoyl-CoA thioester substrate (COH). Amino acid side chains were capped 
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at carbon atoms with a link atom: Asn50, Asp65, and Ser83 at their α-carbon atoms and 
His134 at its β-carbon atom. The substrate was capped at the C4 atom of the hexanoyl-CoA 
molecule and at the second carbon atom from the thioester sulfur of the CoA group. The QM 
region was enclosed in a 27-Å x 40-Å x 27-Å cell. The enzyme was studied in the three 
possible protonation states of His134. The HIP134 system included a total of 49 atoms in the 
QM region with a net zero charge, and for the HID134 system 48 atoms and a –1 charge. The 
HIE134 case was not considered after classical MD (Results section). Kohn-Sham orbitals 
were expanded in a plane-wave basis set with a kinetic energy cutoff of 70 Ry. Ab initio 
pseudopotentials generated by the Troullier-Martins scheme
28
 were used, as was the Perdew-
Burke-Ernzerhoff functional
29
 in the generalized gradient-correction of density functional 
theory. 
CPMD simulations used a time step of 0.145 fs (6 atomic units of time) and a fictitious 
electron mass of 700 atomic units. The system reached a constant temperature of 300K by 
coupling it to a Nosé-Hoover thermostat
30
 of 3500 cm
–1
 frequency. Running QM/MM MD 
while annealing the ionic velocities until the maximal component of the nuclear gradient was 
<10
–2
 optimized the geometry. Active-site distance constraints were placed, and the system 
was simulated for 0.87 ps, or 6,000 time steps, of QM/MM MD. The final QM/MM MD 
frame is the starting geometry for metadynamics QM/MM simulations. The CPMD program 
(CPMD–Program) was used for all QM/MM simulations. 
 
Metadynamics 
The metadynamics technique
31
 was used to induce the enzymatic reaction and to 
reconstruct the free energy surface (FES) of the process. Metadynamics is used to simulate 
rare events by reducing the dimensions of a system, and it has been used to solve problems in 
chemistry, materials science, and biophysics.
32
 Collective variables (CVs) are chosen, and 
repulsive energy terms (Gaussian-like potentials) are added in CV space of the system 
explored by MD. This allows the system to escape free energy minima and to explore non-
equilibrium conformations. CVs need to clearly describe the event desired to be explored and 
to differentiate between initial and final states. Further, the FES of the simulated event as a 
function of CV space can be reconstructed by summing the Gaussian-like repulsive terms 
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added during the simulation. Metadynamics was first used to simulate an enzymatic reaction 
in 2006.
33
 
Coordination numbers (CNs) indicate the presence of a covalent bond. The CN between 
atoms a and b is given by: 
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where dab is the distance between atoms a and b, d
o
 is the threshold distance of bonding, and 
p and q are exponents that determine the curve of CN as a function of dab. CNab values range 
from 0 (no bond) to 1 (bond present).  
The CVs chosen in this work are differences of CNs between two bonds (Figure 6.3).
34
 
CVnucl describes the nucleophilic attack of the water molecules, being the difference 
between the CN of the thioester carbon atom and nucleophilic water molecule and the CN 
between the thioester carbon and sulfur atoms (Equation 2). CVprot–ser describes the proton-
ation of the thioester from active-site serine residue, being the difference between the CN of 
the thioester sulfur and the Ser83 hydrogen atom and the CN between the Ser83 hydrogen 
and oxygen atoms (Equation 3). Similarly, CVprot–asn describes the protonation of the 
thioester sulfur atom by the active-site Asn50 residue, being the difference between the CN 
of the thioester sulfur and the Asn50 hydrogen atoms and the CN between the Asn50 
hydrogen and nitrogen atoms (Equation 4). The values of all CVs range from –1 in the 
reactant side of the reaction to +1 in the product side of the reaction. 
 
CVnucl = CN(Owat-Ccoh) – CN(Ccoh-Scoh)      (2) 
CVprotser = CN(Scoh-Hser) – CN(Hser-Oser)    (3) 
CVprotasn = CN(Scoh-Hasn) – CN(Hasn-Nasn)   (4) 
 
Metadynamics simulations were done with the Car-Parrinello approach where the 
Lagrangian includes extra terms that describe the fictitious dynamics of the CVs.
34
 These are 
coupled by a harmonic potential to the real CV values. Mass and force constants of the 
harmonic potential were chosen to ensure the best agreement between real and fictitious 
particles. A mass constant of 20 amu and force constant of 7 au were chosen. The height of 
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the repulsive Gaussian-like terms used was either 0.005 or 0.002 Hartree atomic units of 
energy (3 or 1.25 kcal/mol), and the width 0.08 or 0.05 Å. Gaussian-like potentials were 
added every 200 MD steps.  
 
Results and discussion 
Classical and QM/MM Molecular Dynamics 
Due to its active-site location, all possible protonation states of His134 were explored. 
The classical MD protocol was performed independently, without restraints in the 
equilibration nanosecond, on the system with HID134, HIE134, and HIP134 protonation 
states. Crystallographic His134 coordinates were compared to the His134 coordinates after 
classical MD (Supplementary Information, Figure 6S-A), and the RMSD between 
corresponding non-hydrogen atoms was calculated, yielding 0.78 Å for the HID134 system, 
1.45 Å for the HIE134 system, and 0.85 Å for the HIP134 system. The histidine residue side 
chain changed conformation significantly in the HIE134 case, but not so for HID134 and 
HIP134. The HIE case therefore was not explored further. 
The system and active-site coordinates were analyzed after performing the classical MD 
and QM/MM MD protocols on the HID134 and HIP134 systems. The final frames after 
classical MD and after QM/MM MD were compared to crystallographic coordinates. The 
RMSD values of active-site residues and the whole enzyme between crystallographic 
coordinates corresponding with final classical MD and QM/MM MD coordinates are shown 
in Table 6.1 for both the HID134 and HIP134 systems. Also, active-site residues of the final 
frames from classical MD and QM/MM MD are shown with their corresponding crystal-
structure residues superimposed (Figure 6S-B). Low RMSD values and similar structures 
reveal the final classical MD frame as a good starting frame for QM/MM MD, and the final 
QM/MM MD frame as a good starting geometry for QM/MM metadynamics simulations. 
 
QM/MM Metadynamics: Reaction Pathway and Free Energy Surface 
QM/MM metadynamics simulations on the HIP134 system used CVnucl and CVprot–ser 
as collective variables, while the HID134 system used CVnucl and CVprot–asn to explore the 
reaction. The HIP134 system simulation achieved enzymatic reaction (discussed in this 
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section), while the HID134 system simulation did not (next section). 
The QM/MM metadynamics simulation of the HIP134 system ran for 8.7 ps (60,000 time 
steps). The values of CVnucl and CVprot–ser over the simulation time can be seen in Figure 
6.4A. Relevant bond lengths are also shown as a function of simulation time. Figure 6.4B 
shows two distances, Oasp–Hwat and Hwat–Owat, that represent the activation of the water 
nucleophile by Asp65 acting as a base. Figure 6.4C shows the distance between the 
nucleophilic water oxygen atom to the thioester carbon atom, Owat–Ccoh, and the thioester 
bond length, Ccoh–Scoh, representing thioester hydrolysis. In Figure 6.4D the distance 
between the thioester sulfur atom and the Ser83 hydrogen atom, Scoh–Hser, and the length 
between the Ser83 hydrogen and oxygen atoms, Hser–Oser, appear, showing substrate 
protonation. Figure 6.4E shows the distances between the Ser83 oxygen atom and the 
HIP134 hydrogen atom, Oser–Hhip, and between the HIP134 hydrogen and nitrogen atoms, 
Hhip–Nhip, which represent the protonation of Ser83 by HIP134. 
The reactant state was explored during the first 1 ps of simulation time. The values of the 
CVs remain between –1 and –0.05, and the water molecule O–H bond, the Ser83 O–H bond, 
and the HIP134 N–H bond oscillate around their average bond lengths. Between 1 ps and 3 
ps of simulation time, CVnucl approaches zero, while CVprot–ser remains close to –1. This 
represents the nucleophilic water molecule approaching the thioester carbon atom, and the 
thioester bond length increasing (Figure 6.4C). During the same time, the Ser83 O–H bond 
length does not increase significantly, nor does the Ser83 hydrogen atom approach the 
thioester sulfur atom (Figure 6.4D). 
The enzymatic reaction occurs near 3 ps of simulation time. The value of CVnucl first 
changes from ~0 to ~1, and quickly afterward CVprot–ser changes from –1 to ~1. This shows 
that the nucleophilic attack occurs first, quickly followed by protonation of the thioester 
sulfur atom by the Ser83 hydrogen atom, completing hydrolysis of the thioester substrate. 
After reaction occurred, Asp65 became aspartic acid as it took a hydrogen from water during 
reaction (Figure 6.4B), the thioester bond broke and the fatty acid product was made (Figure 
6.4C). This is irreversible, represented by the value of CVnucl that remains near 1 for the 
remainder of the simulation. However, the value of CVprot–ser changes after the reaction. 
After the thioester bond breaks, the CoASH product switches between its thiol and thiolate 
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forms, sharing a hydrogen atom with Ser83. A serine residue will not readily donate a proton 
when close to neutral pH, and for that to occur, it has to receive a proton as well. At the same 
time that Ser83 protonates the thioester, it receives the HIP134 hydrogen atom. 
By summing all the Gaussian-like repulsive energy terms added during the metadynamics 
simulation in CV space, the free energy surface (FES) of the system as a function of CVnucl 
and CVprot–ser was reconstructed. Figure 6.5 shows the FES of the system, with its main 
reaction path states highlighted. From the FES, the energy barrier of the reaction is estimated 
to be between 20 and 25 kcal/mol. Based on the kcat values of hTHEM2
14
 at two 
temperatures, the reaction activation energy was calculated to be 19.14 kcal/mol, showing 
good agreement between experimental and simulation estimates of the TE reaction energy 
barrier. 
The reactant state (R), intermediate reactant state (R’), transition state (TS), intermediate 
product state (P’), and product state (P) can be distinguished in the FES. The simulation 
trajectory starts in R , passes to R’ with some recrossing between them, then explores TS, 
and falls into the product well after first passing through P’. The simulation trajectory 
oscillates between the P and P’ states (Figure 6.4A, CVprot–ser), but there is no recrossing 
the TS (Figure 6.4A, CVnucl). The product well is considerably deeper than the -45 kcal/mol 
shown in Figure 6.5, as the simulation was stopped before reaching the bottom of the well, 
since the fatty acid and CoASH products would not reform back into the thioester substrate. 
The summation of Gaussian-like repulsive energy terms in the P state corresponds to -45 
kcal/mol. 
The geometries of each reaction pathway state appear in Figures 6.6 and 6.7, relevant 
bond length values are found in Table 6.2, and the electrostatic potential charges of relevant 
atoms are in Table 6.3. The simulation first explored R and R’ where no reaction occurred. 
R’ differs from the reactants in that the water molecule comes closer to the thioester (Owat–
Ccoh, Table 6.2) and an increase in thioester bond length occurs (Ccoh–Scoh, Table 6.2). 
Otherwise, the two states have roughly equal distances between the water molecule and 
Asp65, the thioester to Ser83, and Ser83 to HIP134 (Table 6.2). The electrostatic potential 
charges of relevant atoms do not differ much between R and R’ except for that of Scoh, 
which decreases as the thioester bond length increases. 
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In the TS (Figure 6.7), Asp65 takes a proton from the water molecule (Oasp–Hwat, 
Hwat–Owat, Table 6.2), the activated nucleophilic water molecule comes in close contact 
with the thioester carbon atom (Owat–Ccoh, Table 6.2), and the thioester bond length 
increases. A tetrahedral-like geometry is observed (Figure 6.7B) between Ccoh, Ocoh, Scoh, 
C2coh, and Owat. Gly57 helps to stabilize the tetrahedral-like intermediate, where Ocoh 
comes within hydrogen-bonding distance (2.32 Å) to the Gly57 hydrogen atom during the 
TS. Also in the TS, protonation is set to happen as the Ser83 hydrogen atom approaches 
Scoh, and the HIP134 hydrogen atom approaches the Ser83 oxygen atom. The electrostatic 
charges of relevant atoms change at the TS. The Oasp atom goes from negative to neutrally 
charged as it accepts a proton from the water molecule. The Owat negative charge decreases 
as it becomes hydroxide ion-like and approaches the thioester carbon atom, forming part of 
the tetrahedral-like intermediate seen in the TS. The charge on the thioester carbon atom, 
Ccoh, decreases slightly, and the thioester oxygen atom charge changes from close to zero to 
negative. The thioester sulfur atom charge decreases again as the thioester bond breaks. The 
Ser83 oxygen atom charge becomes less negative as its hydrogen atom approaches the 
thioester group and accepts a proton from HIP134. 
In P and P’, Asp65 has accepted a proton from the water molecule, the thioester substrate 
has been hydrolyzed, and the fatty acid is formed. P and P’ differ in the protonation state of 
the CoASH product. In P’, Ser83 still holds its hydrogen atom while accepting the HIP134 
hydrogen atom, and a thiolate product CoAS
–
 appears. In P, the thiolate has accepted the 
Ser83 hydrogen and has become a thiol (CoASH), Ser83 has taken the HIP134 hydrogen 
atom, and HIP134 has lost a hydrogen atom, changing to its HID protonation state. The 
relevant atomic charges do not differ much between the P and P’ states except for Scoh, 
which is more negative in P’ as part of a thiolate group. The Ccoh charge has become more 
positive in P and P’, and the HIP134 charge has become negative, as it has lost its hydrogen 
atom to Ser83. 
 
Non-reactive HID134 System 
The QM/MM metadynamics simulation of the HID134 system ran for 12.18 ps (84,000 
time steps). The values of CVnucl and CVprot–asn over the simulation time can be seen in 
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Figure 6S-C and the FES in Figure 6S-D. No reaction was observed in this metadynamics 
simulation. The simulation only explored the reactants, as the CVnucl and CVprot–asn values 
never became positive, and the FES was only constructed in the reactant state, where all 
repulsive Gaussian-like terms were added. The simulation was stopped when the energy 
barrier to escape the reactant state exceeded 100 kcal/mol. 
The HID134 system did not include CVprot–ser, as a serine residue will not readily give 
up a proton at near-neutral pHs without receiving an additional proton beforehand. The only 
residue in a position to protonate Ser83 is His134, and that cannot occur in its HID 
protonation state. Likewise, it is unlikely that Asn50 can give a proton at near-neutral pHs 
without receiving an additional proton. There are no residues in the enzyme that can donate a 
proton to the Asn50 C=O group, so that it can donate a proton from its NH2 group to the 
thioester. Figure 6S-E shows residues that appear within proton-donating distance of Asn50 
in the reactant state of the HID134 system: the C=O in the Asn50 side chain forms hydrogen 
bonds with backbone N-H groups from Ile52 and Thr54. Although not catalytic, Asn50 plays 
an important active-site role by positioning the substrate and stabilizing the TS tetrahedral-
like intermediate (an Ocoh–Hasn distance of 3.27 Å). 
 
Conclusions 
Based on previous work
14
 and the metadynamics QM/MM simulations performed in this 
study, a proposed mechanism of hTHEM2 can be seen in Figure 6.8. Asp65 acts as a base 
that activates a water molecule that performs a nucleophilic attack on the thioester carbon 
atom, hydrolyzing the substrate. HIP134 acts as an acid and donates a proton to Ser83, which 
in turn protonates the substrate thioester sulfur atom. In the TS, the thioester and nucleophilic 
water molecule form a tetrahedral-like intermediate while HIP134 starts to donate a proton to 
Ser83, which approaches the thioester sulfur atom. Asn50 and Gly57 play a role in 
positioning the substrate and stabilizing the TS tetrahedral-like intermediate. This study 
supports with first-principles calculations the basic character of Asp65, the hydrolysis of the 
thioester by a nucleophilic attack on the thioester carbon by an activated water molecule, and 
the proposed tetrahedral-like geometry of the TS. Additionally, new evidence is given that 
suggests that HIP134 protonates the thioester via Ser83. 
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Two main mechanisms have been proposed for HotDog-fold TEs: one where aspartate or 
glutamate residues act as a nucleophile, forming an enzyme-substrate intermediate that is 
hydrolyzed by a water molecule, and the second a one-step acid-base-like catalytic 
mechanism as proposed in this work for hTHEM2. Although only the first mechanism has 
been observed in Clan TE-A enzymes, both appear in Clan TE-B enzymes. It is likely that all 
HotDog-fold TEs employ either or both mechanisms for catalysis, unlike α/β hydrolase-fold 
TEs that appear to always use a serine protease-like mechanism. 
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Tables 
 
Table 6.1: RMSDs (Å) of Final Classical and QM/MM MD Frames Compared to 
Crystallographic Coordinates 
 
 HID HID HIP HIP 
 –––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 Residue(s) classical MD QM/MM MD classical MD QM/MM MD 
____________________________________________________________________ 
Full enzyme 0.75 0.72 0.92 0.91 
 Asn50 0.68 0.75 0.80 0.65 
 Asp65 0.87 1.00 0.91 0.56 
 Ser83 0.91 1.04 0.86 0.83 
 His134 0.52 0.51 0.61 0.54 
____________________________________________________________________ 
 
 
Table 6.2: Bond Lengths (Å) along Reaction Pathway 
 
 Bond R R’ TS P’ P 
Oasp–Hwat 1.61 ± 0.10 1.60 ± 0.11 1.10 ± 0.06 0.99 ± 0.01 0.99 ± 0.01 
Hwat–Owat 1.03 ± 0.03 1.04 ± 0.03 1.41 ± 0.17 4.58 ± 0.52 4.48 ± 0.52 
Owat–Ccoh 3.16 ± 0.17 2.82 ± 0.49 1.81 ± 0.09 1.35 ± 0.03 1.35 ± 0.03 
Ccoh–Scoh 1.81 ± 0.10 2.11 ± 0.08 2.26 ± 0.04 4.62 ± 0.40 4.56 ± 0.33 
Scoh–Hser 2.52 ± 0.16 2.33 ± 0.31 1.82 ± 0.07 1.58 ± 0.04 1.37 ± 0.07 
Hser–Oser 1.03 ± 0.07 1.04 ± 0.07 1.09 ± 0.05 1.33 ± 0.05 2.04 ± 0.29 
Oser–Hhip 1.78 ± 0.13 1.74 ± 0.14 1.34 ± 0.05 1.06 ± 0.04 1.02 ± 0.04 
Hhip–Nhip 1.05 ± 0.03 1.06 ± 0.05 1.15 ± 0.05 1.60 ± 0.14 1.74 ± 0.16 
 
 
Table 6.3: Electrostatic Potential Charges of Relevant Atoms along Reaction Pathway 
 
Atom R R’ TS P’ P 
Oasp –0.15 ± 0.04 –0.13 ± 0.04 0.01 ± 0.02 0.00 ± 0.03 0.02 ± 0.03 
Owat –0.28 ± 0.04 –0.24 ± 0.05 –0.13 ± 0.04 0.00 ± 0.03 0.01 ± 0.04 
Ccoh 0.07 ± 0.02 0.08 ± 0.02 0.04 ± 0.02 0.19 ± 0.03 0.19 ± 0.03 
Ocoh –0.01 ± 0.02 0.01 ± 0.04 –0.12 ± 0.02 –0.14 ± 0.12 –0.17 ± 0.10 
Scoh –0.05 ± 0.08 –0.26 ± 0.08 –0.43 ± 0.04 –0.65 ± 0.06 –0.45 ± 0.06 
Oser –0.16 ± 0.04 –0.14 ± 0.05 –0.05 ± 0.02 0.04 ± 0.03 –0.06 ± 0.06 
Nhip 0.05 ± 0.02 0.06 ± 0.04 0.05 ± 0.01 –0.10 ± 0.04 –0.12 ± 0.05 
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Figures 
 
Figure 6.1: A) Overall structure with inhibitor shown, and B) active-site residues of TE8 
human THEM2 thioesterase (PDB 3F5O) 
 
 
 
Figure 6.2: QM region. Active site residues in blue, and section of substrate in purple. 
Relevant atoms labeled in notation used throughout 
 
 
 
Figure 6.3: Collective variables displayed in active site 
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Figure 6.4: Variation of CVs (A) and bond lengths (B–E ) during TE8 human THEM2-
catalyzed hydrolysis of the thioester substrate. X-axes represent simulation time in 
picoseconds. Y-axis in A represents value of CVs. Y-axis in B–E  represents distance in Å 
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Figure 6.5: Free energy surface of TE8 human THEM2-catalyzed hydrolysis of the thioester 
substrate. Contour lines are separated by 2.5-kcal/mol intervals 
 
 
 
Figure 6.6: Positions of catalytic residues, substrate, and water during the reaction pathway 
of TE8 human THEM2-catalyzed hydrolysis of the thioester substrate 
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Figure 6.7: A) Transition-state positions of active-site residues, substrate, and water, and B) 
tetrahedral-like structure geometry of water and substrate during TE8 human THEM2-
catalyzed hydrolysis of the thioester substrate 
 
 
 
Figure 6.8: Proposed mechanism of the TE8 human THEM2-catalyzed hydrolysis of the 
thioester bond in an acyl-CoA substrate 
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Supplementary Information for Chapter 6 
Mechanism of a HotDog-fold acyl-CoA thioesterase proposed by QM/MM 
metadynamics simulation 
 
Figure 6S-A 
 
 
 
Figure 6S-B 
 
 
 
Figure 6S-C  
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Figure 6S-D 
 
 
 
Figure 6S-E 
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CHAPTER 7 
STRUCTURAL CLASSIFICATION AND PROPERTIES OF 
KETOACYL REDUCTASES, HYDROXYACYL DEHYDRATASES, 
AND ENOYL REDUCTASES 
David C. Cantu, Tingsong Dai, Zachary S. Beversdorf, and Peter J. Reilly 
Department of Chemical and Biological Engineering, Iowa State University 
 
Modified from a paper published in Protein Engineering Design & Selection, 25, 803-811, 
with the same title and authors. 
 
Abstract 
Ketoacyl reductases (KRs), hydroxyacyl dehydratases (HDs), and enoyl reductases (ERs) 
are part of the fatty acid and polyketide synthesis cycles. Their reverse reactions, catalyzed 
by acyl dehydrogenases (equivalent to ERs), enoyl hydratases (equivalent to HDs), and 
hydroxyacyl dehydrogenases (equivalent to KRs), are part of fatty acid degradation by β-
oxidation. These enzymes have been classified into families based on similarities in their 
primary and tertiary structures, and these families and structures are included in the ThYme 
(Thioester-active enzYmes) database. Members of each family have strong sequence 
similarity and have essentially the same tertiary structure, mechanism, and catalytic residues. 
 
Introduction 
Fatty acids and polyketides are a structurally and functionally diverse family of chemicals 
abundant throughout nature. In producing fatty acids, six biosynthetic steps, catalyzed by 
acyl-coenzyme A (CoA) synthases, acyl-CoA carboxylases, ketoacyl synthases, ketoacyl 
reductases (KRs), hydroxyacyl dehydratases (HDs), and enoyl reductases (ERs), elongate 
acyl chains by two carbon atoms per cycle until cleavage of CoA or acyl carrier protein 
(ACP) activating agents by thioesterases stops the process (Figure 3.1). This process can be 
catalyzed by a single multimodular enzyme, fatty acid synthase (FAS) in type I fatty acid 
synthesis, or by individual enzymes catalyzing each reaction in type II fatty acid synthesis. 
In polyketide synthesis, the KR-, HD-, and ER-catalyzed steps do not have to occur at 
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every turn, thus leaving keto or hydroxy groups or double bonds in the acyl chain. Also, 
substrates other than malonyl-CoA can elongate the acyl chain, adding different functional 
groups to it. The polyketide synthesis cycle is terminated by hydrolysis of the thioester bond 
between the chain and ACP or CoA, either with water or with a hydroxy group in the chain, 
the latter cyclizing the molecule. These two cycles have been proposed as a potential source 
for industrial and specialty biorenewable chemicals.
1
 
Fatty acids are broken down by β-oxidation, where the KR-, HD-, and ER-catalyzed steps 
in the fatty acid synthesis cycle operate in reverse, with these enzymes given names 
characteristic of the reverse reactions. Oxidation of an acyl-CoA molecule to give 2-enoyl-
CoA is catalyzed by acyl-CoA dehydrogenase (equivalent to ER) with a flavin adenine 
dinucleotide (FAD) prosthetic group. Hydration of 2-enoyl-CoA is catalyzed by 2-enoyl 
hydratase (equivalent to HD), yielding 3-hydroxyacyl-CoA. The third step is oxidation of 3-
hydroxyacyl-CoA by catalysis with L-3-hydroxyacyl-CoA dehydrogenase (equivalent to KR) 
using nicotinamide adenine dinucleotide (NAD
+
) to give 3-ketoacyl-CoA. A final step, 
catalyzed by 3-ketoacyl-CoA thiolase and involving addition of CoA, removes an acetyl-
CoA molecule and leaves an acyl-CoA molecule two carbon atoms shorter than before. 
Information about enzymes and their catalytic domains has been organized into several 
databases such as GenBank,
2
 UniProt,
3
 the Protein Data Bank
4
 (PDB), and the International 
Union of Biochemistry and Molecular Biology enzyme nomenclature system, which uses 
standardized Enzyme Commission (EC) numbers.
5
 GenBank and UniProt are enzyme 
sequence (primary structure) databases, which can expedite searches to group enzymes into 
families based on their similar primary structures. The PDB is a database for three-
dimensional (tertiary) protein structures, useful for further family classification. On the other 
hand, the EC system specifies enzymes by their functions rather than by their structures. This 
is problematical when enzymes with similar sequences have multiple EC numbers. 
Furthermore, many enzymes with similar substrate specificities and products and therefore 
similar EC numbers have very different primary structures and therefore belong to non-
related families. 
We have established the ThYme (Thioester-Active EnzYmes) database
6
 in which fatty 
acid and polyketide synthesis enzymes are classified by their primary and tertiary structures. 
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In this article we report the classification of KR, HD, and ER enzyme groups. Each enzyme 
group consists of more than one family, where members of different families have essentially 
different sequences, implying that in general they may be descended from different protein 
ancestors. Enzymes in a family must have strongly similar primary structures, must have 
nearly identical tertiary structures (if known), and must share general mechanisms as well as 
catalytic residues located in the same tertiary structure positions. 
 
Computational methods 
Methods for identifying families were developed in our previous work
7
 and here are 
applied to KRs, HDs, and ERs. The process can be summarized in five major steps: 
1) Experimentally verified enzyme sequences were used as queries. They were gathered from 
UniProt, using only reviewed entries noted as having “evidence at protein level”. 
2) Successive Basic Local Alignment Search Tool
8
 (BLAST) searches and comparison 
among results reduced query sequences to a few representative ones. 
3) The catalytic domains of representative query sequences were subjected to BLAST to 
populate the families, using an E-value of 0.001 to differentiate among them. These domains 
were identified by referring to Pfam-A,
9
 or they were found in the query sequence by 
constructing a hidden Markov model profile
10
 from a multiple sequence alignment (MSA) 
based on the initial BLAST result. 
4) Experimentally confirmed enzymes were surveyed to search for missing enzyme families. 
5) Families were confirmed by MSAs using MUSCLE,
11 
tertiary structure superpositions and 
comparisons with MultiProt,
12
 and catalytic residue positions. 
Values of root mean square deviation (RMSD) between two structures, RMSDave (among 
three or more structures), and Pave (the average percentage of α-carbon atoms of the amino 
acid residues used to calculate the RMSD between two compared structures) were calculated, 
as explained in detail in the Supporting Information in reference 7. 
 
Results and discussion 
Family Identification 
Seventeen putative KR, HD, and ER families were identified. They include four KR 
  
 
91 
 
families (KR1–KR4), eight HD families (HD1–HD8), and five ER families (ER2–ER6, ER1 
having been deleted) (Table 7.1). 
A representative tertiary structure and the characteristic structural fold of each family 
appear in Table 7.2 NAD(P)-binding Rossmann folds are found in families KR1–KR4, ER2, 
ER4, and ER5. KR2 enzymes have an additional 6-phosphogluconate dehydrogenase C-
terminal fold, and ER5 enzymes have an additional GroES-like fold. Families HD1 and 
HD3–HD6 have HotDog folds. HD2 enzymes have ClpP/crotonase folds, while ER3 and 
ER6 members have TIM barrel folds. No tertiary structures are known for families HD7 and 
HD8. 
Superimposing one structure per species within each family gave low RMSD values, 
ranging from 0.62 to 2.00 Å, and high Pave values, ranging from 77.9 to 99.7% (Table 7.2), 
indicating three-dimensional structural similarity among sequences in each family. 
Furthermore, when catalytic residues in different members in the same family have been 
identified, they are nearly always the same, appear in the same relative positions, and can be 
superimposed (Table 7.3). Finally, as seen below, the same mechanism is found throughout a 
family. 
 
Family KR1 
Family KR1, with over 55,000 primary structures at the time of writing, is the largest 
family in any enzyme group in ThYme. They come from bacteria, eukaryota, and archaea, 
and they display many different functionalities. KR1 includes many reductases and 
dehydrogenases, most not part of fatty acid and polyketide synthesis or of β-oxidation. A 
sample of the functions of enzymes in KR1 appears in Table 7.1 along with a representative 
UniProt accession code. 
The β-oxoacyl-ACP reductases (EC 1.1.1.100) are found in KR1. They reduce β-
ketoacyl-ACP to β-hydroxyacyl-ACP in type II fatty acid biosynthesis, where the individual 
enzymes of the fatty acid synthesis cycle are separate proteins. They are present in bacteria as 
FabG enzymes and are also found in plant chloroplasts.
13
 These enzymes are also present in 
eukaryotic mitochondria,
14
 where type II fatty acid synthesis also occurs.
15
 3-Oxoacyl-CoA 
reductases, the enzymes that catalyze the KR step in fatty acid elongation,
16
 are also found in 
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KR1. 
Also in KR1 are ER enzymes that reduce enoyl groups in acyl chains to single bonds, 
2,4-dienoyl-CoA reductases (DECR), which are auxiliary enzymes in fatty acid β-
oxidation,
17
 and trans-2-enoyl-CoA reductases,
18
 present during fatty acid elongation. 
Most enzymes in KR1 belong to the short-chain dehydrogenase/reductase (SDR) 
superfamily. These enzymes have been extensively reviewed
19
 and classified.
20
 Not all SDR 
enzymes are present in KR1. The present ones include the 3-hydroxyacyl-CoA 
dehydrogenases (EC 1.1.1.35) that catalyze the reverse (from a hydroxyacyl to a ketoacyl) 
reaction on various acyl-CoA substrates in fatty acid β-oxidation, as well as many short-chain 
dehydrogenases, carbohydrate dehydrogenases, and steroid dehydrogenases. 
KR1 tertiary structures are conserved NAD(P)-binding Rossmann folds. Their catalytic 
sites include a highly conserved triad formed by Tyr, Lys, and Ser residues.
20
 The 
mechanism in KR1 enzymes is exhibited by Streptomyces coelicolor actinorhodin polyketide 
ketoreductase. The Ser residue forms a hydrogen bond with the substrate keto group. The Lys 
residue orients the ribosyl ring of NAD(P)H by forming a hydrogen bond with its hydroxyl 
groups. The protonated Tyr residue hydrogen-bonds with a hydroxyl group of the ribosyl ring 
and adds a proton to the substrate keto group. A hydride ion is transferred to the substrate 
carbon atom of the keto group from the nicotinamide ring of NAD(P)H, leaving the latter 
positively charged.
21
 A water-mediated proton relay then takes place to reprotonate the Tyr 
residue. 
Most KR1 (and SDR) enzymes employ the above catalytic mechanism. The catalytic Tyr, 
Lys, and Ser residues of Brassica napus 3-oxoacyl-ACP reductase (FabG), S. coelicolor 
polyketide-ACP reductase, Candida tropicalis 3-hydroxyacyl-CoA dehydrogenase, Bacillus 
megaterium glucose dehydrogenase, and Comamonas testosteroni steroid dehydrogenase are 
in the same position when superimposed (Figure 7.1A). However, even though their 
structures are nearly identical to those of other KR1 members (Figure 7.1B), the catalytic 
residues of dienoyl-CoA reductases appear in a different conformation
19
 (Figure 7.1C). This 
has been noted, and the enzymes with ER function in KR1 have been described as “divergent 
SDRs”.19 
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Family KR2 
KR2 mainly contains acyl-CoA dehydrogenases sequences involved with fatty acid β-
oxidation. Their most common function is dehydrogenation of 3-hydroxyacyl-CoA substrates 
of various chain lengths. Included are the aerobic or anaerobic bacterial fatty acid oxidation 
complex subunit dehydrogenase domains
22
 (FadB or FadJ), plant peroxisomal fatty acid β-
oxidation multifunctional protein (MFP) dehydrogenase domains
23
 expressed during seed 
germination, and eukaryotic peroxisomal and mitochondrial β-oxidation dehydrogenase 
domains, some active on long-chain fatty acids.
24
 
Human 3-hydroxyacyl-CoA dehydrogenase (HADH) displays the KR2 enzyme 
mechanism. A nitrogen atom from a His ring abstracts a proton from the substrate hydroxyl 
group while its position is stabilized by a hydrogen bond between the other His-ring nitrogen 
atom and an adjacent Glu residue. Meanwhile, a hydride ion is transferred from the substrate 
carbon atom bonded to the dehydrogenated hydroxyl atom to a carbon atom in the NAD(H) 
pyrimidine ring.
25
 The His and Glu residues appear in the same conformation in a FabB 
enzyme (Table 7.3). Even though KR1 and KR2 share the same NAD(P)-binding Rossmann 
fold, they employ different mechanisms and contain different catalytic residues. 
 
Family KR3 
In KR3 are the β-oxoacyl-ACP reductase (EC 1.1.1.100) domains of fungal fatty acid 
synthases (FASs), which are part of type I fatty acid synthesis. Fungal FASs are composed of 
two subunits, with the KR domain residing in the subunit along with the ketoacyl synthase 
domain.
26
 Bacterial sequences are also present, all produced by actinobacteria. 
Apparently no mechanism has been proposed for any enzyme in this family. Three 
residues in the active site of the KR3 domain of Saccharomyces cerevisiae fatty acid 
synthase are Ser827, Tyr839, and Lys843,
27
 the same residues found in essentially the same 
positions relative to each other as in KR1 enzymes (Table 7.3). This and the fact that the 
same NAD(P)-binding Rossmann fold is also found in KR3 suggest that the KR3 domain in 
the α subunit of fungal FASs employs the same mechanism as KR1, or SDR superfamily, 
enzymes. 
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Family KR4 
The KR4 family is composed of β-oxoacyl-ACP reductases (EC 1.1.1.100) that form the 
KR4 domains of animal FASs, as well as bacterial and fungal multimodular polyketide 
synthases (PKSs). The animal FASs contain all catalytic domains, KR among them, in a 
single unit needed for fatty acid synthesis.
28
 PKSs vary according to their product molecule, 
yet most require a keto-reduction step and have KR domains.
29
 
KR4 enzymes also have the NAD(P)-Rossmann binding fold. Their catalytic sites, like 
those in KR1 and KR3 members, also include Tyr, Ser, Lys triads, and they employ a similar 
catalytic mechanism. However, in KR4 enzymes the Lys residue appears in a different 
conformation.
30
 Animal FASs and bacterial erythromycin PKSs have Tyr, Ser, and Lys 
residues in the same conformation as each other (Table 7.3). 
 
Family HD1 
The HD1 enzymes found in bacteria have enoyl-CoA hydratase activity and catalyze the 
reverse HD reaction, where an enoyl group is hydrated to a hydroxy group. The enoyl-CoA 
hydratases involved in polyhydroxyalkanoate biosynthesis
31
 are found in HD1; however, the 
biochemical in vivo function is not completely understood for most of the sequences. Hisano 
and coworkers proposed that an Asp residue activates a water molecule and a His residue 
donates a proton to the substrate.
31
 Johansson and coworkers also found that Asp and His 
residues are essential for catalysis in another HD1 bacterial enoyl-CoA hydratase.
32
 HD1 
enzymes also include plant and animal sequences; among them is human 3-hydroxyacyl-
ACP dehydratase, which catalyzes the HD step in mitochondrial type II fatty acid synthesis.
33
 
 
Family HD2 
HD2 enzymes also have enoyl-CoA hydratase activity, and they are active on many 
substrates in several pathways. Included are the enoyl-CoA hydratases (ECHs) active in 
mitochondrial fatty acid β-oxidation.34 Also present are plant peroxisomal fatty acid β-
oxidation MFP enoyl-CoA hydratase domains expressed during seed germination.
23
 Other 
proteins found in HD2 are eukaryotic peroxisomal and mitochondrial β-oxidation enoyl-CoA 
hydratase domains, some active on long-chain fatty acids.
24
 Some of these multimodular 
enzymes are also present in KR2, as their dehydrogenase domain belongs to that family. 
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The mechanism of HD2 enzymes is exhibited by enoyl-CoA hydratases. It was proposed 
that a Glu residue acts as an acid by donating a proton to the substrate while another Glu 
residue activates a water molecule for nucleophilic attack of the hydroxyl group.
35
 
 
Family HD3 
HD3 enzymes are produced by bacteria and eukaryotes and are either hydratases or 
dehydratases. HD3 contains the HD domains of fungal multimodular FASs. Fungal FASs are 
composed of two subunits, with their HD domains residing in the subunit along with ER, 
acyltransferase, and thioesterase domains.
26
 HD3 enzymes also appear with KR3 and ER3 
enzymes in the same fungal FAS sequences, although each family is found in a different 
catalytic domain. The enoyl-CoA hydratase domains of peroxisomal fatty acid β-oxidation 
bifunctional proteins are present in HD3.
36
 
The hydration mechanism is an attack by a water molecule coordinated by two catalytic 
residues, Asp808 and His813 in Candida tropicalis 2-enoyl-CoA hydratase 2, on the 
substrate double bond.
37
 These residues correspond to Asp1551 and His1564 in Sacc-
haromyces cerevisae FAS.
27
 
 
Family HD4 
The HD4 family is composed mainly of 3-hydroxyacyl-ACP dehydratases (EC 4.2.1.61) 
that form the HD domains of animal multimodular FASs. Several HD domains from bacterial 
multimodular PKSs are also present. HD4 enzymes also appear with KR4 and ER4 enzymes 
in the same animal FAS sequences, although again each family is found in a different 
catalytic domain. 
The proposed mechanism of HD4 dehydratases, by analogy with HD5 dehydratases, is 
deprotonation of the substrate by a His residue and protonation of the substrate’s hydroxyl 
group by an Asp residue, followed by detachment of a water molecule and formation of a 
double bond in the substrate.
38
 
 
Family HD5 
Most sequences in HD5 are 3-hydroxyacyl-ACP dehydratases that catalyze the HD 
reaction in type II fatty acid synthesis and are known as FabA enzymes. They are almost 
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exclusively present in proteobacteria. These enzymes act on medium-length acyl chains, 
especially on ten-carbon ones.
39
 
In E. coli β-hydroxydecanoyl-ACP dehydratase, the uncharged Nτ atom on a His residue 
abstracts a proton from the substrate’s C2 atom, leaving the former positively charged, while 
the protonated carboxyl group on an Asp residue of the adjacent enzyme subunit abstracts the 
hydroxyl group on the C3 atom, producing a water molecule and leaving the C3 atom 
negatively charged.
40
 Leesong and coworkers also identified the HotDog fold in FabA 
enzymes, which enzymes in HD1, HD3, HD4, and HD6 also contain. 
 
Family HD6 
Most HD6 sequences are FabZ enzymes that catalyze the HD reaction in type II fatty acid 
synthesis. They are present in bacteria and in a few plants and other eukaryota. FabZ 
enzymes are very similar to FabA ones, but they have broad substrate specificities, acting 
both on short- and on long-chain acyl chains.
39
 Kostrewa and coworkers proposed a 
mechanism with Plasmodium falciparum HD FabZ
41
 identical to the mechanism of HD5 
FabA.
40
 
 
Family HD7 
Family HD7 contains mainly fungal sequences, among them 3-hydroxyacyl-ACP 
dehydratases, which catalyze the HD step in mitochondrial type II fatty acid synthesis.
42
 
Autio and coworkers by phylogenetic analysis separated fungal (HD7) from animal (HD1) 
mitochondrial type II fatty acid synthesis HD sequences.
33
 No tertiary structures have been 
resolved for HD7, although it likely has a HotDog-like fold due to slight sequence similarity 
with family HD1. 
 
Family HD8 
All HD8 sequences are eukaryotic, with fungal, plant, and animal sequences present; 
there is no known tertiary structure for this family. Sequences include the 3-hydroxyacyl-
CoA dehydratases, which catalyze the HD step in fatty acid chain elongation in the 
endoplasmic reticulum.
43
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Family ER1 
This family has been merged into KR1 in ThYme, as all its entries are present in KR1. 
 
Family ER2 
ER2 enzymes are present mainly in bacteria, but they also are found in plants, green 
algae, and acomplexans. Most enzymes are enoyl-ACP reductases (EC 1.3.1.9), also known 
as FabI enzymes, that catalyze the ER step in type II fatty acid synthesis.
44
 ER2 enzymes also 
have a NAD(P)-Rossmann binding fold. They have also been labeled as “divergent SDRs”,19 
as they possess the same fold as SDR enzymes, but their catalytic residues and mechanisms 
are different. They are known target enzymes for antimicrobial drugs, and their tertiary 
structures complexed with ACP have been resolved.
45
 
The mechanism of ER2 enzymes is exhibited by InhA, the Mycobacterium tuberculosis 
homolog of FabI enzymes. A Lys residue holds the NADH cofactor in place by a hydrogen 
bond between its amine group and a hydroxyl group of the NADH ribosyl group. The Tyr 
residue’s hydroxyl hydrogen atom forms a hydrogen bond with the substrate thioester 
carbonyl oxygen atom. A hydride ion from NADH is transferred to the C3 atom of the 
substrate, followed by a proton, presumably from the solvent, transferring to the C2 atom. 
 
Family ER3 
ER3 enzymes include the enoyl-ACP reductases that form the ER domains of 
multimodular fungal FASs, composed of two subunits, with the ER domain residing in the 
subunit along with HD, acyltransferase, and thioesterase domains.
26
 ER3 enzymes in fungal 
FASs have TIM barrel folds, and they are flavin mononucleotide (FMN)-dependent.
46
 Jenni 
and coworkers have proposed a two-step mechanism without specifying individual 
residues.
46
 Many actinobacterial sequences are also present in ER3, but their functions have 
not been experimentally verified. 
 
Family ER4 
The ER4 family includes the enoyl-ACP reductase domains of multimodular animal 
FASs, as well as bacterial and fungal multimodular PKSs. The animal FASs are homodimers 
containing all catalytic domains, ERs among them, needed for fatty acid synthesis.
28
 PKSs 
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vary according to their product molecule, yet most require an enoyl reduction step and have 
ER domains.
29
 ER4 enzymes have NAD(P)-binding Rossmann folds, but they are not part of 
the SDR superfamily. 
Little is known about the catalytic mechanism of ER4 enzymes. Candidate proton donors 
to the substrate double bond after hydride transfer from NADPH are Lys1771 and Asp1797 
(S. scrofa ER numbering).
38
 
 
Family ER5 
Members of ER5 appear in eukaryota and bacteria. The largest number are trans-2-enoyl-
CoA reductases (EC 1.3.1.38). They are usually mitochondrial in eukaryotes, and they have 
been characterized in fungi as ETR1’s (2-enoyl thioester reductase-1’s)47 and in mammals as 
MECRs (mitochondrial trans-2-enoyl-CoA reductases). They are thought to be involved with 
mitochondrial fatty acid synthesis. 
By analogy with other ERs, Airenne and coworkers proposed that a Tyr residue of 
Candida tropicalis enoyl thioester reductase forms a hydrogen bond to the substrate carbonyl 
oxygen atom, stabilizing the transition state and allowing hydride ion transfer from NADPH 
to the substrate double bond.
48
 Later it was proposed that a Trp residue is also key for 
catalysis.
49
 
 
Family ER6 
ER6 members include 2,4-dienoyl-CoA reductases (EC 1.3.1.34), known as FadHs in 
bacteria, that use NADPH to remove double bonds at even-numbered positions along the acyl 
chain used in fatty acid metabolism.
50
 ER6 also includes many other reductases and NADPH 
dehydrogenases such as Old Yellow Enzyme. 
ER6 enzymes have TIM barrel folds. They are iron-sulfur enzymes that contain FMN and 
FAD, and they need NADPH to provide electrons for catalysis. A mechanism was proposed 
where in the final step Tyr and His residues protonate the substrate.
51
 
 
Families in fatty acid synthesis and elongation 
How KR, HD, and ER families appear in the different types of fatty acid synthesis is 
summarized in Table 7.4 and Figure 7.2. In fungal type I fatty acid synthesis, KR3, HD3, and 
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ER3 domains are present in large multidomain FASs made up of two subunits. For animal 
type I fatty acid synthesis, KR4, HD4, and ER4 domains are found in single large 
multidomain FASs. In type II fatty acid synthesis, present in bacteria and plants, with 
freestanding independent enzymes, the KR (FabG) enzymes are present in KR1, the HD 
enzymes are present in HD5 (FabA) and HD6 (FabZ), and the ER enzymes (FabI) are found 
in ER2. For mitochondrial type II fatty acid synthesis in eukaryotes, the KR enzymes appear 
in KR1, the animal HD enzymes are found in HD1, the fungal HD enzymes are in HD7, and 
the ER enzymes appear in ER5. Eukaryotic fatty acid elongation in the endoplasmic 
reticulum also includes KR, HD, and ER steps;
43
 their enzymes are found in KR1 and HD8. 
Both KR and ER steps appear in KR1, into which ER1 has been merged. 
The NAD(P)-binding Rossmann fold in KRs is maintained in all types of fatty acid 
synthesis. The HotDog fold prevails in HDs, except for HD2 enzymes, which have 
ClpP/crotonase folds, and for HD7 and HD8, for which no tertiary structures have been 
resolved. ER folds vary by family. Fungal ER domains have TIM barrel folds, while both 
animal and bacterial ER enzymes contain NAD(P)-binding Rossmann folds, and 
mitochondrial ER enzymes contain a GroES-like fold in addition to the NAD(P)-binding 
Rossmann fold. The catalytic residues and mechanisms are conserved among individual KR, 
HD, and ER families. 
 
Conclusions 
KRs, HDs, and ERs are essential components of the fatty acid synthesis and elongation, 
polyketide synthesis, and β-oxidation degradation cycles. They have been classified into 
different families by their primary and tertiary structures. This has led to four KR families, 
eight HD families, and five ER families. Their catalytic domains, functions, and mechanisms 
characterize each family. 
 
References 
 
1. Nikolau, B.J., Perera, M.A.D.N., Brachova, L. and Shanks, B. (2008) Plant J., 54, 536–545. 
2. Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J. and Sayers, E.W. (2009) Nucleic 
Acids Res., 37, D26–D31. Retrieved from http://www.ncbi.nlm.nih.gov/genbank/. 
3. UniProt Consortium (2010) Nucleic Acids Res., 38, D142–D148. Retrieved from 
http://www.uniprot.org/. 
  
 
100 
 
4. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. 
and Bourne, P.E. (2000) Nucleic Acids Res., 28, 235–242. Retrieved from 
http://www.pdb.org/pdb/home/home.do. 
5. IUBMB (1992). Enzyme Nomenclature 1992. Academic Press, San Diego. Retrieved from 
http://www.chem.qmul.ac.uk/iubmb/enzyme/. 
6. Cantu, D.C., Chen, Y., Lemons, M.L. and Reilly, P.J. (2011) Nucleic Acids Res., 39, D342–D346. 
Retrieved from http://www.enzyme.cbirc.iastate.edu. 
7. Cantu, D.C., Chen, Y. and Reilly, P.J. (2010) Protein Sci., 19, 1281–1295. 
8. Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W. and Lipman, D.J. 
(1997) Nucleic Acids Res., 25, 3389–3402. Retrieved from http://blast.ncbi.nlm.nih.gov/Blast.cgi. 
9. Finn, R.D., Mistry, J., Tate, J., Coggill, P., Heger, A., Pollington, J.E, Gavin, O.L., Gunesekaran, 
P., Ceric, G., Forslund, K., Holm, L., Sonnhammer, E.L.L., Eddy, S.R. and Bateman, A. (2010) 
Nucleic Acids Res., 38, D211–D222. Retrieved from http://pfam.sanger.ac.uk/. 
10. Eddy, S.R. (1998) Bioinformatics, 14, 755–763. 
11. Edgar, R.C. (2004) Nucleic Acids Res., 32, 1792–1797. Retrieved from 
http://www.drive5.com/muscle/. 
12. Shatsky, M., Nussinov, R. and Wolfson, H.J. (2004) Proteins Struct. Func. Bioinf., 56, 143–156. 
Retrieved from http://bioinfo3d.cs.tau.ac.il/MultiProt/. 
13. Rawlings, M. and Cronan, J.E., Jr. (1992) J. Biol. Chem., 267, 5751–5754. 
14. Schneider, R., Brors, B., Buerger, F., Camrath, S. and Weiss, H. (1997) Curr. Genet., 32, 384–
388. 
15. Hiltunen, J.K., Schonauer, M.S., Autio, K.J., Mittelmeier, T.M., Kastaniotis, A.J. and Dieck-
mann, C.L. (2009) J. Biol. Chem., 284, 9011–9015. 
16. Han, G., Gable, K., Kohlwein, S.D., Beaudoin, F., Napier, J.A. and Dunn, T.M. (2002) J. Biol. 
Chem., 277, 35440–35229. 
17. Helander, H.M., Koivuranta, K.T., Horelli-Kuitunen, N., Palvimo, J.J., Palotie, A. and Hiltunen, 
J.K. (1997) Genomics, 46, 112–119. 
18. Das, A.K., Uhler, M.D. and Hajra, A.K. (2000) J. Biol. Chem., 275, 24333–24340. 
19. Kavanagh, K.L., Jornvall, H., Personn, B. and Oppermann, U. (2008) Cell. Mol. Life Sci., 65, 
3895–3906. 
20. Kallberg Y., Oppermann, U. and Personn, B. (2010) FEBS J., 277, 2375–2386. 
21. Korman, T.P., Hill, J.A., Vu, T.N. and Tsai, S.-C. (2004) Biochemistry, 43, 14529–14538. 
22. Campbell, J.W., Morgan-Kiss, R.M. and Cronan, J.E., Jr. (2003) Mol. Microbiol., 47, 793–805. 
23. Graham, I.A. and Eastmond, P.J. (2002) Prog. Lipid Res. 41, 156–181. 
24. Uchida, Y., Izai, K., Orii, T. and Hashimoto, T. (1992) J. Biol. Chem., 267, 1034–1041. 
25. Barycki, J.J., O’Brien, L.K., Strauss, A.W. and Banaszak, L.J. (2001) J. Biol. Chem., 276, 36718–
36726. 
26. Mohamed, A.H., Chirala, S.S., Mody, N.H., Huang, W.Y. and Wakil, S.J. (1988) J. Biol. Chem., 
263, 12315–12325. 
27. Lomakin, I.B., Xiong, Y. and Steitz, T.A. (2007) Cell, 129, 319–332. 
28. Wakil, S.J. (1989) Biochemistry, 28, 4523–4530. 
29. Khosla, C., Gokhale, R.S., Jacobsen, J.R. and Cane, D.E. (1999) Annu. Rev. Biochem., 68, 219–
253. 
30. Keatinge-Clay, A.T. and Stroud, R.M. (2006) Structure, 14, 737–748. 
31. Hisano, T., Tsuge, T., Fukui, T., Tadahisa, I., Miki, K. and Doi, Y. (2003) J. Biol. Chem., 278, 
617–624. 
32. Johansson, P., Castell, A., Jones, T.A. and Bäckbro, K. (2006) Protein Sci., 15, 2300–2309. 
33. Autio, K.J., Kastaniotis, A.J., Pospiech, H., Miinalainen, I.J., Schonauer M.S., Dieckmann, C.L. 
and Hiltunen, J.K. (2008) FASEB J., 22, 569–578. 
  
 
101 
 
34. Minami-Ishii, N., Taketani, S., Osumi, T. and Hashimoto, T. (1989) Eur. J. Biochem., 185, 73–
78. 
35. Engel, C.K., Mathieu, M., Zeelen, J.P., Hiltunen, J.K. and Wierenga, R.K. (1996) EMBO J., 15, 
5135–5145. 
36. Osumi, T. and Hashimoto, T. (1979) J. Biochem. (Tokyo) 85, 131–139. 
37. Koski, M.K., Haapalainen, A.M., Hiltunen, J.K. and Glumoff, T. (2004) J. Biol. Chem., 279, 
24666–24672. 
38. Maier, T., Leibundgut, M. and Ban, N. (2008) Science, 321, 1315–1322. 
39. Heath, R.J. and Rock, C.O. (1996) J. Biol. Chem., 271, 27795–27801. 
40. Leesong, M., Henderson, B.S., Gillig, J.R., Schwab, J.M. and Smith, J.L. (1996) Structure, 4, 
253–264. 
41. Kostrewa, D., Winkler, F.K., Folkers, G., Scapozza, L. and Perozzo, R. (2005) Protein Sci., 14, 
1570–1580. 
42. Kastaniotis, A.J., Autio, K.J., Sormunen, R.T., and Hiltunen, J.K. (2004) Mol. Microbiol., 53, 
1407–1421. 
43. Cinti, D.L., Cook, L., Nagi, M.N. and Suneja, S.K. (1992) Prog. Lipid Res., 31, 1–51. 
44. Bergler, H., Wallner, P., Ebeling, A., Leitinger, B., Fuchsbichler, S., Aschauer, H., Kollenz, G., 
Högenauer, G. and Turnowsky, F. (1994) J. Biol. Chem., 269, 5493–5496. 
45. Rafi, S., Novichenok, P., Kolappan, S., Zhang, X., Stratton, C.F., Rawat, R., Kisker, C., 
Simmerling, C. and Tonge, P.J. (2006) J. Biol.Chem., 281, 39285–39293. 
46. Jenni, S., Leibundgut, M., Boehringer, D., Frick, C., Mikolasek B. and Ban, N. (2007) Science, 
316, 254–261. 
47. Torkko, J.M., Koivuranta, K.T., Miinalainen, I.J., Yagi, A.I., Schmitz, W., Kastaniotis, A.J., 
Airenne, T.T., Gurvitz, A. and Hiltunen, K.J. (2001) Mol. Cell. Biol., 21, 6243–6253. 
48. Airenne, T.T., Torkko, J.M.,Van den Plas, S., Sormunen, R.T. Kastaniotis, A.J., Wierenga, R.K. 
and Hiltunen, J.K. (2003) J. Mol. Biol., 327, 47–59. 
49. Chen, Z.-J., Pudas, R., Sharma, S., Smart, O.S., Juffer, A.H., Hiltunen, J.K., Wierenga,, R.K. and 
Haapalainen, A.M. (2008) J. Mol. Biol., 379, 830–844. 
50. He, X.-Y., Yang, S.-Y. and Schulz, H. (1997) Eur. J. Biochem. 248, 516–520. 
51. Hubbard, P.A., Liang, X., Schulz, H. and Kim, J.J. (2003) J. Biol. Chem., 278, 37553–37560. 
  
 
102 
 
Tables 
 
Table 7.1: Enzymes present in KR, HD, and ER families 
 
_________________________________________________________________________________________________________ 
Family General function Specific function or enzyme name
a
 Representative 
   UniProt designation 
_________________________________________________________________________________________________________ 
KR1 Acyl-ACP reductase 3-Oxoacyl-ACP reductase (FabG) P0AEK2 
  3-Oxoacyl-ACP reductase (OAR1) P35731 
  3-Oxoacyl-ACP reductase (MabA) P0A5Y4 
  Actinorhodin polyketide synthesis P16544 
 Acyl-CoA reductase 3-Oxoacyl-CoA reductase P38286 
  2,4-Dienoyl-CoA reductase (DECR) Q16698 
  trans-2-Enoyl-CoA reductase  Q9BY49 
 Other reductases Carbonyl reductase P16152 
  Napthalene reductase Q12634 
  Xylulose reductase Q7Z4W1 
 Acyl-CoA dehydrogenase 3-Hydroxyacyl-CoA dehydrogenase (HADH II) Q99714 
  Peroxisomal multifunctional enzyme P97852 
 Carbohydrate dehydrogenase Glucose dehydrogenase P40288 
  Mannitol 2-dehydrogenase O93868 
 Steroid dehydrogenase 11-β-Hydroxysteroid dehydrogenase P28845 
  3-β,20-α-Hydroxysteroid dehydrogenase P19992 
  3-β,17-β-Hydroxysteroid dehydrogenase P19871 
 Other dehydrogenases Alcohol dehydrogenase P10807 
KR2 Acyl-CoA dehydrogenase 3-Hydroxyacyl-CoA dehydrogenase (FadB) P28793 
  Peroxisomal multifunctional protein  P07896 
  Hydroxyacyl-CoA dehydrogenase (HADH) Q16836 
KR3 Acyl-ACP reductase 3-Oxoacyl-ACP reductase domain of FASs (subunit α) P19097 
KR4 Acyl-ACP reductase 3-Oxoacyl-ACP reductase domain of FASs P49327 
   3-Oxoacyl-ACP reductase domain of PKSs Q03131 
1
0
2
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HD1 Acyl-CoA hydratase  Enoyl-CoA hydratase O32472 
 Acyl-ACP dehydratase Hydroxyacyl-ACP dehydratase P86397 
HD2 Acyl-CoA hydratase Enoyl-CoA hydratase P14604 
HD3 Acyl-ACP dehydratase 3-Hydroxyacyl-ACP dehydratase domain of FASs (subunit β) P07149 
 Acyl-CoA hydratase Multifunctional enzyme type 2 P51659 
HD4 Acyl-ACP dehydratase 3-Hydroxyacyl-ACP dehydratase domain of FASs P49327 
HD5 Acyl-ACP dehydratase 3-Hydroxyacyl-ACP dehydratase (FabA) P0A6Q3 
HD6 Acyl-ACP dehydratase 3-Hydroxyacyl-ACP dehydratase (FabZ) Q5G940 
HD7 Acyl-ACP dehydratase Hydroxyacyl-ACP dehydratase P38790 
HD8 Acyl-CoA dehydratase 3-Hydroxyacyl-CoA dehydratase (HACD) B0YJ81 
ER2 Acyl-ACP reductase Enoyl-ACP reductase (ENR) (FabI) P0AEK4 
   Long-chain enoyl-ACP reductase (InhA) P0A5Y6 
ER3 Acyl-ACP reductase Enoyl-ACP reductase domain of FASs (subunit β) P07149 
ER4 Acyl-ACP reductase  Enoyl-ACP reductase domain of FASs  P49327 
  Enoyl-ACP reductase domain of PKSs Q03132 
ER5 Acyl-ACP reductase  Enoyl-ACP reductase Q8WZM3 
 Acyl-CoA reductase Enoyl-CoA reductase Q9BV79 
ER6 Acyl-CoA reductase 2,4-Dienoyl-CoA reductase (FadH) P42593 
 Other reductases Old Yellow Enzyme Q02899 
 
_________________________________________________________________________________________________________ 
a: non-exhaustive  
1
0
3
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Table 7.2: Representative tertiary structures and folds in KR, HD, and ER families 
___________________________________________________________________________ 
Family Representative Fold Total number  RMSD, Pave, 
 tertiary structure  of tertiary Å % 
   structuresa 
___________________________________________________________________________ 
KR1 1EDO NAD(P)-binding Rossmann 324 2.00 80.1 
KR2 1WDK 6-Phosphogluconate  20 1.20 91.3 
  dehydrogenase C-terminal 
  and NAD(P)-binding Rossmann 
KR3 2PFF (KR domain) NAD(P)-binding Rossmann 6 0.93 98.5 
KR4 2VZ8 (KR domain) NAD(P)-binding Rossmann 10 1.28 98.1 
HD1 2C2I HotDog 6 1.47 78.1 
HD2 1DUB ClpP/crotonase 43 1.37 85.5 
HD3 2PFF (HD domain) HotDog 13 1.20 79.7 
HD4 2VZ8 (HD domain) HotDog 2 — — 
HD5 1MKA HotDog 3 0.62 91.5 
HD6 2GLL HotDog 21 1.04 89.9 
HD7 — — 0 — — 
HD8 — — 0 — — 
ER2 1C14 NAD(P)-binding Rossmann 107 1.45 77.9 
ER3 2PFF (ER domain) TIM barrel 6 0.76 99.7 
ER4 2VZ8 (ER domain) NAD(P)-binding Rossmann 3 1.45 85.1 
ER5 2VCY GroES-like and  7 1.43 90.9 
  NAD(P)-binding Rossmann 
ER6 1PS9 TIM barrel 90 1.31 84.5 
___________________________________________________________________________ 
 
a: as of February 2012
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Table 7.3: Catalytic residues in KR, HD, and ER families for representative structures 
_________________________________________________________________________________________________________ 
Family Catalytic residues PDB file Function Producing organism 
_________________________________________________________________________________________________________ 
KR1 Ser154, Tyr167, Lys171 1EDO 3-Oxoacyl-ACP reductase (FabG) Brassica napus 
KR1 Ser144, Tyr157, Lys161 1X7G Polyketide-ACP reductase Streptomyces coelicolor 
KR1 Ser150, Tyr163, Lys167 2ET6 3-hydroxyacyl-CoA dehydrogenase Candida tropicalis 
KR1 Ser145. Tyr158, Lys162 1GCO Glucose dehydrogenase Bacillus megaterium 
KR1 Ser138, Tyr151, Lys155 1HXH Steroid dehydrogenase Comamonas testosteroni 
KR2 His451, Glu463 1WDK 3-Hydroxyacyl-CoA dehydrogenase (FadB) Pseudomonas fragi 
KR2 His158, Glu170 3HAD Hydroxyacyl-CoA dehydrogenase (HADH) Homo sapiens 
KR3 Ser827, Tyr839, Lys843 2PFF 3-Oxoacyl-ACP reductase domain of FASs Saccharomyces cerevisae 
KR4 Lys1995, Ser2021, Tyr2034 2VZ8 3-Oxoacyl-ACP reductase domain of FASs Sus scrofa 
KR4 Lys1776, Ser1800, Tyr1813 2FR0 3-Oxoacyl-ACP reductase domain of PKSs Saccharopolyspora eryth. 
HD1 Asp31, His36 1IQ6 Enoyl-CoA hydratase Aeromonas caviae 
HD2 Glu144, Glu164 1DUB Enoyl-CoA hydratase Rattus norvegicus 
HD3 Asp1559, His1564 2PFF 3-Hydroxyacyl-ACP dehydratase domain of FASs S. cerevisiae 
HD3 Asp808, His813 1PN2 Enoyl-CoA hydratase domain of multifunctional C. tropicalis 
   enzyme type 2 
HD4 His878, Asp1033 2VZ8 3-Hydroxyacyl-ACP dehydratase domain of FASs S. scrofa 
HD5 His70, Asp84a 1MKA 3- Hydroxyacyl-ACP dehydratase (FabA) Escherichia coli 
HD6 His58, Glu72a 2GLL 3- Hydroxyacyl-ACP dehydratase (FabZ) Helicobacter pylori 
ER2 Tyr156, Lys163 1C14 Enoyl-ACP reductase (ENR) (FabI) E. coli 
ER2 Tyr158, Lys165 1BYR Long chain enoyl-ACP reductase (InhA) Mycobacterium tubercul. 
ER3 — 2PFF Enoyl-ACP reductase domain of FASs S. cerevisiae 
ER4 Lys1771, Asp1797 2VZ8 Enoyl-ACP reductase domain of FASs S. scrofa 
ER5 Tyr94, Trp311 2VCY Enoyl-CoA reductase H. sapiens 
ER6 Tyr166, His252 1PS9 2,4-Dienoyl-CoA reductase (FadH) E. coli 
_________________________________________________________________________________________________________ 
a Separate subunit 
 
  
1
0
5
 
  
 
106 
 
Table 7.4: KR, HD, and ER families in fatty acid synthesis and elongation 
 ___________________________________________________________________________________________________ 
Type I fatty acid synthesis Type II fatty acid synthesis Fatty acid elongation 
 ____________________________________________________________________________________________________ 
Fungal Animal Bacterial and plant Eukaryotic mitochondrial Eukaryotic endoplasmic reticulum 
 ____________________________________________________________________________________________________ 
KR3 KR4 KR1 KR1 KR1 
HD3 HD4 HD5/HD6 HD1/HD7 HD8 
ER3 ER4 ER2 ER5 KR1 
1
0
6
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Figures 
 
Figure 7.1: Catalytic residues and tertiary structures of KR1 members. A: Catalytic residues 
of Brassica napus 3-oxoacyl-ACP reductase (1EDO, white), Streptomyces coelicolor 
polyketide-ACP reductase (1X7G, green), Candida tropicalis 3-hydroxyacyl-CoA 
dehydrogenase (2ET6, yellow), Bacillus megaterium glucose dehydrogenase (1GCO, 
purple), and Comamonas testosteroni steroid dehydrogenase (1HXH, blue) are in the same 
position when superimposed. B: Tertiary structures of the same enzymes, 1EDO (white), 
1X7G (green), 2ET6 (yellow) 1GCO (purple), 1HXH (blue), along with Homo sapiens 
enoyl-CoA reductase (1W6U, brown), are similar when superimposed. C: The catalytic 
residues of two enoyl-CoA reductases (1W6U, brown) and (1EDO, white) appear in different 
conformations. 
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Figure 7.2: Main fatty acid synthesis enzymes. KR3: Saccharomyces cerevisiae 3-oxoacyl-
ACP reductase domain of FAS (2UV9); KR4: Sus scrofa 3-oxoacyl-ACP reductase domain 
of FAS (2VZ9); KR1: Brassica napus 3-oxoacyl-ACP reductase (1EDO); HD3: Homo 
sapiens acyl-CoA hydratase domain of multifunctional enzyme type 2 (1S9C) ; HD4: S. 
scrofa 3-hydroxyacyl-ACP dehydratase domain of FAS (2VZ8); HD5: Escherichia coli 3-
hydroxyacyl-ACP dehydratase (FabA) (1MKA); ER3: S. cerevisiae enoyl-ACP reductase 
domain of FAS (2UV8); ER4: S. scrofa enoyl-ACP reductase domain of FAS (2VZ8); ER2: 
E. coli enoyl-ACP reductase (FabI) (1C14). 
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CHAPTER 8 
ACYL CARRIER PROTEIN STRUCTURAL CLASSIFICATION AND 
NORMAL MODE ANALYSIS 
David C. Cantu, Michael J. Forrester, Katherine Charov, and Peter J. Reilly 
Department of Chemical and Biological Engineering, Iowa State University 
 
Modified from a paper published in Protein Science, 21, 655-666, with the same title and 
authors. 
 
Abstract 
All acyl carrier protein (ACP) primary and tertiary structures were gathered into the 
ThYme database. They are classified into 16 families by amino acid sequence similarity, 
with members of the different families having sequences with statistically highly significant 
differences. These classifications are supported by tertiary structure superposition analysis. 
Tertiary structures from a number of families are very similar, suggesting that these families 
may come from a single distant ancestor. Normal vibrational mode analysis was conducted 
on experimentally determined freestanding structures, showing greater fluctuations at chain 
termini and loops than in most helices. Their modes overlap more so within families than 
between different families. The tertiary structures of three ACP families that lacked any 
known structures were predicted as well. 
 
Introduction 
Acyl carrier proteins (ACPs) usually have 70 to 100, but occasionally more, amino acid 
residues, and they are usually linked through an interior serine residue to the terminal 
phosphate group of a 4’-phosphopantetheine prosthetic group. In turn, the latter binds fatty 
acids, polyketides, and other moieties by a thioester bond to its terminal thiol group, 
activating them for reactions that usually produce longer acyl chains, but also many other 
compounds (Table 8.1). 
ACP molecules have many more anionic than cationic residues and rather few 
hydrophobic residues.
1
 Their tertiary structures feature three generally parallel α-helices 
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(helices I, II, and IV) with a shorter crosswise α-helix (helix III). Helix II has many 
conserved anionic residues and plays an important role in ACP-enzyme interactions.
2
 Helix 
III is not present in all ACP structures, and it displays helix-loop equilibrium conformations.
3 
ACPs are either independent, freestanding structures, or they are covalently bound as part 
of multimodular enzymes such as fatty acid synthases (FASs), polyketide synthases (PKSs), 
and non-ribosomal peptide synthases (NRPSs). Acyl chains attached to freestanding ACPs 
are held within the hydrophobic pocket formed by the α-helices until they are subjected to 
reaction,
4–7
 when they are expelled into the active site of the enzyme catalyzing the reaction.
8
 
The mechanism of delivering an acyl substrate to an enzyme active site from ACP’s cavity, 
which may be accompanied by flexing of the ACP, is not completely understood. Those 
ACPs that are part of enzymes may not hold acyl chains within their hydrophobic pockets,
9
 
as these chains are less exposed to solvent and to cell membranes.
10 
Freestanding ACPs, at least, appear to be quite flexible, being found in multiple confor-
mers
3,5,11
 and having very flexible loops and α-helices.12–15 
We have gathered all available ACP primary and tertiary structures into the ThYme data-
base.
16
 There we have classified ACPs into families, following the same techniques that we 
have used earlier with thioesterases
17
 and ketoacyl synthases,
18
 which are described in 
Computational Methods. In general, members of a protein family have strong sequence 
similarity. They should also have tertiary structures that can be superimposed with small root 
mean square deviations (RMSDs) between corresponding amino acid residues. These 
similarities may imply that members are descended from a common protein ancestor. 
Members of different families have primary structures with statistically highly significant 
differences. However, slight similarities in amino acid residue alignments between ACP 
families may suggest that those without known tertiary structures are related to those with 
known structures. We describe this work with ACPs for the first time here. 
This article is an account also of two further efforts: 1) a normal mode analysis of experi-
mentally determined tertiary structures of freestanding apo-ACPs to describe their dynamic 
structures; and 2) the attempted computational prediction of tertiary structures of 
freestanding ACPs in three families with no known experimentally determined structures. 
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Results and discussion 
ACP families 
Following the protocol described in the Computational Methods section led to 16 ACP 
families being defined. A multiple sequence alignment of representative members of these 
families shows very limited sequence similarity (Figure 8.1). Only the serine residue at 
position 39 (ACP1 numbering), to which the prosthetic group is attached, is almost 
completely conserved (except for ACP15). In addition, there is substantial conservation at 
positions 35 (glycine), 38 (aspartate), and 67 (threonine). A number of positions have almost 
exclusively hydrophobic residues. In ACP15, the only residue that is completely conserved 
near the position otherwise occupied by a serine residue is Thr40 (ACP1 numbering). 
The same representative sequences of ACP families were subjected to pairwise sequence 
alignments to identify common residues between two sequences in different families. Even 
though there is low sequence similarity over the 16 families, there is substantial similarity 
from one family to the next (Figure 8S-A, Supplementary Information). The relationship of 
the families to each other is shown by two versions of a phylogenetic tree (Figure 8.2 and 
Figure 8S-B). They show ACP15 and ACP16 peripheral to the other ACP families, as they 
are in Figure 8.1. 
Table 8.1 summarizes the 16 ACP families, showing 1) approximate numbers of 
sequences in each family; 2) domains of life that produce each family; 3) whether ACP 
families are composed of freestanding proteins or are parts of multidomain enzymes; 4) the 
end products of enzymes with which ACP families interact; 5) representative UniProt 
accession codes of the ACPs; and 6) related literature. 
Families ACP1 through ACP3 are involved with fatty acid synthesis. ACP1 members are 
freestanding ACPs, present in type II fatty acid synthesis, bacterial long-chain fatty acid 
synthesis, and mitochondrial fatty acid synthesis. ACP2 and ACP3 proteins are parts of 
multidomain FASs, involved with fungal and animal type I fatty acid synthesis, respectively. 
A substantial amount of research has been conducted on these ACPs; much of it is covered in 
the exhaustive review of Chan and Vogel.
10 
Proteins in ACP4 and ACP5 are freestanding ACPs involved with polyketide synthesis. 
In ACP4 is AcpK, part of the pksX pathway of Bacillus subtilis in making bacillaene.
24
 ACP5 
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includes ACPs involved with the synthesis of the antibiotics actinorhodin,
25
 frenolicin,
26
 and 
oxytetracycline
27
 in various Streptomyces species. 
ACP6 through ACP9 and also ACP11 include the ACP domains of large multidomain 
PKSs. Among ACP6 sequences are the ACP domains of larger enzymes involved in making 
complex lipids found in Mycobacterium cell walls, including mycocerosic acid,
28
 and other 
sulfolipids.
29
 ACP7 includes the ACP domain of fungal PKS 6-methylsalicylic acid 
synthase.
30
 ACP8 includes mainly fungal sequences; among them are the ACP domains of 
PKSs involved with aflatoxin production,
31
 and the ACP domains of naphthopyrone PKSs 
that make the yellow pigment in conidia.
32
 ACP9 includes the ACP domain of PKS or 
chalcone synthase stlA, which produces acylpyrones.
33
 ACP11 includes the ACP domains of 
lovastatin synthases.
43 
ACP10, the family with the most members, includes the ACP domains of many PKSs, 
the peptide carrier protein (PCP) domain of NRPSs, hybrid PKS/NRPS enzymes, and 
ferrichrome synthases.
34–42
 The enzymes in this family make a variety of natural products 
from secondary metabolism. A representative sample of them is shown in Table 8.1. 
Families ACP12 and ACP13 include the ACP domains of enterobactin synthases,
44,46
 
isochorismatases,
45
 and mycobactin synthases.
45
 ACP14 has been merged into ACP10 and no 
longer exists. 
The prosthetic group in ACP15 and ACP16 is 2’-(5”-phosphoribosyl)-3’-dephospho-
CoA, instead of 4’-phosphopantetheine, linked to an interior serine residue of apo-ACP 
through its 5”-phospho group and to the acyl molecule with a thioester bond through its 
terminal thiol group. ACP15 proteins include the ACPs active with malonate decarboxylases 
in bacteria that convert malonate to acetate and CO2 as an energy source.
47
 ACP16 enzymes 
include the ACPs active with citrate lyases that convert citrate to oxaloacetate and acetate in 
bacteria.
48 
Members of ACP17 do not carry acyl groups, but instead they are D-alanyl carrier 
proteins, as the moiety bound by 4’-phosphopantetheine is D-alanine, which is ligated using 
adenosine triphosphate to poly(ribitol phosphate). These enzymes are involved with the 
production of D-alanyl lipoteichoic acid.
49 
The members of all but four families, ACP1, ACP8, ACP10, and ACP13, are produced 
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exclusively by either bacteria or eukaryota. More specifically, virtually all members of ACP2 
and ACP8 and all members of ACP7 and AC11 are produced by fungi (the latter three 
families all by ascomycota), while all ACP3 members come from animals. AC9 members are 
from slime molds. Members of different bacterial phyla produce different members of ACP4, 
ACP12, ACP15, ACP16, and ACP17. ACP5 and ACP6 members are all from actinobacteria, 
with the latter being only from Mycobacterium species. 
In summary, ACPs have diverged into different families based on primary structures that 
have statistically highly significant differences. They are either freestanding or are covalently 
bound to enzymes, they are specific to different substrates, they are produced by different 
classes of organisms, and they have sharply defined roles. 
 
Existing ACP tertiary structures 
Families ACP1, ACP2, ACP3, ACP5, ACP8, ACP10, ACP12, ACP13, and ACP17 
contain members with known tertiary structures (Figure 8.3). All but ACP8, ACP12, and 
ACP13 have more than one known structure. Most known structures and their properties 
were reviewed by Chan and Vogel.
10
 All tertiary structures are tabulated, with links to the 
Protein Data Bank (PDB), in the ACP section of the ThYme database. 
We superimposed one tertiary structure per species within each putative ACP family and 
calculated their RMSDs using the protocol in the Computational Methods section. ACP2 and 
ACP17 have multiple known structures of freestanding ACPs or of ACP domains, but they 
all come from the same species. Therefore their RMSDs were not calculated, as this would 
represent structure conservation among the same sequence and not sequences in a family. 
ACP2 domains in yeast FAS structures contain four extra helices in the C-terminal region,
22
 
not seen in other ACPs, making them about twice as long as the others (Figure 8.2). We 
found ACP3 and ACP10 domains in enzymes containing them by superimposing 
freestanding ACPs and extracting the former for RMSD calculations. In ACP10, we chose to 
superimpose the structures in the A/H conformer, very similar to other ACPs, one of three 
conformers in which ACP10 structures have been found.
50
 Structures within putative families 
should have low RMSDave values and high Pave values (average percentage of α-carbon 
atoms of the amino acid residues between two structures compared for calculations). Shown 
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in Table 8.2 are the structures used, RMSDave values (ranging from 1.74 Å to 2.02 Å), and 
Pave values (ranging from 84.8% to 94.4%). These findings further indicate that the structures 
represent members in the same families. 
If different families have members with tertiary structures that can be closely aligned, 
even though their primary structures are different, then they may have a more distant 
common protein ancestor and may be gathered into the same clan. To determine this, one 
tertiary structure each from ACP1 (PDB accession code 1X3O), ACP2 (2UV8), ACP3 
(2CG5), ACP5 (1OR5), ACP8 (2KR5), ACP10 (2JGP), ACP12 (2FQ1), ACP13 (2ROQ), 
and ACP17 (1HQB) (Figure 8.3) were superimposed. Of these, ACP2, ACP3, ACP8, 
ACP10, and ACP12 were domains in larger enzymes. The first four helices of the ACP2 
structure were well superimposed on the structures of the other families. The superposition of 
the structures of these nine families resulted in an RMSDave value of 2.34 Å and a Pave value 
of 76.2%, indicating that at least those families may descend from a distant common ancestor 
and may be gathered into the same clan. The moderate percentages of common residues 
between different pairs of families (Figure 8S-A) suggest that other ACP families may also 
have the same common ancestor. However, this conclusion must await determination of 
tertiary structures of members of these families. 
 
Normal mode analysis of freestanding ACP structures 
We subjected seven tertiary structures of freestanding apo-ACPs to normal mode 
analysis, using the Anisotropic Network Model (ANM) web server.
51
 We did not attempt to 
subject ACPs that were part of larger proteins to normal mode analysis, since their structures 
and fluctuations are most likely affected by their proximity of other parts of the protein. 
ACP1 members were PDB accession codes 2EHS and 2EHT (two conformers of the same 
protein) from Aquiflex aeolicus, 1T8K from Escherichia coli, 1X3O from Thermus 
thermophilus, and 2QNW from Toxoplasma gondii. The one ACP5 member was 2AF8 from 
Streptomyces coelicolor, while 1HQB in ACP17 was from Lactobacillus rhamnosus. All are 
produced by bacteria but one; T. gondii is an apicomplexan protozoan. 
The residue fluctuations of the five slowest modes of each structure are plotted in Figure 
8S-C. Chain ends, especially the N-terminal one, and loops were predicted to fluctuate more 
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than the three long and parallel α-helices (helices I, II, and IV), which move very little. The 
region between helices II and IV, which in ACP1 structures comprises the loop between 
helices II and III and the crosswise helix III, strongly fluctuated in many structures. In ACP5 
and ACP17 structures helix III is replaced by a loop. This region was proposed to act as a 
gatekeeper in the acyl chain delivery process,
52
 as the acyl chain is exposed through a fissure 
following a conformational rearrangement. The acyl chain delivery process is unknown; 
sword-unsheathed or switchblade-like mechanisms have been proposed. Lower fluctuations 
are seen in the loop between helices I and II. The N-terminal region of helix II, where the 4’-
phosphopantetheine prosthetic group is attached, shows relatively higher fluctuations than 
the rest of helix II. In general, the vibrations of the first five slowest modes in any structure 
are moderately to strongly correlated in location, although much less so in magnitude. 
We compared the normal modes of two conformers (2EHS and 2EHT) of the same 
structure in ACP1, of two bacterial structures (1T8K and 1X3O) in ACP1, of bacterial 
(1T8K) and eukaryotic (2QNW) structures in ACP1, of ACP1 (1T8K) and ACP5 (2AF8) 
structures, of ACP1 (1T8K) and ACP17 (1HQB) structures, and of ACP5 (2AF8) and 
ACP17 (1HQB) structures. They were analyzed as explained in the Computational Methods 
section. Results are summarized in Table 8.3, overlap charts are shown in Figure 8S-D, and 
residue fluctuation comparisons of the three most overlapped modes for each case are shown 
in Figure 8S-E. 
The two conformers of the same structure showed a very low frame-averaged RMSD 
(RMSDf-ave, as defined in the Computational Methods section), showing that their structural 
similarity was conserved throughout the motion of the slowest normal mode. Several of their 
slowest normal modes showed some overlap (Figure 8S-D). Residue fluctuations (Figure 8S-
E) show that 2EHT has larger amplitudes than 2EHS in the N-terminal region, while 2EHS 
has larger amplitudes in the central and C-terminal regions. Their fluctuations appear in very 
similar residue locations. 
Two different structures within ACP1 display lower overlaps than two conformers of the 
same structure (Figure 8S-D). Values of RMSDf-ave are higher than between two conformers 
of the same structure, but still are < 2 Å, as would be expected of two structures within a 
family. In both cases, fluctuations appear conserved in residue location but not so in 
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amplitude (Figure 8S-E), although they appear more correlated between the bacterial and 
eukaryotic structures. 
Comparing the normal modes between structures in different families showed that the 
slowest mode of each structure was the most highly overlapped (Figure 8S-D), especially 
between ACP1 and ACP5 and between ACP5 and ACP17. The slowest modes in each 
structure display an overall twisting rather than stretching of discrete loops, and overlap 
highly due to their low flexibility. Their RMSDf-ave values are higher than in previous cases, 
showing structural differences between two families. However, within the most overlapped 
normal mode, structural differences are not great. Residue fluctuation for modes other than 
the most overlapped (Figure 8S-E) are poorly correlated in both amplitude and location, 
especially between ACP1 and ACP5 and between ACP5 and ACP17, but less so between 
ACP1 and ACP17. 
Even though overlap charts (Figure 8S-D) do not differ much for comparisons within and 
between families, residue fluctuations (Figure 8S-E) are more conserved between two 
structures within a family than between two structures in different families. However, 
fluctuation amplitudes can be quite different in different structures produced by organisms in 
the same genus and, especially noteworthy, in different conformers of the same structure. 
Differences in fluctuation amplitudes may be due to slight crystal packing effects that could 
be present in loops. 
 
Determination of tertiary structures of freestanding ACPs by computation 
To determine whether the homology modeling and molecular dynamics (MD) protocol 
described in the Computational Methods section is a trustworthy method of determining 
tertiary structures of freestanding ACPs whose structures were previously unknown, we used 
experimentally determined freestanding structures of two families from ACP1 (2EHS), 
ACP5 (1OR5), and ACP17 (1HQB) as templates to predict the structure of the third family. 
We did not use ACP domains as templates or predict unknown ACP domains of large 
multidomain enzymes, as their folded states may be influenced by nearby sections of the 
larger protein. 
Results are shown in Table 8.4. The amino acid identities, based on pairwise alignments 
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between individual family members, between template and target structures vary between 
20.0% and 23.4%. Two RMSD values between predicted and crystal tertiary structures 
(RMSDp-c) are reported: first the value of the predicted structure by homology modeling to 
its crystal structure, and second the predicted structure after MD refinement to its crystal 
structure. RMSDp-c values of homology modeling predictions vary between 1.17 Å and 2.10 
Å, and RMSDp-c values after MD refinement vary between 1.42 Å and 1.96 Å. The predicted 
structures superimposed to their crystal structures can be seen in Figure 8.4. As indicated by 
low RMSDp-c values (< 2 Å) and by visual inspection, the protocol described can predict 
freestanding ACP structures when the template used for homology modeling is at least 20% 
identical in sequence to the target. 
We then attempted to predict tertiary structures for sequences in ACP4, ACP15, and 
ACP16, which contain freestanding members with no known structures. The structure of 
Bacillus subtilis AcpK (UniProt ID Q7PC63) in ACP4 was predicted using as a template 
2EHS from ACP1, with which it has an amino acid identity of 25.6%. The predicted structure 
of ACP4 (Figure 8.5) is very similar to structures in other ACP families, and it clearly shows 
a cavity and three long helices (helices I, II, and IV). When the predicted ACP4 structure was 
superimposed to structures in ACP1 (2EHS), ACP5 (1OR5), and ACP17 (1HQB), the 
resulting RMSDs were 1.92 Å, 2.12 Å, and 2.21 Å, respectively. 
Subjecting Malonomonas rubra malonate decarboxylase (UniProt ID: O06925) from 
ACP15 and E. coli citrate lyase (UniProt ID: P69330) from ACP16 to the homology 
modeling and MD protocol resulted in unfolded structures that lacked the standard three 
parallel helices and cavity seen in other ACPs. However, they are most likely not intrinsically 
unstructured. Ten models were then predicted for each sequence using threading programs. 
Four of the ten ACP15 models (1, 5, 6, and 8) displayed two main α-helices and four β-
strands (Figure 8S-F), while seven of the ten ACP16 models (1, 2, 4–8) showed two main α-
helices with three β-strands. Representative models of the four and seven similar structures of 
ACP15 and ACP16, respectively, are shown in Figure 8.5. When superimposed, the four 
similar models in ACP15 have RMSDave and Pave values of 0.73 Å and 88.7%, and the seven 
similar models of ACP16 show values of 0.99 Å and 91.3%. 
ACP15 and ACP16 carrier proteins are used in reactions that break substrates into 
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smaller units, unlike other ACPs, which are involved in building large molecules from small 
units. Also, ACP15 and ACP16 do not use the same 4’-phosphopantetheine prosthetic group 
present in other ACPs. These facts further suggest that ACP15 and ACP16 may be 
structurally different from other ACP families, and if this is correct, ACP15 and ACP16 
members may descend from different ancestors than most or all of the other ACPs. The 
multiple sequence alignment (Figure 8.1), phylogenetic tree (Figures 8.2, 8S-B), and 
threading predictions (Figures 8S-F) support this. However, only experimentally determined 
structures will show if ACP15 and ACP16 are indeed different from other ACP families. 
 
Computational methods 
Family identification and phylogeny 
Families were identified following the procedures outlined earlier.
16–18
 In brief, families 
were based on sequences with evidence at protein level from the UniProt database
53
 or the 
literature, and populated by use of BLAST
54
 (downloadable version 2.2.19) to query the non-
redundant (nr) protein sequence database.
55
 A cutoff E-value of 0.001 (likelihood that 
similarity between query and compared sequence is due to chance) was used as the exclusion 
criterion. Families were confirmed with multiple sequence alignments of the retrieved 
sequences, using MUSCLE 3.6,
56
 and with tertiary structure superimpositions. 
Phylogenetic trees were built using Molecular Evolutionary Genetics Analysis 5 
(MEGA5),
57
 based on a multiple sequence alignment containing three sequences per family 
made with MUSCLE 3.6. The minimum evolution algorithm
58
 was used, gaps were treated 
with pairwise deletion, and an amino acid Jones-Taylor-Thorton (JTT) matrix
59
 was chosen 
as the model. A bootstrap test with 1000 replicates was performed to further verify the 
results. 
 
Tertiary structure superposition and RMSD calculations 
In this study, all tertiary structures were superimposed with MultiProt.
60
 All RMSD 
values were calculated between -carbon atoms using MATLAB, to consider the most 
possible -carbon atoms in the calculation; MultiProt reports the RMSD for only aligned 
residues. Values of RMSD (between two structures), RMSDave (between three or more 
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structures), and Pave (the average percentage of α-carbon atoms of the amino acid residues 
used to calculate the RMSD between two compared structures) were calculated, as explained 
in detail in the Supporting Information in Cantu et al. (2010).
17
 When a NMR-resolved 
structure was superimposed, only the lowest-energy frame was used, chosen following 
single-point energy calculations with the ff99SB AMBER force field.
61 
 
Normal Mode Analysis 
Normal modes of individual ACPs were calculated using the ANM web server,
51
 by 
assuming that a molecule’s natural vibrations can be predicted by attaching a spring of 
uniform force constant to each α-carbon atom of the molecule and allowing the system to 
oscillate. The cutoff distance and distance weights were changed until the best correlation 
between theoretical and experimental B-factors was achieved. Structures were submitted 
individually to the ANM server, which computed the vibrational normal modes of each 
molecule and returned an animated PDB file for the 20 slowest vibrational modes, their 
associated eigenvectors, and residue fluctuations. No significant crystal packing effects were 
found when viewing the symmetric molecules of the PDBs submitted. 
To compare the normal modes between two structures, overlap charts showing the 20 
slowest vibrational modes of two structures were made by taking the dot product of the 
eigenvectors from both structures, yielding an 20 x 20 overlap chart where each cell ranges in 
value from 0 (no overlap) to 1 (complete overlap). From this, the highest overlapped mode 
was chosen, and the animated structure PDB files of such mode were separated into 
individual PDB files for each frame. Then the frame from one structure was superimposed 
with the corresponding frame in the other, and RMSD and P values was calculated. This was 
done for each frame, and the averages among all frames were taken, resulting in values of 
RMSDf-ave and Pf-ave. This notation is used here to differentiate the RMSD between two 
structures averaged over different frames in a normal mode (Table 8.3), from RMSDave, 
which refers to the average RMSD of superimposing three or more structures (Table 8.2). 
 
Tertiary Structure Determination 
A homology modeling and MD protocol was used for structure predictions. Homology 
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modeling was done with the I-TASSER server,
62,63
 using other ACP structures as templates 
without alignment or restraints. 
The resulting predicted structures were loaded in AmberTools1.4 using the ff99SB 
AMBER force field. The structures were placed in a 12-Å TIP3P water box,
64
 and Na
+
 ions 
were added to neutralize system charge. 
The system was then simulated with the sander module of AMBER.
65
 Solvent and ions 
were minimized first with 1000 steps while restraining the protein with 500 kcal/Å-mol 
weights. An unrestrained 10,000-step minimization followed. The system was then heated 
from 0 K to 300 K at constant volume for 25 to 100 ps while weakly restraining the protein 
with 10 kcal/Å-mol weights. Finally, the system was equilibrated at constant pressure and 
temperature and run unrestrained for 1.5 to 2 ns. 
Sequences were predicted to not be intrinsically unfolded using the IUPred
66
 server that 
bases its predictions by calculating inter-residue energy interactions. 
Threading predictions were done using the LOMETS
67
 server, which generates tertiary 
structures from sequences using eight different known threading programs. Unlike homology 
modeling, no templates are specified. The ten best threading models from the output were 
taken. 
RMSDs between predicted structures to experimental crystal structures in the validation 
runs (Table 8.4) are labeled as RMSDp-c, to differentiate it from the other RMSDs used here. 
 
Concluding remarks 
Considering that ACPs, except those of ACP2, are all of roughly the same length and in 
nearly all cases they bind and activate acyl chains prior to their being subjected to enzymatic 
catalysis, it is noteworthy that they can be separated into 16 families by their highly 
significant differences in primary structure. It is perhaps equally noteworthy that many of 
these families have very similar tertiary structures, signifying that they may be descended 
from a common distant ancestor. We predicted the normal vibrational modes of freestanding 
ACPs, finding them more conserved within families. Also, we extended knowledge of three 
families possessing freestanding ACPs, one family by predicting its characteristic tertiary 
structure to be like those of many other ACP families, and two families by apparently 
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showing that they do not have similar structures. 
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Tables 
 
Table 8.1: Acyl Carrier Protein Families 
__________________________________________________________________________________________________________________ 
 Approximate     Representative 
 number of Producing   End product  UniProt 
Family sequences
a
 domain Role  (non-exhaustive list) accession code Reference 
 __________________________________________________________________________________________________________________ 
ACP1 2,870 B, E, A
b
 Freestanding ACPs: 
   in type II fatty acid synthesis Fatty acids P0A6A8 19 
   in bacterial long-chain fatty acid synthesis Long-chain fatty acids P0A2W5 20 
   in mitochondria Fatty acids P52505 21 
ACP2 180 E ACP domains of fungal FASs Fatty acids P19097 22 
ACP3 190 E ACP domains of animal FASs Fatty acids P49327 23 
ACP4 50 B Freestanding ACPs in polyketide synthesis Bacillaene Q7PC63 24 
ACP5 100 B Freestanding ACPs in polyketide synthesis Actinorhodin Q02054 25 
    Frenolicin Q54996 26 
    Oxytetracycline P43677 27 
ACP6 100 B ACP domains in PKSs Mycocerosic acid Q02251 28 
    Phthioceranic acids O07798 29 
ACP7 30 E ACP domains in PKSs 6-Methylsalicylic acid P22367 30 
ACP8 240 B, E ACP domains in PKSs Aflatoxin Q12053 31 
    Conidial yellow pigment Q03149 32 
ACP9 80 E ACP domain in PKSs/chalcone synthases Acylpyrones Q55E72 33 
ACP10 7,000 B, E, A ACP/PCP domain in PKSs/NRPSs and ACP Surfactin P27206 34 
   domain in ferrichrome synthases Erythronolide Q03131 35 
    Gramicidin P0C061 36 
    Phthiocerol Q7TXL8 37 
    Tyrocidine O30409 38 
    Plipastatin O31827 39 
    Enniatin Q00869 40 
    Ferrichrome Q9P7T1 41 
    Bacillaene Q05470 42 
ACP11 120 E ACP domains in PKSs Lovastatin Q9Y8A5 43 
ACP12 280 B ACP domains in enterobactin synthases Enterobactin P0ADI4 44 
1
2
5
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   ACP domains in isochorismatases Mycobactins P71717 45 
ACP13 220 B, E ACP domains in enterobactin synthases Enterobactin P11454 46 
ACP15 200 B Freestanding ACPs active with malonate Acetate O06925 47 
   decarboxylases 
ACP16 300 B Freestanding ACPs active with citrate lyases Acetyl-CoA P02903 48 
ACP17 250 B Freestanding D-alanyl carrier proteins  D-Alanyl lipoteichoic acid P55153 49 
__________________________________________________________________________________________________________________ 
a 
Present in the ThYme database at the time of writing this article.
 
b
 A, archaea; B, bacteria; E, eukaryota. Most prevalent producers bolded. 
1
2
6
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Table 8.2. Acyl Carrier Protein Tertiary Structures 
__________________________________________________________________________________________________ 
 RMSDave Pave   Total number of PDB 
Family (Å) (%) Tertiary structures
a
  accessions in family 
__________________________________________________________________________________________________ 
ACP1 2.01 86.4 1HY8, 1KLP, 1L0H, 1X3O, 2DNW, 2EHS, 2FQ0, 2FVE 45 
    2KOO, 2KW2, 2KWL, 2L0Q, 2L3V, 2L4B, 2QNW 
ACP2 — — 2PFF 6b 
ACP3 2.02 94.4 2CG5
c
, 2PNG 4 
ACP5 1.75 84.8 1NQ4, 1OR5, 2AF8 14 
ACP8 — — 2KR5 1 
ACP10 1.74 85.9 1DNY, 2GDW, 2JGP
c
, 2JU2, 2VSQ
c
 9 
ACP12 — — 2FQ1 1 
ACP13 — — 2ROQ 1 
ACP17 — — 1DV5 2b 
 ____________________________________________________________________________________________________________________________________________________ 
a
 For ACP1, ACP3, ACP5, and ACP10 all structures listed were superimposed to yield reported RMSDave and Pave values; for 
others a representative sequence is shown. Only one structure per species within a family was superimposed. 
b
 RMSD not calculated, as all resolved ACP domains in existing tertiary structures come from the same species. 
c
 Only ACP domain of a larger structure. 
1
2
7
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Table 8.3: Normal Mode Analysis Comparisons 
___________________________________________________________________________ 
   Highest overlap 
Structural PDB between two RMSDf-ave Pf-ave 
comparison designations modes (Å) (%) 
___________________________________________________________________________ 
Same structure, two conformers 2EHS, 2EHT 0.47 0.90 99.1 
Same family, two bacterial structures 1T8K, 1X3O 0.42 1.51 80.9 
Same family, bacterial and eukaryotic 1T8K, 2QNW 0.47 1.05 95.7 
ACP1 to ACP5 1T8K, 2AF8 0.65 2.70 61.2 
ACP1 to ACP17 1T8K, 1HQB 0.58 2.08 85.9 
ACP5 to ACP17 2AF8, 1HQB 0.64 2.67 71.1 
___________________________________________________________________________ 
 
 
 
Table 8.4: Tertiary Structure Prediction Validation 
 
Target  Template Amino acid RMSDp-c RMSDp-c 
structure structure identity (%)
a
 (homology) (Å) (MD) (Å) 
ACP1  ACP5 23.4 1.17 1.42 
ACP1 ACP17 20.8 1.44 1.48 
ACP5 ACP1 21.7 1.97 1.87 
ACP5 ACP17 20.5 2.10 1.96 
ACP17 ACP1 20.0 1.73 1.93 
ACP17 ACP5 21.3 1.78 1.88 
a
 Percentage of same residues in same position between template and target structures 
divided by the number of residues in the template
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Figures 
 
Figure 8.1: Multiple sequence alignment of single members of each of the 16 ACP families, 
roughly arranged in order of similarity to each other. ACP1: Borrelia burgdorferi; ACP2: 
Schizosaccharomyces pombe; ACP3: Gallus gallus; ACP4: Bacillus subtilis; ACP5: 
Streptomyces rimosus; ACP6: Mycobacterium tuberculosis; ACP7: Penicillium patulum; 
ACP8: Aspergillus nidulans; ACP9: Dictyostelium discoideum; ACP10: Saccharopolyspora 
erythraea; ACP11: Aspergillus terreus; ACP12: Escherichia coli; ACP13: E. coli; ACP15: 
Klebsiella pneumoniae; ACP16: K. pneumoniae; ACP17: Lactobacillus rhamnosus. 
 
 
 
Figure 8.2: Phylogenetic tree of ACP families. 
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Figure 8.3: Tertiary structures of single members of ACP families. ACP1: Thermus 
thermophilus (PDB accession code 1X3O); ACP2: Saccharomyces cerevisiae (2UV8); 
ACP3: Homo sapiens (2CG5); ACP5: Streptomyces roseofulvus (1OR5); ACP8: Aspergillus 
parasiticus (2KR5); ACP10: Brevibacillus parabrevis (2JGP); ACP12: E. coli (2FQ1); 
ACP13: E. coli (2ROQ); and ACP17: Lactobacillus casei (1HQB). 
 
 
 
Figure 8.4: Predicted tertiary structure of an ACP1 member using ACP5 (green) and ACP17 
(blue) tertiary structures as templates, compared to a known ACP1 (red) tertiary structure; of 
an ACP5 member using ACP1 (yellow) and ACP17 (blue) tertiary structures as templates, 
compared to a known ACP5 (red) tertiary structure; of an ACP17 member using ACP1 
(yellow) and ACP5 (green) tertiary structures as templates, compared to a known ACP17 
(red) tertiary structure. Known structure templates: ACP1: 2EHS; ACP5: 1OR5; ACP17: 
1HQB. 
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Figure 8.5: Tertiary structure of ACP4 (Bacillus subtilis AcpK) predicted by homology 
modeling and MD. Representative models of tertiary structures of ACP15 (Malonomonas 
rubra malonate decarboxylase ACP) and ACP16 (E. coli citrate lyase ACP) predicted by 
threading. 
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Supplementary Information for Chapter 8 
Acyl carrier protein structural classification and normal mode analysis 
 
Figure 8S-A: Color map representation of amino acid identities between randomly chosen 
sequences in two families based on pairwise alignments. Values are shown as a 
percentage; those above the diagonal are based on the shorter sequence compared, while 
those below the diagonal are based on the longer sequence compared. 
 
Figure 8S-B: Detailed phylogenetic tree of the 16 ACP families. 
 
Figure 8S-C: Individual residue fluctuations of the five slowest vibrational normal modes for 
Protein Data Bank (PDB) ACP1 structures 1T8K, 1X3O, 2EHS, 2EHT, 2QNW, ACP5 
structure 2AF8, and ACP17 structure 1HQB. Fluctuation scale normalized to largest residue 
fluctuation within each structure. Residues corresponding with -helices are highlighted. 
 
Figure 8S-D: Overlap charts between the 20 slowest vibrational normal modes of two 
structures, 0 being no overlap and 1 complete overlap. Shown for two conformers (2EHS 
and 2EHT) of a single structure in ACP1, two bacterial structures (1T8K and 1X3O) in 
ACP1, a bacterial (1T8K) and a eukaryotic (2QNW) structure in ACP1, an ACP1 (1T8K) and 
ACP5 (2AF8), an ACP1 (1T8K) and ACP17 (1HQB), and an ACP5 (2AF8) and ACP17 
(1HQB). 
 
Figure 8S-E: Comparative residue fluctuations of the three most overlapped vibrational 
normal modes between compared cases. Fluctuation scale normalized to largest residue 
fluctuation between the two compared structures. See table for corresponding modes in 
each comparison and color key: 
 
 
Figure 8S-F: Tertiary structure models for ACP15 and 16 predicted by threading 
 
Comparison 1st most 
overlapped modes 
2nd most 
overlapped modes 
3rd most overlapped 
modes 
Two conformers 6 (red) and  
6 (red lined) 
2 (green) and 
1 (green lined) 
7 (blue) and 
5 (blue lined) 
Two Bacterial 1 (red) and  
4 (red lined) 
2 (green) and 
3 (green lined) 
2 (green) and 
1 (green dotted) 
Bacterial and 
Eukaryotic 
1 (red) and 
1 (red lined) 
1 (red) and 
3 (red dotted) 
6 (green) and 
5 (green lined) 
ACP1 and ACP5 1 (red) and 
1 (red lined) 
2 (green) and 
4 (green lined) 
2 (green) and 
3 (green dotted) 
ACP1 and 
ACP17 
4 (red) and 
2 (green lined) 
1 (green) and 
1 (green lined) 
2 (blue) and 
3 (blue lined) 
ACP5 and 
ACP17 
1 (red) and 
1 (green lined) 
2 (green) and 
5 (green lined) 
2 (green) and 
9 (green dotted) 
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Figure 8S-A 
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Figure 8S-B 
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Figure 8S-C  
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Figure 8S-D 
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Figure 8S-E 
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Figure 8S-F 
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CHAPTER 9 
CONCLUSIONS 
 
The ThYme database provides a useful source of information on fatty acid and polyketide 
synthesis enzymes. These enzymes have been classified and organized into families based on 
amino acid sequence similarity, which can help to predict active sites, catalytic residues, and 
mechanisms of individual sequences, as well as providing a standardized nomenclature. 
Family membership was confirmed by multiple sequence alignments, structure 
superimpositions, and positions of the catalytic residues. Detailed and timely reviews on 
thioesterases (TEs), ketoacyl reductases, hydroxyacyl dehydratases, enoyl reductases, and 
acyl carrier proteins (ACP), as well as their products and pathways, were also published. 
Normal vibrational mode analysis showed that the dynamic behavior of ACP structures 
was conserved within families. Also, the tertiary structures of the members of three ACP 
families were predicted: those of one family were like those of many other ACPs, while those 
of the other two appear not to be similar. 
A TE family whose members determine fatty acid chain length was statistically divided 
into subfamilies based on primary structure. This guided the choice of sequences for 
experimental characterization, to explore their substrate specificities and enzyme activity 
spaces. From the experimental work that followed, sequences that provide previously 
unknown functional diversities relative to chain length specificity as well as acyl chains that 
contain additional chemical functionalities were revealed. However, subfamily membership 
and substrate specificity were not correlated. 
TEs had not been studied before with first-principles methods. From quantum mechanics/ 
molecular mechanics metadynamics simulations, the mechanism of a TE was confirmed, the 
electronic and atomic details of its transition state were revealed, its associated energy barrier 
was estimated, and new evidence was found suggesting proton-donating catalytic residues 
previously not considered. The proposed mechanism can be extended to all members of this 
TE family, and it further confirms that TEs of the HotDog fold perform catalysis differently 
than other TEs.
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Abstract 
It has been difficult to identify the proton donor and nucleophilic assistant/base of 
endoplasmic reticulum -(12)-mannosidase I, a member of glycoside hydrolase Family 47, 
which cleaves the glycosidic bond between two -(12)-linked mannosyl residues by the in-
verting mechanism, trimming Man9GlcNAc2 to Man8GlcNAc2 isomer B. Part of the 
difficulty is caused by the enzyme’s use of a water molecule to transmit the proton that 
attacks the glycosidic oxygen atom. We earlier used automated docking to conclusively 
determine that Glu435 in the yeast enzyme (Glu599 in the corresponding human enzyme) is 
the nucleophilic assistant. The commonly accepted proton donor has been Glu330 in the 
human enzyme (Glu132 in the yeast enzyme). However, for theoretical reasons this 
conclusion is untenable. Theory, automated docking of -D-3S1-mannopyranosyl-(12)--
D-
4
C1-mannopyranose and water molecules associated with candidate proton donors, and 
estimation of dissociation constants of the latter have shown that the true proton donor is 
Asp463 in the human enzyme (Asp275 in the yeast enzyme). 
 
Introduction 
Endoplasmic reticulum -(12)-mannosidase I (ERManI, EC 3.2.1.113) belongs to gly-
coside hydrolase family 47 (GH47).
1
 It cleaves the glycosidic bond between two -(12)-
linked mannosyl residues by the inverting mechanism
1–3
 and trims Man9GlcNAc2 to 
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Man8GlcNAc2 isomer B.
2,3
 Other GH47 -(12)-mannosidases cleave other mannosyl 
residues to yield other products.
4
  
Members of GH47 have an (,)7-barrel fold (Figure A1) and an active-site calcium 
ion
5–10
 that is necessary for high enzyme activity and thermostability.
11
 Saccharomyces 
cerevisiae and human ERManI enzymes are 35% similar in primary sequence,
2
 but the amino 
acids involved in catalysis are practically the same.
6
 Both enzymes have essentially the same 
crystal structure, and inhibitor binding causes little conformational change.
6,10
 
In the inverting mechanism, an amino acid residue acting as a nucleophilic assistant/base 
helps a water molecule to perform a nucleophilic attack on the anomeric carbon. A second 
amino acid residue aids glycosidic bond cleavage by donating a proton to the glycosidic 
oxygen atom.
12
 However, in ERManI the proton must be relayed by a water molecule, as no 
active-site carboxyl group is close enough to the glycosidic oxygen for direct proton 
donation. In addition, all three potential proton-donating groups coordinate water molecules 
(Figure A2).
6
 This is very unusual.  
The complexed substrate conformation changes during cleavage. Human ERManI binds 
the inhibitors kifunensine and 1-deoxymannojirimycin in its subsite –1 in the unusual 1C4 
conformation.
6
 The glycon of methyl 2-S-(α-D-mannopyranosyl)-2-thio-α-D-
mannopyranoside (S-Man2) is bound in the 
3
S1 conformation, leading to the suggestion that 
its transition state is a 
3
H4 conformer, intermediate between 
1
C4 and 
3
S1 conformers.
10
 An 
automated docking study indicated that the substrate glycon in yeast ERManI must be in the 
1
C4 conformation to enter the active site.
13
 It then passes through 
3
H2, 
O
S2, 
3,O
B, and 
3
S1 
conformations to reach the putative 
3
E transition-state conformer, structurally adjacent to the 
3
H4 conformer.
13
 After hydrolysis, the β-mannose molecule that had been the glycon finds 
itself successively in the 
1
C4, 
1
H2, and B2,5 conformations before being expelled from the 
enzyme active site.
14 
It has been difficult to identify the ERManI catalytic proton donor and nucleophilic assis-
tant/base. A crystal structure of the yeast enzyme with glycerol in the active site led to two 
hypotheses: 1) that Glu132 is the nucleophilic assistant to the water nucleophile, and that 
Asp275 or Glu435, probably the former, is the proton donor; and 2) alternatively and less 
likely, that Glu435 is the nucleophilic assistant, with Glu132 being the proton donor.
5
 A 
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companion study with human ERManI again led to two hypotheses similar to those above: 1) 
that Glu599 (Glu435 in the corresponding yeast enzyme) is the nucleophilic assistant to 
Water5, with Glu330 (Glu132) as the proton donor, transmitting a proton through Water8; 
and 2) that Asp463 (Asp275) is the nucleophilic assistant, with Water17 being the actual 
nucleophile, with Glu330 as the proton donor (Figure A2).
6
 A later study on human ERManI 
adopted the first hypothesis, suggesting that Arg334 (Arg136) contributed to the general acid 
function.
10
 Work on Hypocrea jecorina and mouse GH47 enzymes with more capacious 
active sites yielded the same conclusions about the catalytic residues.
7,9
 An automated 
docking study of yeast ERManI did not challenge Glu132 as the proton donor, acting through 
Water195, and identified Glu435 rather than Asp275 as the nucleophilic assistant to 
Water54.
15 
The nine invariant yeast ERManI acidic residues were mutated before any crystal 
structure was available. E214Q, D275N, E279Q, E435Q, and E503Q were not active, 
whereas D86N, E132Q, E438Q, and E526Q had <2% of the activity of wild-type ERManI.
11
 
A similar study on a GH47 enzyme from Aspergillus saitoi found the activity of E124Q 
(E132Q in yeast ERManI), E124D, D269N (D275N), D269E, E411Q (E435Q), and E411D 
as 0.02%, 0.2%, 0%, 1.9%, 0%, and 0.74% of the wild-type enzyme.
16
 A third mutagenesis 
project conducted on human ERManI gave kcat/KM values of 3.5%, 0.1%, 0.0005%, 0.006%, 
and 0.0003% of the wild-type value for E330Q (E132Q in yeast ERManI), D463N (D275N), 
E599Q (E435Q), E330Q/E599Q, and D463N/E599Q, respectively.
10
 
In summary, identification of the ERManI catalytic proton donor and its associated water 
molecule is uncertain, because all three potential catalytic carboxyl groups coordinate water 
molecules, and because mutating each of these groups in yeast, Aspergillus, and human 
ERManI causes loss of all or nearly all activity. Therefore we have in this article considered 
the theory of GH catalysis and then the relative merits of putative proton donor/water 
systems, and have followed this with extensive use of computation, both by automated 
docking to determine orientations of substrate and water molecules, and by estimating pKa’s 
of these groups. 
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Theory 
Electrostatic transition state stabilization in relation to syn- versus anti-protonation 
Enzyme-catalyzed reactions are mediated by preferential stabilization of the transition 
state,
17
 and electrostatic factors contribute the most to this stabilization.
18–20
 At the glycoside 
substitution transition state, the local charge distribution of the glycon ring oxygen atom 
differs most substantially from that of the ground state or any local minimum conformation. 
In the latter cases, the ring oxygen atom always bears two fully occupied sp
3
 lone pairs, 
whereas that in a glycoside transition state bears a fully occupied sp
2
-hybrid and an electron-
deficient 2pz orbital that overlaps with the anomeric carbon atom’s antibonding orbital from 
the partially leaving or incoming groups. Since the ring oxygen atom is sterically relatively 
accessible, one expects that GHs will strategically position at least one electron-rich 
functional group (e.g. with a correctly oriented free electron pair) to intercept and stabilize 
this transient change in the local charge. A search for such a strategically positioned enzyme 
residue at the syn-A and/or syn-B space quadrants, axially above and/or underneath the ring 
oxygen atom of the glycon complexed in subsite –1 of GHs from different families, has 
indeed confirmed that syn-protonators, with their proton-donating carboxyl residues residing 
in the syn-half-space and close to the glycon’s ring oxygen atom, invariably use the 
conjugate base of the proton donor for electrostatic transition-state stabilization.
21
 On the 
other hand, anti-protonators, their proton donors being in the anti-half-space and thus 
inherently far away from the ring oxygen, contain at least one electrostatic transition-state-
stabilizing residue within the syn-half-space. 
 
The Glu330/Water8 system as the putative proton donor 
An indication that Glu330 in human ERManI (PDB code 1X9D) may not be the proton 
donor, with Water8 as the transferer of its proton to the glycosidic oxygen atom, is that this 
residue is in contact distance (3.05 Å) with Arg334 (Figure A2). The Glu330/Arg334 system 
is expected to be zwitterionic, with Glu330 deprotonated and Arg334 protonated. Another 
counter-indication is that the possible proton-transferring Water8 is not semilaterally 
positioned versus the average ring plane of the S-Man2 glycon occupying subsite –1 of the 
1X9D complex structure, but it is instead near-orthogonally positioned. Indeed, a proton 
  
 
149 
 
donor is expected to reside near-laterally, within the anti- or the syn-half-space (Figure A3), 
to the glycon occupying subsite –1, as observed in many GH families.22,23 Instead, it is the 
observed oxygen atom of Water17, associated with the former putative nucleophilic assistant 
Asp463, that is clearly lateral and anti-positioned, at 3.60 Å from S-Man2’s glycosidic sulfur 
atom, which fits with the following observations. 
 
The occurrence of the exo-anomeric effect in relation to syn- versus anti-protonation 
In the 1X9D complex, the S-Man2 O5'–C1'–S2–C2 dihedral angle is 73°, and therefore 
the thioglycosidic bond displays the exo-anomeric effect.
24
 The same is observed for the O5'–
C1'–O2–C2 dihedral angles in the best-docked Man2 ligands of this study. This effect stab-
ilizes the glycosidic bond by about 4 kcal/mol,
25
 which is mainly attributed to a hyperconjug-
ative overlap of the O5'–C1' antibonding orbital with an antiperiplanar-oriented lone-pair 
orbital lobe of the glycosidic heteroatom. This lobe is semilaterally positioned versus the 
glycon and in 1X9D is directed toward Water17, which resides in the anti-half-space (Figure 
A3). It indicates that GH47 enzymes are anti-protonators, since protonation of the lone pair 
that is involved in the exo-anomeric effect automatically removes this stabilizing effect en 
route to the transition state. Oligosaccharides that span subsites –1 and +1 of anti-protonating 
GHs appear to always show their glycosidic bonds in conformations dictated by the exo-
anomeric effect, with protonation of the lone pair that is involved in it, whereas those 
complexed in syn-protonating enzymes consistently do not show an exo-anomeric effect 
conformation at this subsite junction.
21
 
In the case of anti-protonators, where the proton donor is situated semi-laterally versus 
the sugar’s average ring plane and rather near to the C2 atom of the sugar entity in subsite –1, 
the protonation necessarily has to occur on a lone pair of the glycosidic oxygen that is also 
semi-laterally positioned, and this is automatically so when the glycosidic bond resides in a 
conformation that conforms to the exo-anomeric stabilizing effect. In the case of syn-
protonators, where the proton donor is again situated semi-laterally versus the sugar’s 
average ring plane but is now rather near to the ring oxygen atom, the β- or α-scissile 
glycosidic bond must turn clockwise or counterclockwise, respectively, out of the exo-
anomeric effect conformation, thereby bringing a lone pair of the glycosidic oxygen atom 
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into a semi-lateral position that is within reach of the syn-proton donor. This is a consequence 
of the original syn- versus anti-protonation insight by Heightman and Vasella.
22
 It is also 
derived from the correlation of the non-exo-anomeric effect conformation of the glycosidic 
bond versus syn-protonation that can be repeatedly observed in crystal structures with 
Michaelis complexes spanning subsites –1 and +1 of syn-protonating glycoside hydrolases, 
such as in PDB structures 1QJW, 1OVW, 2QZ3, 1W2U, and 1ITC. On the other hand, the 
exo-anomeric effect is preserved with Michaelis complexes of anti-protonators, such as in 
PDB structures 1VO3, 1JYW, 1IEX, 4A3H, 1KWF, and 1CKX. 
 
The Asp463/Water17 system as the putative proton donor 
The Oδ1 atom of the carboxyl group of Asp463 in human ERManI (1X9D)
10
 is 3.70 Å 
from Water17 and 2.72 Å from the C4–O atom of the D-mannosyl moiety in subsite +1 
(Figure A2). Furthermore, Water17 is in contact distance to the lone pair involved in the exo-
anomeric effect. The Oδ2 atom of Asp463 is 4.24 Å from Water17 and 2.51 Å from the C3–
O atom of this D-mannosyl residue. It is thus possible that Asp463 has a double role: 1) as an 
indirect proton donor, through Water17, to the glycosidic oxygen atom; and 2) as an 
interactor with the D-mannosyl residue occupying subsite +1. 
If Water17 is indeed the transmitter of the proton from Asp463 to the substrate glycosidic 
oxygen atom, then one of its hydrogen atoms should be pointing toward this glycosidic 
oxygen atom while one of its lone pairs should be directed toward Asp463. One purpose of 
this work is to investigate the specific orientation of Water17 by means of automated docking 
experiments. 
 
The role of the Glu330/Arg334/Water8 system 
Within the syn-A space quadrant of the glycon in the S-Man2 complex with human 
ERManI, Oε1 of the nucleophilic assistant Glu599 is 3.54 Å from, and nearly axial to, the 
ring oxygen atom, a situation analogous to many other anti-protonating α-GHs (Figures A2 
and A3).
21
 At syn-B the Water8 oxygen atom is 4.32 Å from and axial to the ring oxygen 
atom. It should be noted that the glycon in the observed complex resides in a 
3
S1 confor-
mation, whereas in passing to a 
3
H4- or 
3
E-type transition state this ring oxygen atom will 
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move even closer to Water8. For Water8 to be an electrostatic transition-state stabilizer rather 
than the transmitter of a donated proton, one of its free electron pairs should be directed 
toward the ring oxygen atom, so that it can intercept and stabilize the transient electron-
deficient 2pz orbital. This may very well be so, since the nearest neighbors of the Water8 
oxygen atom are 1) the ligand’s glycosidic sulfur atom at 3.23 Å; 2) Oε2 of the likely 
deprotonated Glu330 at 2.63 Å, each to where the hydrogen atoms of Water8 may very well 
be pointing; as well as 3) Nω2 of the likely protonated Arg334 at 2.73 Å, to where the other 
lone pair of Water8 may be directed. This suggests that the role of the conserved 
Glu330/Arg334 system is to specifically orient Water8 for electrostatic transition-state 
stabilization of the glycon's ring oxygen atom. If this rationale is correct, then it should be 
possible to reproduce this specific orientation of the hydrogen atoms of Water8 by automated 
docking, which is the other purpose of this work. 
 
Computational methods 
Plan of work 
This project uses automated docking, which we have used previously with yeast 
ERManI
13–15
 and with several other GHs and lectins, to more surely identify the catalytic 
proton donor in ERManI. Here we docked substrates and water molecules into the human 
ERManI crystal structure to determine whether Glu330 paired with Arg334 is mediating 
proton donation through Water8, or whether it is Asp463 mediating proton donation through 
Water17. We have supplemented this work with computation to determine the probable 
protonation states of the putative catalytic residues. 
 
Automated docking 
We docked ligands using AutoDock 3.0
26
 into the human ERManI crystal structure 
1X9D.
10
 The normal ligands used were -D-mannopyranosyl-(12)--D-mannopyranose 
(Man2), with its glycon and aglycon having 
3
S1 and 
4
C1 conformations, respectively, and a 
water molecule. Ligands were given the desired three-dimensional conformation and 
hydrogen atoms were added using PCModel (Serena Software, Bloomington, IN, 
http://www.serenasoft.com). Man2 was pair-fitted with S-Man2 in the enzyme active site with 
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PyMOL (DeLano Scientific, Palo Alto, CA, http://pymol.sourceforge.net) so that both had 
the same coordinates. Then charges were assigned to the ligands using GAMESS.
27
 AutoTors 
in the AutoDock suite was used to define the ligand torsions. The designations of nonpolar 
hydrogen atoms, those bonded to carbon atoms, were changed so that the program could 
differentiate them from the polar hydrogen atoms bonded to oxygen atoms.  
Hydrogen atoms were added to the enzyme using the WHAT IF
28
 webpage. Charges of each 
atom were added, as well as solvation parameters. Nonpolar hydrogen atoms were specified. 
Grid maps with 0.375 Å spacing were created using AutoGrid in the AutoDock package. 
To calculate the electron-affinity map, AutoGrid assumes that full and fractional charges on 
atoms are located at their centers. However, this is not so with heteroatoms containing a free 
electron pair. Oxygen atoms have two local negative charges, both somewhere near the 
centers of the lone pairs. It is remarkable that AutoDock/AutoGrid and other empirical mod-
eling programs yield reliable dockings, even with such a serious deviation from the real 
situation. 
AutoDock was used to find ligand docking positions in the enzyme active site and to cal-
culate the total binding energy (ETotal), while holding the enzyme but not the ligands rigid. 
This was a two-step process, a global search using the Lamarkian genetic algorithim option 
followed by a Solis and Wets local search.
26
 Our global searches were stopped after 1000 
runs, yielding 1000 possible ligand locations in the enzyme. These were gathered into 
clusters so that all members of each cluster were within a root mean squared deviation 
(RMSD) of 1 Å of all other members. After the global search, the best-fitted member of each 
of six clusters with significant numbers of members was chosen based on its conformation 
and location in the enzyme active site, and on its ETotal value. Then, to enhance dockings, 
local minimizations were done on each of the six ligands found by the global search.
13
 The 
optimally-docked ligand was chosen from the six locally-minimized ones based on the 
criteria stated above, and final values of the intermolecular energy, EInter, between ligand and 
enzyme were determined. This rigorous docking procedure characteristically yields much 
more negative EInter values than those normally attained with AutoDock. 
To confirm that AutoDock places molecules in the correct location in the active site of 
ERManI, we docked S-Man2 and measured the RMSD between docked and crystal-structure 
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ligands as 0.23 Å. Also, we docked a Water8 molecule and a Water17 molecule in ERManI 
with S-Man2 bound in the active site, yielding distances between the oxygen atoms of the 
docked and crystal water structures of 0.44 Å and 0.53 Å, respectively. 
Following this, each regular docking set had the same protocol: S-Man2 in the human 
ERManI structure was removed and Man2 was docked, followed by a water molecule, either 
Water8, adjacent to Glu330 and Arg334, or Water17, adjacent to Asp463, into the enzyme 
active site. This was followed by redocking Man2 and then the water molecule. 
In the first docking set, Man2 and Water8 were docked in ERManI while varying the 
protonation states of Glu330, a putative proton donor, and Arg334, adjacent to it. The 
enzyme’s putative nucleophilic assistant, Glu599, was deprotonated in all dockings, as was 
Asp463, the other putative proton donor. All the water molecules in the enzyme were re-
moved except for Water5, which is coordinated by Glu599 and is maintained in its crystal-
structure position. There are fifteen possible ways in which Glu330 and Arg334 can be 
protonated or deprotonated: four in which both are deprotonated (Glu
–
/Arg
0a
, Glu
–
/Arg
0b
, 
Glu
–
/Arg
0c
, and Glu
–
/Arg
0d
), where a proton has been abstracted from each of four positions 
of the two Arg334 amino groups, one in which Glu330 is deprotonated and Arg334 is 
protonated (Glu
–
/Arg
+
), eight in which Glu330 is protonated and Arg334 is deprotonated 
(Glu
0e
/Arg
0a
, Glu
0e
/Arg
0b
, Glu
0e
/Arg
0c
, Glu
0e
/Arg
0d
, Glu
0f
/Arg
0a
, Glu
0f
/Arg
0b
, Glu
0f
/Arg
0c
, and 
Glu
0f
/Arg
0d
), and two in which both are protonated (Glu
0e
/Arg
+
 and Glu
0f
/Arg
+
), where a 
proton is found on each of two Glu330 oxygen atoms.  
In the second docking set, Man2 and Water17 were docked in ERManI with varying 
protonation states of Asp463, the other putative proton donor. Glu330 and Glu599 were 
deprotonated and Arg334 was protonated. Water5 and Water8 were located in their crystal-
structure positions. There are three possible ways in which Asp463 can be deprotonated or 
protonated (Asp
–
, Asp
0a
, and Asp
0b
), and all three were investigated. 
 
Computational determination of pKa values of potential catalytic residues 
The web-accessible program H++ automatically computes pKa values of dissociable 
groups in macromolecules.
29,30
 It was used here to estimate the pKa’s of Glu330, Arg334, 
Asp463, and Glu599 in the unliganded human ERManI crystal structures 1FMI
6
 and 1X9D
10
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and in the latter crystal structure when it was complexed with S-Man2. H++ requires a 
contiguous amino acid sequence; however, 1X9D lacks the coordinates of Pro676, which is 
near the surface on the opposite side of the enzyme from the active site. These coordinates in 
1X9D were restored by taking those from an automatic overlap with 1FMI using the Swiss–
PDB viewer.
31
 Conversely, 1FMI lacks the coordinates of Trp389 and Thr390, located on the 
enzyme surface 15 Å from its active site. The unbroken sequence of the structure was 
restored by using the residues’ coordinates from an automatic overlap with 1X9D. 
The H++ program can process only one ligand within a macromolecule, so all water mol-
ecules were removed (solvation effects are implicitly accounted for by the program’s meth-
odology), as were SO4
2–
, Ca
2+
, and 1,4-butandiol (when it was present). Removal of Ca
2+
, 
even though it is essential for ERManI recognition of the glycon through the latter’s C2'–OH 
and C3'–OH groups, should not drastically influence the pKa values of the residues (the 
putative proton donors Glu330 and Asp463, Arg334, and the putative nucleophilic assistant 
Glu599), since Ca
2+
 is sufficiently far away from them. The ligand atom names were 
indicated as LIGAND to be recognized as such by H++. Default physical conditions were 
used: a salinity of 0.15, internal and external dielectric constants of 6 and 80, respectively, 
and a pH of 6.5. 
 
Results and discussion 
Docking of Man2 and Water8 with different Glu330 and Arg334 protonation states 
The first docking set (Tables A1 and A2) was designed to study the effect of the different 
protonation states of Glu330 and Arg334 while docking Man2 and Water8, the latter located 
between these two amino acid residues and Man2. Many of these protonation states, as when 
Glu330 is unprotonated, requiring Arg334 to be the proton donor, are unlikely in practice but 
serve as controls to validate ligand dockings that could indicate successful proton donation to 
the glycosidic oxygen atom. Exploring all possible protonation states also tests the ability of 
AutoDock to differentiate between viable and non-viable ones. 
A number of criteria can be employed to choose successful protonation states. Among 
them are 1) significantly negative sums of EInter for Man2 and Water8 docking; 2) low 
RMSDs of docked Man2 to crystal-structure Man2; 3) low distances between the docked 
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oxygen atom in Water8 and the crystal-structure Water8 oxygen atom (no protons appear in 
crystal-structure Water8); 4) intermediate distances between the nearer proton in docked 
Water8 and the docked glycosidic oxygen atom (O2 of Man2), between the proton in Glu330 
and the docked Water8 oxygen atom, between the oxygen atom of docked Water8 and the 
ring oxygen atom of the glycon (O5' of docked Man2), and between a proton in Arg334 and 
the docked Water8 oxygen atom; and 5) correct docked Water8 orientation. Proton donation 
by the Glu330/Arg334/Water8 system is suggested if one of Water8’s protons is aimed at the 
docked Man2 glycosidic oxygen atom and its oxygen atom is facing Glu330 and Arg334. 
Ability to electrostatically stabilize the transient and electron-deficient 2pz orbital of the O5' 
atom at the transition state is suggested if a lone pair of the oxygen atom in Water8 is aimed 
at it. 
Sums of EInter values for Man2 and Water8 docking range from –174.3 to –227.9 kcal/mol 
(Table A1). Sums less negative than ~190 kcal/mol are unlikely to indicate successful proton 
donation. These are generated by the protonation states Glu
–
/Arg
0b
, Glu
–
/Arg
+
, Glu
0e
/Arg
0c
, 
Glu
0f
/Arg
0a
, Glu
0f
/Arg
0b
, and Glu
0f
/Arg
0c
. 
RMSD values of docked Man2 to crystal-structure S-Man2 range from 0.80 to 1.29 Å 
(Table A1). Relatively large RMSD values (greater than ~1.1 Å) when ERManI is in the Glu
–
/Arg
0a
, Glu
–
/Arg
0c
, Glu
0f
/Arg
0a
, and Glu
0f
/Arg
+
 protonation states lessen their likelihood of 
proton donation compared to those with lower RMSD values. 
Docking of Water8 yields two different ranges of distances (0.27–0.54 Å and 1.32–2.55 
Å) between their docked and crystal-structure oxygen atoms (Table A1). Protonation states, 
such as Glu
–
/Arg
0a
, Glu
–
/Arg
0b
, Glu
0e
/Arg
0a
, Glu
0e
/Arg
0b
, Glu
0e
/Arg
0d
 Glu
0f
/Arg
0b
, and 
Glu
0f
/Arg
+
,  having distances in the second range are unlikely to successfully donate a proton 
through Water8 to the glycosidic oxygen atom. 
The distances 1) between the nearer proton of docked Water8 and the O2 atom of docked 
Man2 range between 1.68 and 4.03 Å; 2) those between the docked Water8 oxygen atom and 
the proton associated with the Oε2 atom in crystal-structure Glu330 are from 1.73 and 4.78 
Å; 3) those between the oxygen atom of docked Water8 and the O5' atom in docked Man2 
range from 3.90 to 5.21 Å; and 4) those between the docked Water8 oxygen atom and the 
nearer proton associated with the Nω2 atom in crystal-structure Arg334 range from 1.65 and 
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4.61 Å (Table A1). Values of >4 Å in the first two cases indicate a lesser probability of 
successful proton donation from Glu330 to Water8 to the glycosidic oxygen atom, while 
values of >5 Å in the third case suggest that a lone pair of Water8 would be unlikely to 
electrostatically stabilize the glycon ring oxygen during the transition state, and values of >4 
Å in the fourth case suggest a lessened ability of Arg334 to stabilize and orient Water8 or to 
donate a proton through it to the glycosidic oxygen atom. These criteria suggest that the 
protonation states Glu
–
/Arg
0a
, Glu
0e
/Arg
0a
, Glu
0e
/Arg
0b
, Glu
0f
/Arg
0a
, Glu
0f
/Arg
0b
, and 
Glu
0f
/Arg
+
 are less likely candidates for successful proton donation. 
Also measured were the distances between the oxygen atom of crystal-structure Water5, 
the putative nucleophile, and the C1' atom of docked Man2, which it attacks, for the different 
protonation states. In all cases these values are in an acceptable range between 2.89 and 3.38 
Å. 
The ligand dihedral angle (O5'–C1'–O2–C2) should be about 70°, indicating the presence 
of the exo-anomeric effect. Furthermore, the orientation of Water8 is extremely important for 
proton donation. Its oxygen atom should face Glu330 and Arg334, one of its lone pairs needs 
to face the ring oxygen atom of Man2, and one of its protons should face the glycosidic 
oxygen atom. Only two protonation states, Glu
–
/Arg
0d
 and Glu
–
/Arg
+
, satisfy these criteria 
(Table A2). 
Use of the criteria listed above suggests that only one of these fifteen protonation states, 
Glu
–
/Arg
0d
, is a good proton donor candidate. However, in that state Glu330 has no proton to 
donate and Arg334 is not positively charged, leaving no readily available proton for 
donation. 
Chemical reasoning suggests that the Glu330/Arg334 system can donate a proton only 
from double-protonated systems such as Glu
0e
Arg
+
 and Glu
0f
Arg
+
, with the proton being 
donated by a protonated Glu330. However, its protonation is not predicted by H++, as will be 
noted below. With Glu
0e
Arg
+
, Water8 is oriented correctly for proton transfer, but it is 
misoriented for transition-state stabilization. Glu
0f
Arg
+
 fails many criteria necessary for 
successful proton donation.  
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Docking of Man2 and Water17 with different Asp463 protonation states 
Man2 and Water17 were docked in the second set, with Asp463 in different protonation 
states (Tables A2 and A3). Five criteria are important here: 1) the sums of EInter values for 
Man2 and Water17 docking should be more negative than ~190 kcal/mol, as before; 2) 
RMSD values between crystal-structure and docked Man2 should be less than ~1.1 Å, as 
before; 3) distances between oxygen atoms of crystal-structure and docked Water17 should 
be less than ~1.1 Å ; 4) distances between a proton in docked Water17 and the O2 atom of 
docked Man2 should be <4 Å, between a proton in Asp463 and the oxygen atom of docked 
Water17 should be <4 Å, and between the oxygen atom of crystal-structure Water8 and the 
O5' atom of docked Man2 should be should be < 5 Å; and 5) docked Water17 should be 
oriented so that a proton is aimed at the O2 atom of docked Man2 and a lone pair is facing 
Asp463. 
Sums of EInter values in Asp
–
, Asp
0a
, and Asp
0b
 are –186.7, –193.9, and –193.4 kcal/mol, 
respectively (Table A3), less negative than in many cases when the protonation states of 
Glu330 and Asp334 are varied. The least negative energy sum occurs with Asp
–
, the only 
state of the three in which proton donation is not possible. 
In all three cases, the RMSDs of docked Man2 relative to crystal-structure S-Man2 are 
under 1.0 Å (Table A3). The distances between the oxygen atoms of crystal-structure and 
docked Water17 are ≤1.1 Å. Distances between the nearer proton in docked Water17 and the 
O2 atom of docked Man2 are ~3 Å, while those between the nearer proton in Asp463, when 
present, and the Water17 oxygen atom are ≤3 Å, allowing proton donation from Asp463 
through Water17 to the Man2 glycosidic bond. Furthermore, distances between Water8’s 
oxygen atom and the O5' atom range between 4.41 and 4.83 Å, suggesting that Water8 can 
electrostatically stabilize Man2 during the transition state. Distances between the oxygen 
atom of crystal-structure Water5 and the C1' atom of docked Man2 are between 3.06 and 3.30 
Å in all four cases, an acceptable range. 
The orientation in which Water17 docks indicates its probability of proton donation. With 
Asp
–
 and Asp
0b
, proton donation cannot occur because Water17 is not correctly oriented so 
that one of its hydrogen atoms is pointing toward the glycosidic oxygen atom while one of its 
lone pairs is directed toward Asp463 (Table A2). However, Water17 docks in the correct 
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position and with the right orientation to donate a proton from Asp
0a
. 
These docking results suggest that the only protonation state of Asp463 eligible to donate 
a proton to the glycosidic oxygen atom of Man2 is Asp
0a
. Since the Glu330/Arg334 system 
has no protonation states that appear likely to be proton donors, Asp463 appears by docking 
analysis to be the actual proton donor in ERManI. 
 
Determination of pKa values with H++ 
Finally, we used H++ to predict the pKa values and protonation states of the potential catal-
ytic residues in human ERManI (Table A4). Glu330 and Arg334 have predicted pKa’s of near 
zero and much above 14, respectively, so at physiological pH’s the former is deprotonated 
and the latter is protonated, to the extent that its protons are so strongly bound that they 
cannot be donated. The putative proton donor Asp463, with a predicted pKa in the basic 
range, appears to be mainly or completely protonated, while the putative nucleophilic 
assistant Glu599, with a predicted pKa greatly below zero, indeed appears to be completely 
deprotonated. 
H++ uses single-structure continuum solvent methodology, giving an average pKa error 
of about one unit, with potentially larger errors at both very negative and very positive pKa 
values.
29
 However, it should give reasonable estimates of whether a dissociable group is 
protonated or not at these extremes. It is clear that movement of amino acid side-chains 
during substrate binding and catalysis can change their pKa values. However, Glu330, 
Asp334, Asp463, and Glu599 are all part of α-helices (Figure A2) and therefore have low 
potential for movement. Furthermore, Arg334 is located one turn on an α-helix from Glu330 
and will always face in the same direction as the latter despite any movement. These results 
further confirm, as predicted by theoretical considerations and confirmed by docking 
analysis, that Asp463 acts as the proton donor in human ERManI. 
 
Non-suitability of Glu330 as the nucleophilic assistant/base 
With Glu330 eliminated as the putative proton donor, the question arises as whether it 
could be the nucleophilic assistant instead of Glu599. Glu330 is on the opposite side of the 
ligand from Water5, the natural nucleophile, preventing contact between them. An alternative 
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possibility is for Water8 to be the nucleophile with Glu330 as the nucleophilic assistant. This 
would require that GH47 members hydrolyze substrates through an internal SNi substitution, 
with the leaving group departing and the nucleophile replacing it from the same side. 
Although such a mechanism is known,
32,33
 the leaving group would need to be much better 
than the mannosyl residue here. Furthermore, a classical base–assistant system rather than the 
Glu330–Arg334 zwitterionic system would need to compensate for a highly oxocarbenium-
type SNi transition state. 
 
Conclusions 
We have conducted this project to clearly identify the proton donor in ERManI, and by 
extension in all GH47 α-1,2-mannosidases. This question has remained open because no 
carboxyl group is close enough to the C1’ atom of the glycon for direct proton transfer, and 
because all three carboxyl groups near the substrate’s glycosidic bond coordinate water 
molecules. In summary, our theoretical, docking, and pKa prediction studies show that 
Asp463 is the proton donor in human ERManI. Theoretical considerations based on the 
ERManI crystal structure
10
 indicate that GH47 enzymes are anti-protonators, and that 
Asp463 is the only potential proton donor located in the anti-quadrant of the ERManI active 
site. Only protonated Asp463 allows a water molecule to be positioned to donate a proton to 
the Man2 glycosidic oxygen atom and to allow another water molecule to electrostatically 
stabilize the ring oxygen atom of Man2. Glu330 paired with Arg334 is not the proton donor 
because Glu330 is deprotonated, due to its proximity to Arg334. Arg334 cannot be the proton 
donor because even when positively charged, it binds protons too tightly for them to be 
released. 
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Tables 
 
Table A1: Energies and distances from docking Man2 and Water8 into the human ERManI active site 
__________________________________________________________________________________________________________________ 
 Charge status Man2 docking Water8 docking Distance, Å 
______________ ______________________ _______________________ ____________________________________________ 
 H(Water8)– H(Glu330)– O(Water8)–
 H(Arg334)
h– 
 Glu330 Arg334 EInter, kcal/mol RMSD, Å EInter, kcal/mol Distance, Å O2(Man2) O(Water8) O5'(Man2) O(Water8) 
__________________________________________________________________________________________________________________ 
 – 0a –151.2 1.18 –49.6 1.73 3.60 — 5.21 4.07 
 – 0b –151.3 0.99 –37.6 1.73 1.98 — 4.19 3.57 
 – 0c –161.7 1.29 –34.3 0.51 3.36 — 4.20 1.87 
 – 0d –162.0 0.80 –33.1 0.40 3.31 — 4.57 2.18 
 – + –141.6g 0.87 –33.4 0.38 3.47 —  4.44 1.65 
 0
e
 0
a
 –182.6 0.94 –32.9 1.81 1.91 2.33 4.33 4.61 
 0
e
 0
b
 –186.4 0.94 –41.5 2.55 2.07 2.81 4.60 4.37 
 0
e
 0
c
 –149.0 1.09 –32.6 0.38 2.45 1.73 4.23 2.19 
 0
e
 0
d
 –152.4 1.06 –39.2 1.32 1.68 1.99 3.99 3.16 
 0
e
 + –169.3 1.10 –31.9 0.41 2.45 1.82 4.76 1.81 
 0
f
 0
a
 –148.2 1.24 –30.6 0.54 4.03 2.85 4.14 2.69 
 0
f
 0
b
 –150.6 1.08 –36.2 1.68 1.82 4.21 4.10 3.52 
 0
f
 0
c
 –140.6 0.99 –33.7 0.27 3.23 3.04 4.28 2.09 
 0
f
 0
d
 –162.6 0.87 –35.1 0.37 3.51 3.09 4.65 2.17 
 0
f
 + –167.8 1.25 –35.0 2.13 1.74 4.78 3.90 4.03 
__________________________________________________________________________________________________________________ 
a
 Proton missing in more distant position of Arg334 N2 atom 
b
 Proton missing in nearer position of Arg334 N2 atom 
c
 Proton missing in nearer position of Arg334 N1 atom 
d
 Proton missing in more distant position of Arg334 N1 atom 
e
 Proton associated with Glu330 O2 atom missing 
f
 Proton associated with Glu330 O1 atom missing 
g
 Bolded numerals signify values that lessen possibility of proton donation 
h
 Distance is that to the nearer available proton bound to Arg334 N2 atom 
1
6
1
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Table A2: Orientations from docking Man2 and either Water8 or Water17 into the human ERManI active site 
_________________________________________________________________________________________________________ 
Protonation , , 
state degrees
a
 degrees
b
 Comments 
_________________________________________________________________________________________________________ 
Glu
–
/Arg
0a
 122.9
c
 –169.7 Water8 proton aimed at Man2 O5' 
Glu
–
/Arg
0b
 115.9 –145.5 Water8 proton aimed at Man2 O5' 
Glu
–
/Arg
0c
 124.2 –168.7 Water8 lone pair mainly oriented to Man2 O5'; may improve with 
3
H4 transition-state conformation 
Glu
–
/Arg
0d
 81.8 –146.1 Water8 lone pair mainly oriented to Man2 O5'; may improve with 
3
H4 transition-state conformation 
Glu
–
/Arg
+
 72.8 –150.8 Water8 lone pair mainly oriented to Man2 O5'; may improve with 
3
H4 transition-state conformation 
Glu
0e
/Arg
0a
 117.8 –158.5 Water8 proton aimed at Man2 O2, but misaligned lone pairs of Water8 and Man2 O2
d 
Glu
0e
/Arg
0b
 107.6 –150.4 Misoriented Water8 
Glu
0e
/Arg
0c
 108.3 –164.5 Water8 lone pair mainly oriented to Man2 O5'; may improve with 
3
H4 transition-state conformation 
Glu
0e
/Arg
0d
 122.7 –166.8 Water8 lone pair mainly oriented to Man2 O5'; may improve with 
3
H4 transition-state conformation 
Glu
0e
/Arg
+
 66.9 –152.1 Water8 misoriented for transition-state stabilization; oriented correctly for protonation by Glu330 
   or Arg334 
Glu
0f
/Arg
0a
 121.2 –162.7 Misoriented Water8 
Glu
0f
/Arg
0b
 118.5 –169.5 Misoriented Water8 
Glu
0f
/Arg
0c
 110.2 –165.7 Misoriented Water8 
Glu
0f
/Arg
0d
 72.8 –142.1 Misoriented Water8 
Glu
0f
/Arg
+
 121.4 –164.5 Misoriented Water8 
Asp
–
 72.7 –149.9 Water17 lone pair not oriented to Asp463  
Asp
0a
 79.8 –152.4 Favorable orientation for Asp463 proton transfer to Water17 
Asp
0b
 79.5 –154.3 Misoriented Water17 
____________________________________________________________________________________________________________ 
a
  = O5'–C1'–O2–C2 
b
  = C1'–O2–C2–C1 
c
 Bold in  and  columns signifies that ligand is not in exo-anomeric state, but instead is in a near-eclipsed conformation 
d
 Bold in Comments column signifies traits that lessen possibility of proton donation 
1
6
2
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Table A3: Results from docking Man2 and Water17 into the ERManI active site 
________________________________________________________________________________________________ 
Charge status Man2 docking Water17 docking Distance, Å 
___________ ______________________   _______________________ __________________________________ 
 H(Water17)– H(Asp463)– O(Water8)– 
 Asp463  EInter, kcal/mol RMSD, Å EInter, kcal/mol Distance, Å O2(Man2) O(Water17) O5'(Man2) 
________________________________________________________________________________________________ 
 — –155.2 0.89 –31.5 1.10 3.03 — 4.50 
 0
a
 –161.4 0.91 –32.5 0.84 3.09 2.16 4.41 
 0
b
 –164.0 0.94 –29.4 0.67 3.11 3.02 4.83 
________________________________________________________________________________________________ 
a
 Proton associated with Asp463 2 atom missing 
b
 Proton associated with Asp463 1 atom missing 
 
 
 
 
 
Table A4: Dissociation constants of active-site residues in human ERManI 
_____________________________________________________________ 
 Crystal structure 
 ___________________________________________________ 
Residue 1FMI 1X9D 1X9D–Man2 
_____________________________________________________________ 
Glu330 –1.9 0.6 1.7 
Arg334 26.9 25.8 23.4 
Asp463 8.5 9.3 13.1 
Glu599 –9.0 –8.5 –15.0 
1
6
3
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Figures 
 
Figure A1: Human ERManI crystal-structure 1X9D showing complexed S-Man2. 
 
Figure A2: Crystal structure of human ERManI active site. Pink: Glu599 nucleophile; blue: 
possible proton donors, either Asp463 or instead Glu330 paired with Arg334; yellow: S-
Man2; red: oxygen atoms; green: calcium ion. Water5 is between Glu599 and S-Man2, 
Water8 is between Glu330 and S-Man2, and Water17 is between Asp463 and S-Man2. 
 
  
 
165 
 
 
Figure A3: Six-panel illustration of the proposed substitution mechanism conducted by 
GH47 enzymes.These are idealized two-dimensional projections based on the actual three-
dimensional arrangement within the human ERManI 1X9D crystal structure, and they are 
shown in relation to the anti-A, anti-B, syn-A and syn-B space quadrants. The ring oxygen’s 
lone pair involved in the substitution process is indicated in black. When Asp463 is 
deprotonated, Oδ1 and Oδ2 of the carboxylate residue are equivalent because of resonance, as 
are Oε1 and Oε2 of Glu330 and Glu559 when the latter are deprotonated; Nω1 and Nω2 of 
Arg334's guanidino cation are also equivalent. 
Panel 1: Enzyme-occupied situation before the catalytic event. The D-mannosyl glycon 
resides in an ALPH-compliant 
3
S1-like conformation, with the C1'–O2 glycosidic bond axial 
and in an antiperiplanar position versus the axial lone pair (in black) of the ring oxygen atom. 
A lone pair of the glycosidic oxygen atom is antiperiplanar to the C1'–O5' bond, giving rise 
to the exo-anomeric effect. The proton on Oδ1 of Asp463 is transferred to the nearby 
Water17. 
Panel 2: The lone pair of O2 that is involved in the exo-anomeric effect acquires a proton 
from the protonated Water17, which removes this stabilizing effect. The proton donor 
Asp463 as well as the proton-shuttling Water17 reside in the anti-half-space. This enzyme is 
therefore an anti-protonator. 
Panel 3: The ultimate substitution starts. Helped by Glu599 as nucleophilic assistant, Water5 
axially attacks the glycosidic bond. 
Panel 4: The transition state with the D-mannosyl glycon in a 
3
H4 (or the adjacent 
3
E) 
conformation. The transient 2pz orbital (in black) of the ring oxygen atom, overlapping with 
the breaking and forming bonds, is electron-deficient and is locally accessible by the enzyme. 
It is electrostatically stabilized from syn-A by Oε1 of Glu599, and from syn-B by a lone pair 
from Water8. This water molecule is oriented in the shown position by hydrogen bonding to 
the remaining lone pair of the glycosidic oxygen atom and to Oε2 of Glu330, and by a 
hydrogen bond from Nω2 of Arg334 to its other lone pair. 
Panel 5: End of the anomeric substitution. The D-mannose product’s end conformation is the 
1
C4 inverted chair. The hydroxyl group of the newly formed hemiacetal is still protonated, 
and the nearby Oε1 of Glu599 finally acquires this proton. 
Panel 6: End situation of the catalytic event. The products subsequently leave the enzyme, 
and the liberated D-mannose molecule will flip into the ground-state 
4
C1 chair in an indep-
endent conformational process. Finally, a proton exchange between Glu599 and Asp463 will 
reset the enzyme for a next catalytic cycle. 
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